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Abstract
Breast cancer, which is the most common cancer in women, is a complex disease
characterised by multiple molecular alterations. Current routine clinical management re-
lies on availability of robust clinical and pathologic prognostic and predictive factors, like
the Nottingham Prognostic Index, to support decision making. Recent advances in high-
throughput molecular technologies supported the evidence of a biologic heterogeneity of
breast cancer.
This thesis is a multi-disciplinary work involving both computer scientists and molec-
ular pathologists. It focuses on the development of advanced computational models for
the classification of breast cancer into sub-types of the disease based on protein expression
levels of selected markers. In a previous study conducted at the University of Nottingham,
it has been suggested that immunohistochemical analysis may be used to identify distinct
biological classes of breast cancer.
The objectives of this work were related both to the clinical and technical aspects.
From a clinical point of view, the aim was to encourage a multiple techniques approach
when dealing with classification and clustering. From a technical point of view, one of
the goals was to verify the stability of groups obtained from different unsupervised clus-
tering algorithms, applied to the same data, and to compare and combine the different
solutions with the ones available from the previous study. These aims and objectives
were considered in the attempt to fill a number of gaps in the body of knowledge. Sev-
eral research questions were raised, including how to combine the results obtained by a
multi-techniques approach for clustering and whether the medical decision making pro-
cess could be moved in the direction of personalised healthcare.
An original framework to identify core representative classes in a dataset was devel-
oped and is described in this thesis. Using different clustering algorithms and several
validity indices to explore the best number of groups to split the data, a set of classes
may be defined by considering those points that remain stable across different clustering
techniques. This set of representative classes may be then characterised resorting to usual
statistical techniques and validated using supervised learning. Each step of this frame-
work has been studied separately, resulting in different chapters of this thesis. The whole
iii
iv
approach has been successfully applied to a novel set of histone markers for breast cancer
provided by the School of Pharmacy at the University of Nottingham. Although further
tests are needed to validate and improve the proposed framework, these results make it a
good candidate for being transferred to the real world of medical decision making.
Other contributions to knowledge may be extracted from this work. Firstly, six breast
cancer subtypes have been identified, using consensus clustering, and characterised in
terms of clinical outcome. Two of these classes were new in the literature. The second
contribution is related to supervised learning. A novel method, based on the naive Ba-
yes classifier, was developed to cope with the non-normality of covariates in many real
world problems. This algorithm was validated over known data sets and compared with
traditional approaches, obtaining better results in two examples.
All these contributions, and especially the novel framework may also have a clinical
impact, as the overall medical care is gradually moving in the direction of a personalised
one. By training a small number of doctors it may be possible for them to use the frame-
work directly and find different sub-types of the disease they are investigating.
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Chapter 1
Introduction
Worldwide, cancer has become a major issue for human health. The classification of
cancer patients is of great importance for its prognosis. In the last few years, many unsu-
pervised and supervised algorithms have been proposed for this task and modern machine
learning techniques are progressively being used by biologists to obtain proper tumour
information from databases. This thesis investigates different classification algorithms
for breast cancer data and proposes a step-by-step guideline to identify core classes in
data sets in an attempt to produce an automated model for breast cancer classification
which may be useful for future patients presenting at any hospital. This chapter provides
the background and motivation for this research and introduces its aims and objectives.
Later, an outline of the thesis organisation is reported.
1.1 Background and Motivation
TheWorld Health Organization’s Global Burden of Disease statistics identified cancer
as the second largest global cause of death, after cardiovascular disease [23]. Cancer is
the fastest growing segment of the disease burden; global cancer deaths are projected to
increase from 7.1 million in 2002 to 11.5 million in 2030 [133]. Among them, breast
cancer is the second most common type of cancer after lung cancer (10.4% of all cancer
incidence, both sexes counted) [82] and the fifth most common cause of cancer death [81].
1
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Breast cancer is a common disease which affects mostly (but not only) women. The
ability to accurately identify the malignancy is crucial for prognosis and preparation of
effective treatment. Breast cancer is usually, but not always, primarily classified by its
histological appearance [181]. The first symptom, or subjective sign, of breast cancer
is typically a lump that feels different from the surrounding breast tissue. According
to The Merck Manual, more than 80% of breast cancer cases are discovered when the
woman feels a lump [117]. Lumps found in lymph nodes located in the armpits can also
indicate breast cancer. While ‘manual’ screening techniques are useful in determining
the possibility of cancer, further testing is necessary to confirm whether a lump detected
on screening is cancer, as opposed to a benign alternative such as a simple cyst. In a
clinical setting, breast cancer is commonly diagnosed using a “triple test” of clinical breast
examination (breast examination by a trained medical practitioner), mammography, and
fine needle aspiration cytology. Both mammography and clinical breast exam, also used
for screening, can indicate an approximate likelihood that a lump is cancer, and may also
identify any other lesions. Fine Needle Aspiration and Cytology (FNAC), which may
be done in a General Practitioner’s office using local anaesthetic if required, involves
attempting to extract a small portion of fluid from the lump. Clear fluid makes the lump
highly unlikely to be cancerous, but bloody fluid may be sent off for inspection under a
microscope for cancerous cells. Together, these three tools can be used to diagnose breast
cancer with a good degree of accuracy [117].
Several treatments are available for breast cancer patients, depending on the stage of
the cancer. Doctors usually take many different factors into account when deciding how to
treat breast cancer. These kinds of factors may be the patient’s age, the size of the tumour,
the type of cancer a patient has, and many more. To get an idea of how a particular
treatment may work for a specific patient and to predict how long the person may live,
an indicator, called the Nottingham Prognostic Index (NPI) [64], has been introduced.
It is not possible to predict exactly what will happen to each individual person, but this
index can provide a general guidance. The NPI has been defined considering three factors
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(defined below), which are combined using the formula:
NPI= (0.2× tumour diameter in cms)+ lymph node stage+ tumour grade.
The factors involved in the NPI definitions are [180]:
• The size of the cancer
• Whether the cancer has spread to the lymph nodes (lymph glands) under the arm
(and if so, how many nodes are affected) – lymph node stage
• The grade of the cancer.
A more detailed description of the NPI and its clinical use may be found in Section 3.1.1,
while the definition of grade is introduced in Section 7.3.
Cancer research produces huge quantities of data that serve as a basis for the devel-
opment of improved diagnosis and therapies. Advanced statistical and machine learning
methods are needed for interpretation of primary data and generation of new knowledge
needed for the development of new diagnostic tools, drugs, and vaccines. Identification
of functional groups and subgroups of genes responsible for the development and spread
of this type of cancer as well as its subtypes are urgently needed for proper classification
and identification of key processes that can be targeted therapeutically. In addition, accu-
rate diagnostic techniques could enable various cancers to be detected in their early stages
and, consequently, the appropriate treatments could be undertaken earlier [175].
Gene expression profiling using microarray has become a routine research tool in
biomedicine. This high-throughput technology allows the researcher to monitor whole-
genome gene expression profiles under different experiment conditions or disease pheno-
types (including subtypes), as well as time course experiments. This type of screening
helps to identify genes with similar expression pattern under various conditions or time
course. Co-expression of genes often indicates their co-regulation or participation in re-
lated functional biological pathways or processes. One of the strategies in identifying
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these groups of genes with similar expression patterns is by using unsupervised machine
learning techniques such as clustering approaches.
Clustering is a multivariate analysis technique which aims to discover groups of simi-
lar objects within data [14]. An object is described either by a set of measurements or by
relationships between the object and other objects. Cluster analysis does not use category
labels that tag objects with prior identifiers. The absence of category labels distinguishes
cluster analysis from discriminant analysis (and pattern recognition and decision analy-
sis). The objective of cluster analysis is simply to find a convenient and valid organisation
of the data, not to establish rules for separating future data into categories [88]. Clustering
algorithms are used to find structure in the data.
Many clustering algorithms have been developed and applied to the analysis of mi-
croarray data ranging from simple hierarchical clustering to partitional approaches. The
former seeks to build a hierarchy of clusters using either an agglomerative or divisive
strategy. In the agglomerative approach, each observation starts in its own cluster, and
pairs of clusters are merged as one moves up the hierarchy. In the divisive strategy, all
observations start in one cluster, and splits are performed recursively as one moves down
the hierarchy. Hierarchical clustering algorithms are widely used, particularly in the med-
ical field, as they produce a ‘visual result’: a tree (called dendrogram) depicting specified
relationships among the entities [7] may be drawn to illustrate the arrangement of the
clusters produced. On the other hand, partitional clustering produces clusters by optimis-
ing a criterion function defined either locally (on a subset of the data) or globally (defined
over all of the patterns).
Partitional methods have advantages in applications involving large data sets for which
the construction of a dendrogram is computationally prohibitive [89]. All the clustering
approaches mentioned so far are usually referred to as ‘heuristic’ approaches. However,
a different kind of algorithms (model-based techniques) are also used to identify groups
in data. Model-based clustering assumes that data are generated by a model and tries to
recover the original model from the data themselves. The model recovered from the
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data then defines clusters and an assignment of points to clusters [116]. Sometimes,
model-based approaches assume that the model underlying data is in reality a mixture
of probability distributions such as multivariate normal distributions [9]. All these kinds
of analysis usually provide a good starting point for further examination of specific path-
ways and relevant biological processes. However, the complexity of this problem requires
fine tuning and human intervention for determination of useful gene clusters associated
with specific biological functions.
Other methods of classification (learning) are the so-called ‘supervised algorithms’.
Supervised machine learning is the search for algorithms that reason from externally sup-
plied instances to produce general hypotheses, which then make predictions about future
instances. In other words, the goal of supervised learning is to build a concise model of
the distribution of class labels in terms of predictor features. The resulting classifier is
then used to assign class labels to the testing instances where the values of the predictor
features are known, but the value of the class label is unknown [101].
Algorithms for supervised learning range from decision trees to artificial neural net-
work and from support vector machines to Bayesian classifiers. Decision tree learning,
used in data mining and machine learning, uses a decision tree as a predictive model
which maps observations about an item to conclusions about the item’s target value. In
these tree structures, leaves represent classifications and branches represent conjunctions
of features that lead to those classifications. Learned trees can also be re-represented as
sets of if-then rules to improve human readability [128].
Artificial Neural Networks (ANNs) provide a general, practical method for learning
real-value, discrete-valued, and vector-valued functions from examples. For certain types
of problems, such as learning to interpret complex real-world sensor data, artificial neu-
ral networks are among the most effective learning methods currently known [80, 128].
However, especially for big data sets, ANNs may become huge and produce set of rules
which are then difficult to interpret, especially for those researchers not familiar with
computational analysis.
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Support Vector Machines (SVMs) can also be used for pattern classification and non-
linear regression. The main idea of a SVM is to construct a hyperplane as the decision
surface in such a way that the margin of separation between positive and negative exam-
ples is maximised in multi-dimensional space. The support vector machine can provide a
good generalisation performance on pattern classification problems despite the fact that it
does not incorporate problem domain knowledge [80].
Bayesian classifiers are based on the assumption that the quantities of interest are
governed by probability distributions and that optimal decisions can be made by reason-
ing about these probabilities together with observed data. In addition, Bayesian learning
provides a quantitative approach to weighing the evidence supporting alternative hypothe-
ses [128].
The whole range of classification techniques (supervised and unsupervised) may well
help the identification of representative groups and subgroups of any kind of cancer and
subsequently guide clinicians to the favourite and most powerful treatment. In particular,
in such a multi-disciplinary work, the development of a new framework for elucidat-
ing core classes in a dataset may help in changing the approach clinicians usually use
when dealing with breast cancer studies. This research project was in fact motivated by
a previous investigation on breast cancer phenotypes using tissue microarray technology
that was carried out by Mrs. Dalia M. Abd El-Rehim et al. from the Departments of
Histopathology and Surgery, The Breast Unit, Nottingham City Hospital and University
of Nottingham, UK, in 2005 [1]. Indeed, a single hierarchical clustering algorithm was
used by the authors to categorise patients in different groups. Following this study, a co-
operation with Professor Ian O. Ellis and his research group at the School of Molecular
Medical Sciences at The University of Nottingham has been established to obtain and
investigate a larger set of data relating to patients presented at Nottingham City Hospital
between 1986 and 1998. A cohort of 1,076 women with primary operable invasive breast
cancer has been made available for a multi-steps analysis in order to refine the phenotypic
characterisation of the disease.
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1.2 Aims and objectives of this Thesis
The ultimate goals of this multi-disciplinary research project concern both the clinical
and technical aspects. From a clinical point of view, this work aims to move the field of
medical decision making from the widely used approach of considering just a single clas-
sification technique (usually hierarchical clustering) to a multi-technique analysis one, in
which different methods are investigated and results are derived from a consensus be-
tween techniques. Considering a more technical and computational aspect, the aim is to
develop an original framework to elucidate core representative classes in a given dataset,
in order to provide a step-by-step guideline which can be applicable across application
domains (with a specific focus on breast cancer data sets).
Several research questions and hypotheses underlying the overall work were identified
at the beginning of the project. Starting from the already published literature on breast
cancer studies, it was noted that an extended review and comparison of different clustering
algorithms had not been carried out yet. This gap of knowledge led to the formulation of
the following research questions:
• Can a multi-techniques approach provide more accurate classification of breast can-
cer patients into sub-types of the disease?
• Is there a way to combine the results obtained by this multi-techniques approach?
• Is it possible to find an automated way to categorise a patient and give her immedi-
ately the most useful treatment?
• From a clinical point of view, can the medical decision making process be moved
in the direction of personalised healthcare? If so, how should doctors be trained for
that?
In order to achieve the aims stated above and to answer the research questions, the
following objectives were identified:
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(i) To establish standard methodologies for the acquisition, storage and extraction of
electronic patient data.
(ii) To collect the various data sets available at the centres into a shared big resource,
of unprecedented size, for breast cancer data.
(iii) To investigate different computational analysis methods (clustering) applicable ac-
ross bioinformatics data and routine clinical information, including pathological
and radiological data.
(iv) To determine an effective method to evaluate clustering results and to combine them
in a set of representative groups of different cancer characteristics.
(v) To develop an automated supervised classification algorithm to be applied to any
possible source of data, independent of their underlying distributions.
(vi) To combine the previously analysed techniques in an original framework to deter-
mine and emphasise core representative classes and validate this framework over
novel data.
The first two objectives are discussed in Chapter 3, the third and fourth will be investi-
gated in Chapter 4, and the fifth in Chapter 5. The last objective is discussed in Chapter 7.
In the next section a more detailed structure of this work is presented.
1.3 Thesis Organisation
This thesis is structured as follows. Chapter 2 presents a literature review of various
clustering approaches developed in the past to categorise data points in groups with high
similarity. Both partitional and fuzzy methods are reported. A review of different clus-
tering methods used in literature to group breast cancer data has been performed and is
reported as well. Cluster validity is introduced in this chapter as a technique to assess the
quality of clustering results and as a method to select the best number of groups to con-
sider in the analysis. Several validity measures used in this thesis work are reviewed and
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analysed in detail. In addition, a general description of techniques developed for consen-
sus clustering is reported, explaining various methods to assess the comparison and the
concordance among different clustering approaches. To conclude the overview on clus-
tering algorithms, the model-based approach is described and the most commonly used
algorithm, Expectation Maximisation, is presented. The chapter ends with a review on su-
pervised classification methods, which are used to build models of the class distribution
labels and to predict the class assignment of possible new objects.
In Chapter 3 a description of the medical background of this research work is pre-
sented. The disease of breast cancer is defined and its possible treatments are reviewed.
Tissue samples of breast cancer were used for this study and in this chapter their collection
and preparation, together with the instruments used for this purpose, are reported. The ba-
sic steps of data pre-processing are also given in Chapter 3, resulting in the development
of a web interface for data storage and acquisition.
Chapter 4 is dedicated to the comparison of several clustering techniques applied on
breast cancer data, namely hierarchical, fuzzy C-means, K-means, Partitioning Around
Medoids (PAM) and Adaptive Resonance Theory (ART). Comparing different results us-
ing statistical analysis and visualisation techniques, an informal consensus clustering is
defined resulting in the development of a set of six breast cancer core classes. Three of
them present luminal characteristics (luminal biomarkers are over-expressed), differenti-
ated by the presence or absence of other markers like estrogen receptors and/or proges-
terone receptors. In one of the six classes the HER2 marker (a human epidermal growth
factor which gives higher aggressiveness in breast cancers) is strongly expressed. The
last two classes are characterised by the over-expression of basal markers and the subse-
quent under-expression of the luminal ones. These two groups differ by the presence or
absence of a marker called p53. These six classes are also characterised in terms of clini-
cal outcome, highlighting some novel interesting results which have not previously been
emphasised in literature. In addition, the work presented here supplies the evidence that
cluster analysis should be treated with caution, as different algorithms produce different
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groupings and it is always difficult to choose the best one. The chapter ends with a short
note of interesting results on triple-negative cancers recently being found across several
different breast cancer data sets analysed.
In Chapter 5 supervised classification methods are used to validate the classifica-
tion obtained in Chapter 4 and to build a model for future possible patients entering the
study. A comparison between three different techniques is performed and then a new
‘non-parametric’ algorithm is developed and presented to cope with the non-normality of
most of the real world data sets. This new method is validated over known case studies
taken from the Machine Learning Repository. Interesting results emerge, in particular in
comparison with Multinomial Logistic Regression.
Chapter 6 provides a description of a recently proposed clustering algorithm called
Affinity Propagation, which combines characteristics of both heuristic and model-based
approaches and has the ability to suggest the number of clusters too. The main differences
with other clustering algorithms like K-means are reported and then results from the appli-
cation of Affinity Propagation over breast and cutaneous cancers are presented. In order
to choose whether to include this algorithm in the proposed framework for core classes
detection, a comparison of the CPU times needed for the computation of both Affinity
Propagation and K-means was also performed. Several groupings known from literature
were confirmed by this recently proposed method; in addition, this technique also sug-
gested novel possible classifications for two of the data sets analysed. However, the time
requested for computation was much longer than the time needed for the K-means one.
A step-by-step guide to identify core characteristic classes within any dataset is pre-
sented in Chapter 7. Starting with the application of different clustering algorithms and
passing through several statistical methods and visualisation techniques to characterise
the results, a set of core classes may be defined by a form of consensus clustering. It
is then possible to verify these classes by using several supervised classification algo-
rithms like decision trees, in order to obtain a set of rules which may be used for new
data points in the future. This proposed framework is finally validated over a novel set of
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histone markers for breast cancer patients. Results are still being analysed and verified by
pathologists and researchers at the University of Nottingham, but, from a clinical point
of view, the identified groups clearly distinguish patients with poor overall survival from
those with low grading score and better survival rate. Considering the technical aspect,
the identified classes result to be well separated and characterised by low, medium and
high levels of biological markers.
The last chapter of this thesis, Chapter 8, concludes the work, drawing the main con-
tributions and highlighting several possible directions for future research. A list of publi-
cations and oral presentations derived from this work thesis is reported at the end of the
chapter.
This work was conducted as a joint research initiative between the University of Not-
tingham and the Institute of Medical Statistics, University of Milan and National Cancer
Institute, Italy. The project itself was part of the BIOPTRAIN consortium, funded in
the EU 6th Framework (FP6) as a Marie Curie Early Stage Training (EST) programme.
The BIOPTRAIN mission was to establish a permanent European multi-centre interdisci-
plinary research training programme of world-class quality in bioinformatics optimisation
algorithms.
1.4 Contributions to knowledge
Three main contributions to knowledge may be extracted from the work presented
in the following chapters. Firstly, the novel framework to elucidate core representative
classes in a dataset is an original methodological approach and its validation over a novel
case study offers relevant results from both the technical and clinical perspectives.
Moreover, using different clustering techniques and a consensus between the resulting
classifications, six diverse breast cancer groups are discovered and their characterisation
appears to be novel in literature, especially in terms of their different clinical outcome.
Finally, a ‘non-parametric’ Bayesian classifier is developed to address the non norma-
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lity of the data in many real world case studies. This novel algorithm is validated over
different data sets from the Machine Learning Repository and results confirm its effec-
tiveness when data is not normally distributed.
This research work led to several refereed papers – five journal papers (three accepted /
published and two submitted) and four conference papers. A complete list of publications
is reported in Section 8.4.
Chapter 2
Literature Review
This chapter provides a literature review of general clustering techniques as well as
clustering approaches in breast cancer studies. As real medical applications are analysed
in this thesis, clustering algorithms that can group breast cancer data are also introduced.
One of the contributions of this work is the use of a consensus clustering approach for
the identification of breast cancer classes which remain stable across different methods.
For this reason, previously published literature on consensus clustering will be discussed.
Later in this chapter, literature reviews on supervised classification and on model-based
clustering will be presented.
The aim of this chapter is to present relevant background information about all the
research subjects which have been used in the development of the original framework and
to point out the gaps in the body of knowledge. This emphasises the motivation of the
thesis: to develop a framework to elucidate core classes in a dataset which can be used
for any available source of data.
2.1 Clustering techniques
Clustering is the process of grouping a set of unlabelled multidimensional patterns
(objects or data points), such that patterns in the same cluster have the most similar char-
acteristics, and patterns within different clusters have the most dissimilar characteristics.
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In most cases a cluster is represented by a cluster centre or a centroid [89, 175]. Cluster-
ing has been applied to a wide range of applications, such as pattern recognition, image
segmentation, spatial data analysis, machine learning, data mining, etc. Classification,
another data analysis method, is often confused with clustering. The distinction between
the two approaches is that classification is a supervised learning process which is trained
on a set of pre-labelled patterns in order to predict into which class new patterns should
be placed. In contrast, clustering is unsupervised, has no predefined classes and does not
involve training examples [66, 90, 175]. As mentioned before, the aim of clustering is to
group the patterns into clusters based on their similarity, which is defined by a distance
measure.
A basic pipeline of a general clustering process can be described in the following
way [89, 90]:
1. Feature selection and/or extraction. Feature selection is the process of identifying
the most effective subset of the original features to use in clustering. Feature ex-
traction is the use of one or more transformations of the input features to produce
new salient features. Either or both of these techniques can be used to obtain an
appropriate set of features to use in clustering [89]. The purpose of this step is
to make the clustering process work more efficiently as only the most important
characteristics need to be considered. The objective is usually to reduce the time
required for the clustering process without adversely affecting the quality of the
clusters obtained [175].
2. Pattern proximity measure appropriate to the data domain. This measure is used
to evaluate the similarity (or dissimilarity) of two data points. A variety of distance
measures may be used depending on the problem under investigation [7, 89]. The
most used ones are the Euclidean distance and correlation coefficients.
3. Clustering or grouping. The grouping step can be performed in a number of ways.
The output clustering (or clusterings) can be hard (a partition of the data into
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groups) or fuzzy (where each pattern has a variable degree of membership in each
of the output clusters). Several of these approaches will be described in this chapter.
4. Assessment of output (if needed). In general, cluster validation may answer, among
other aspects, questions such as: ‘How good are the partitions?’ ‘Is there a better
partitioning possible?’, etc. The assessment of a clustering procedures output ob-
tained in step 3 may be performed using cluster validity analysis. Several validity
indices have been introduced in the past to assess the robustness and separation of
clusters returned by clustering techniques [183].
In general, clustering techniques can be divided into two main categories, namely hi-
erarchical and partitional clustering [7,89]. In each category, many subtypes and variants
have been applied to diverse types of clustering problems. In conventional clustering al-
gorithms, each pattern has to be assigned exclusively to one cluster and the usual process
is to optimise an objective function which somehow reflects the quality of the clusters.
Where the physical boundaries of clusters are well defined, this approach can work well.
However, when using data from real world applications, the boundaries between clusters
might be vague. For this reason, fuzzy clustering extends the traditional clustering concept
by allowing each pattern to be assigned to every cluster with an associated membership
value. Therefore, in case of unclear cluster boundaries, fuzzy clustering may obtain more
useful results.
In the following subsections, the key literature pertaining to both hierarchical and
partitional clustering is identified and analysed.
2.1.1 Hierarchical
Hierarchical clustering is a way to group the data in a nested series of clusters [89].
The output of hierarchical clustering is a cluster tree, termed a dendrogram, which repre-
sents the similarity level between all of the patterns. Figure 2.1 shows a two-dimensional
dataset which contains three clusters (data points have been labelled A – G). The den-
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Figure 2.1: Two dimensional dataset with 3 clusters [89]
drogram corresponding to this figure has been displayed in Figure 2.2 [89]. As shown in
Figure 2.2, a specific number of clusters can be generated through the vertical positioning
of the cut-off line (dashed line in the figure). All of the data connected to the vertical line
intersected by the cut-off line, belong to one cluster [175]. The position of the cutoff line
is normally subjective and is decided based on the solution requirements. It should be
noted that if the cut-off line is placed higher on the diagram, the total number of clusters
is reduced, whereas, if the cut-off line is lowered, more clusters are produced.
To implement the standard method for the analysis of general data, one first constructs
a dissimilarity measure for each pair of objects, often a distance measure. Alternatively,
the dissimilarity measure may be taken to be one minus some measure of association,
typically the correlation coefficient ρ [70]. Based on its algorithmic structure and op-
eration, hierarchical clustering can be further categorised into agglomerative algorithms
and divisive algorithms [89, 90]. The agglomerative method initially considers each of n
patterns as an individual cluster and then the closest pair of distinct clusters is found and
merged, leaving (n− 1) singleton clusters and one cluster with two distinct objects. The
dissimilarity matrix is updated to take into account the merging that has occurred; based
on the new dissimilarity matrix, the two closest distinct clusters are found and merged;
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Figure 2.2: Dendrogram obtained from Figure 2.1 [89]
this continues until one cluster consisting of all n objects remains [70]. The dendrogram
in the agglomerative approach is generated in a bottom-up fashion. In contrast, the divi-
sive method starts by considering all n patterns in one cluster and, at each step, splits the
cluster into two groups based on the similarity within the patterns, such that patterns in
the same group have the highest similarity and patterns in the different groups have the
most dissimilarity. In particular, in the first step, the object in the cluster that has the great-
est dissimilarity to the other elements (the seed) is separated to form a so-called splinter
group and the remaining elements in the original cluster are examined to see whether or
not additional elements should be added to the splinter group. Two clusters result. The
diameter of each cluster (the largest distance between observations in the same cluster) is
then computed to see which is greater. The steps above are repeated with the cluster that
has the greater diameter. This process is iterated until there are n singleton clusters [70].
The divisive approach is based on top-down dendrogram generation [175].
As part of the agglomerative algorithm, the linkage method provides a way to measure
the similarity of clusters based on the patterns in the cluster [66]. The main linkage
methods include single linkage, complete linkage, average linkage and minimum-variant
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(Ward) algorithms [89, 90, 177]. Most of the other linkage methods are variants of these
three. In the single linkage algorithm, the distance between two clusters is measured by
the two closest patterns within the different clusters, thus resulting in the distance between
two clusters being the minimum of all possible pairwise distances [70]. By contrast in the
complete linkage algorithm, the distance between two clusters is measured by the two
furthest patterns within the different clusters (the maximum between all possible pairwise
distances). In average linkage clustering, the distance between two clusters is the average
of the pairwise distances between two elements, one from the first cluster and the other
from the second [70]. The minimum-variant algorithm is distinct from all other methods
because it uses an analysis of variance approach to evaluate the distances between clusters.
In short, this method attempts to minimise the sum of squares of any two (hypothetical)
clusters that can be formed at each step [6].
Depending on the linkage method employed, hierarchical clustering can generate clus-
ters having different characteristics. For example, the single linkage algorithm has a ten-
dency to produce a cluster with an elongated and irregular shape whereas the complete
linkage algorithm can produce tight, compact and roughly hyper-spherical clusters [89],
while the minimum-variant algorithm, although being regarded as very efficient, often
tends to create clusters of small size [6].
A major drawback of hierarchical clustering methods is that group assignment of ob-
jects cannot change once an object has been placed in a cluster. These methods cannot
undo what has been done in previous steps. In contrast, partition methods can reconsider
cluster assignments at every stage [70].
2.1.2 Partitional clustering and K-means
In contrast to hierarchical clustering methods that produce a nested series of parti-
tions, a method like K-means produces only a single partition [89]. Such, so called ‘par-
titional methods’, have advantages in applications involving large data sets for which the
construction of a dendrogram is computationally prohibitive. The partitional techniques
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usually produce clusters by optimising a criterion function defined either locally (on a
subset of the patterns) or globally (defined over all of the patterns). Combinatorial search
of the set of possible labelings for an optimum value of a criterion is clearly computation-
ally prohibitive. In practice, therefore, the algorithm is typically run multiple times with
different starting states, and the best configuration obtained from all of the runs is used as
the output clustering [89].
The most intuitive and frequently used criterion function in partitional clustering tech-
niques is the squared error criterion, which tends to work well with isolated and compact
clusters. Consider a data set X = {x1,x2, . . . ,xn}, containing n patterns, which is to be
clustered into c groups. Let us call V = {v1,v2, . . . ,vc} the corresponding set of centres
and c j the number of patterns in cluster j; let us also assume that each pattern can only
belong to one cluster. The squared error e2 can be expressed as
e2 =
c
∑
j=1
c j
∑
i=1
||xi− v j||2 (2.1)
where xi is the i-th pattern in the j-th cluster, v j is the j-th cluster centre, and ||xi− v j|| is
the Euclidean distance between xi and v j [89].
The K-means method is one of the early established algorithms in partitional cluster-
ing and is the simplest and most commonly used algorithm employing a squared error
criterion [112]. The aim of the algorithm is to minimise the squared error criterion e2
in Equation (2.1). It starts with a random initial partition and keeps reassigning the pat-
terns to clusters based on the similarity between the pattern and the cluster centres until a
convergence criterion is met (e.g., there is no reassignment of any pattern from one clu-
ster to another, or the squared error ceases to decrease significantly after some number of
iterations). The K-means clustering algorithm procedure may be described as follows:
(i) Choose c cluster centres to coincide with c randomly-chosen patterns or c randomly
defined points inside the hypervolume containing the pattern set.
(ii) Assign each pattern to the closest cluster centre, according to the similarity measure
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chosen.
(iii) Recompute the cluster centres v j using the following formula:
v j =
1
c j
c j
∑
i=1
xi, j = 1, . . . ,c (2.2)
where, as for Equation (2.1), c j is the number of patterns in cluster j, xi is the i-th
pattern in the j-th cluster, and c is the total number of clusters.
(iv) Reassign each pattern to the closest cluster centre.
(v) If a convergence criterion is not met, go to step (iii). Typical convergence criteria
are: no (or minimal) reassignment of patterns to new cluster centres, or minimal
decrease in squared error.
2.1.3 Partitioning Around Medoids (PAM)
When partitioning a set of objects into k clusters, the main objective is to find clusters
of objects which show a high degree of similarity, while objects belonging to different
clusters are as dissimilar as possible. Of course, many methods exist that try to achieve
this aim [97]. The PAM algorithm (Partitioning Around Medoids) is based on the search
for k representative objects among the objects of the data set. As evoked by their name,
these objects should represent various aspects of the structure of the data. In the cluster
analysis literature such representative objects are often called centrotypes. In the PAM
algorithm the representative objects are the so-called medoids of the clusters and the aim
of PAM is to minimise the average dissimilarity of objects to their closest medoids [97].
Dissimilarities are nonnegative numbers d(i, j) that are small (close to zero) when two
data points i and j are ‘near’ to each other and become large when i and j are very
different. It is usually assumed that dissimilarities are symmetric and that dissimilarity
of an object to itself is zero, but in general the triangle inequality does not hold [97]. In
general, a Euclidean metric is used for calculating dissimilarities between observations.
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After finding a set of k representative objects, the k clusters are constructed by assigning
each object of the data to the nearest representative object.
In many clustering problems one is particularly interested in a characterisation of the
clusters by means of typical or representative objects. These are objects that represent
the various structural aspects of the set of objects being investigated. There can be many
reasons for searching for representative objects. Not only can these objects provide a
characterisation of the clusters, but they can often be used for further work or research,
especially when it is more economical or convenient to use a small set of k objects instead
of the large set one started off with. In the method used in PAM, the representative object
of a cluster is its medoid, which it is defined as that object of the cluster for which the
average dissimilarity to all the objects of the cluster is minimal [97].
In addition, the results of partitional techniques like K-means and PAM are lists of
clusters with their objects, which are not as visually appealing as the dendrograms of
hierarchical methods [150]. In order to obtain a graphical representation of each clustering
for such methods, Rousseeuw suggested to plot the so-called silhouettes, which were
introduced by himself in [150]. Moreover, the silhouettes plot can be used to select the
number of clusters and to assess how well individual observations are clustered [42]. Let
ai denote the average dissimilarity between i and all other observations in the cluster to
which i belongs. For any other cluster C, let d(i,C) denote the average dissimilarity of i
to all object of C and let bi denote the smallest of these d(i,C). The silhouette width of
observation i is
si = (bi−ai)/max{ai,bi}
and the overall average silhouette width is simply the average of si over all the observa-
tions i,
s=
1
n
∑
i
si.
Intuitively, object with large silhouette width si are well clustered, whereas those with
small si tend to lie between clusters [42]. Kaufman and Rousseeuw suggest estimating
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the number of clusters k by that which gives the largest average silhouette width s [97].
From the preceding definition, it is clear that
−1≤ si ≤ 1
for each observation i. When si is at its largest (close to 1) it can be said that i is ‘well
classified’, as there appears to be little doubt that i has been assigned to an appropriate clu-
ster. A different situation occurs when si is about zero. Then ai and bi are approximately
equal and hence it is not clear whether i should have been assigned to which cluster. The
worst situation takes place when si is close to -1. Then ai is much larger than bi, so i lies
on the average much closer to another cluster rather than the one it has been assigned to.
Therefore it would have seemed more natural to assign object i to another cluster, so it
can be almost concluded that observation i has been ‘misclassified’ [97].
Having computed the quantities si from the dissimilarities, the graphical display can
be constructed. The silhouette of a generic clusterC is a plot of the si, ranked in decreasing
order, for all observations i in C. For each observation i, a bar is drawn, representing its
silhouette width si. Observations are grouped per cluster, starting with cluster 1 at the
top. Observations with a large si (almost 1) are very well clustered, a small si (around 0)
means that the observation lies between two clusters, and observations with a negative si
are probably placed in the wrong cluster. An example of the silhouette plot is shown in
Figure 2.3.
2.1.4 Fuzzy C-means
Fuzzy sets are an extension of classical set theory and are used in fuzzy logic. In
classical set theory the membership of elements in relation to a set is assessed in binary
terms according to a crisp condition – an element either belongs or does not belong to
the set. By contrast, fuzzy set theory permits the gradual assessment of the membership
of elements in relation to a set; this is described with the aid of a membership function
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Figure 2.3: Silhouette plot for a clustering technique
µ→ [0,1]. Fuzzy sets are an extension of classical set theory since, for a certain universe,
a membership function may act as an indicator function, mapping all elements to either 1
or 0, as in the classical notion.
Gitman and Levine [69] appear to have been the first to apply the theory of fuzzy sets
to clustering problems. They developed an algorithm which partitions a given sample
from a “multimodal fuzzy set” into “unimodal fuzzy sets” [69]. The notion of a unimodal
fuzzy set has been chosen by the authors to represent the partition of a data set for two
reasons. First, it is capable of detecting all the locations in the vector space where there
exist highly concentrated clusters of points, since these will appear as modes according
to some measure of ‘cohesiveness’. Second, the notion is general enough to represent
clusters which exhibit quite general distributions of points [69]. An important feature
of this method was the presence of a further ‘dimension’, the order of ‘importance’ of
every point, as an aid in the clustering process. This is accomplished by associating with
every point in the set a grade of membership or characteristic value [195]. Thus the order
of the points according to their grade of membership, as well as their order according
to distance, are used in the algorithm. The latter partitions a sample from a multimodal
fuzzy set into unimodal fuzzy sets [69].
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One of the most widely used fuzzy clustering algorithms is the Fuzzy C-Means (FCM)
algorithm, which was firstly developed by Dunn in 1974 [44] and subsequently improved
by Bezdek in 1981 [12]. Bezdek’s improvement consisted in the introduction of the so-
called fuzzifier parameter m. The algorithm is based on the minimisation of the fuzzy
objective function
J(U,V ) =
n
∑
i=1
c
∑
j=1
(µi, j)
m‖xi− v j‖2. (2.3)
Once again, as in Section 2.1.2, X = {x1,x2, . . . ,xn} represents a collection of n data points
and V = {v1,v2, . . . ,vc} is the corresponding set of cluster centres. In addition, µi, j is the
membership degree of data xi to the cluster centre v j and it must satisfy the two following
conditions:
µi j ∈ [0,1], i= 1, . . . ,n and j = 1, . . . ,c, (2.4)
c
∑
j=1
µi j = 1. (2.5)
Parameter m is called the ‘fuzzifier’ or ‘fuzziness index’ and is used to control the
fuzziness of the membership of each data point. When m= 1 the fuzzy c-means is equiv-
alent to the K-means algorithm and the larger the value of m, the fuzzier the method
becomes. Even though there are no theoretical basis for the optimal selection of the fuzzi-
ness indexm, a value ofm= 2.0 is usually chosen [12]. All the membership degree values
from each observation to all cluster centres form the fuzzy partition matrixU = (µi j)n×c.
The fuzzy c-means algorithm procedure may be described as follows [175]:
(i) Fix the number of cluster c (2 ≤ c < n) and initialise the fuzzy partition matrix U
with a random value such that it satisfies conditions (2.4) and (2.5).
(ii) Calculate the fuzzy centres v j using the following formula:
v j =
n
∑
i=1
(µi j)
mxi
n
∑
i=1
(µi j)
m
, ∀ j = 1, . . . ,c. (2.6)
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(iii) Update the fuzzy partition matrixU using the following formula:
µi j =
1
c
∑
k=1
(
‖xi− v j‖
‖xi− vk‖)
2
m−1
, i= 1, . . . ,n and j = 1, . . . ,c. (2.7)
(iv) If a convergence criterion is not met, go to step (ii). Typical convergence criteria are
that the difference between updated and previous objective function J is less than
a prespecified minimum threshold or that the maximum number of iteration cycles
has been reached.
The fuzzy c-means algorithm, as well as K-means, needs the number of clusters to
be pre-specified in advance as an input parameter to the algorithm. Moreover, both these
techniques begin with random initialisation of the cluster centres. This can lead the ap-
proaches to suffer premature convergence to local optima. If the initial cluster centres
are not appropriate, the iterative improvement of the centre positions can result in locally
optimal solutions being obtained [175]. Also for this reason in this work, as it will be de-
scribed later on, the initial cluster centres for K-means and fuzzy c-means were set using
a hierarchical approach.
Table 2.1 summarises the main concepts and characteristics of the clustering algo-
rithms considered in this thesis. More specifically, the following features of each algo-
rithm are reported: i) the algorithm complexity, ii) the input parameters, iii) the clustering
criterion and iv) the results produced by the algorithm [74].
2.2 Clustering validation
In cluster analysis, one of the most important issues is the choice of the optimal num-
ber of cluster to consider. It is also important to assess the resulting clusters produced by
a single algorithm.
Clustering validation is a concept that is used to evaluate the quality of clustering
results. In addition, if the number of clusters within the data is not known prior to com-
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Category Partitional
Name
Time
Input parameters Results Clustering criterion
Complexitya
K-Means O(nkt) Number of clusters Centres of clusters
minv1,v2,...,vk(Ek)
Ek = ∑
c
j=1∑
c j
i=1 ||xi j− v j||2
PAM O(tk(n− k)2) Number of clusters Medoids of clusters
min(TCih) TCih = ∑ jC jih
C jih = cost of replacing centre i with h
as far as j is concerned
FCM O(nkt) Number of clusters Centre of clusters
minU,v1,v2,...,vk(J(U,V ))
J(U,V ) = ∑ni=1∑
c
j=1(µi, j)
m‖xi− v j‖2
Category Hierarchical
Name
Time
Input parameters Results Clustering criterion
Complexitya
HCA O(n2)
A set of dissimilarities
Cluster tree, the Minimise the sum of squares of any two
for the objects being
dendrogram clusters that can be formed at each step
clustered
an is the size of the dataset, k is the number of cluster defined and t is the number of iterations.
Table 2.1: The main characteristics of the clustering algorithms analysed
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mencing an algorithm, a cluster validity index may be used to determine the best number
of clusters for the given data set. In general, cluster validation may answer, among other
aspects, questions such as [148]:
1. How many cluster should be considered?
2. How good are the partitions?
3. Is there a better partition possible?
In general, cluster validity measures can be expressed in terms of the three types of
criteria named below [88,175].
External criteriameasure performance by matching a clustering structure to a priori
information. For example, an external criterion measures the degree of correspon-
dence between cluster numbers, obtained from a clustering algorithm, and category
labels, assigned a priori. An external criterion can also measure the degree to which
data confirm a priori ideas without a formal cluster analysis being performed.
Internal criteria assess the fit between the structure and the data, using only the data
themselves. For example, an internal criterion would measure the degree to which
a partition, obtained from a clustering algorithm, is justified by the given proximity
matrix.
Relative criteria decide which of two structures is better in some sense, such as
being more stable or more appropriate for the data. For example, a relative criterion
would measure quantitatively whether a single-link or a complete-link hierarchy fits
the data better.
The fundamental idea of the first two types of approach (external and internal criteria)
is to test whether the data points in the given dataset are randomly structured or not,
based on statistical testing. This usually requires some sort of calculation involving pair-
wise comparison between each pair of data points and each cluster, which leads to a
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computationally expensive procedure. In addition, the indices related to these approaches
aspire to measure the degree of the dataset to a pre-specified clustering scheme [74,175].
Conversely, the third approach does not involve statistical tests and allows for the best
clustering structure to be chosen from a set of schemes, defined based on pre-specified
criteria [74, 175].
2.2.1 Validity indices
In this thesis, real world problems from the medical domain are considered. In such
problems the different types of phenotype (corresponding to the number of clusters from
a clustering analysis point of view) are often unknown in advance. However, using a
validity index, or a sort of consensus of several validity indices, the best clustering scheme
may be identified. This can be implemented by applying the clustering techniques within a
range of cluster numbers, and considering the partition with the best cluster validity index
value. The whole procedure may be summarised by the following steps [110,148,175]:
1. For a given data source X , fix all the clustering parameters but the number of clus-
ters c.
2. Set the values of the minimum and maximum number of clusters, respectively cmin
and cmax.
3. For c running between cmin and cmax compute the following three steps:
(a) Initialise the cluster centres.
(b) Apply the clustering method with number of clusters c.
(c) Calculate and store the validity index of the clustering scheme
4. Choose the clustering structure that corresponds to the best validity index value
obtained throughout the procedure.
Although there are many variations of validity indices, they are all either based on
considering the data dispersion in a cluster and between clusters, or considering the scat-
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ter matrix of the data points and the one of the clusters centres. The remaining part of
Section 2.2 is dedicated to the different types of validity indices, suitable for both the
hard clustering and the fuzzy one.
2.2.2 Validity indices for hard clustering
Several validity measures were proposed in recent years. In a technical report Wein-
gessel et al. [183] conducted an examination of 14 indices for determining the number of
clusters on artificial binary data sets being generated according to various design factors
and to resemble real-world data. To provide a variety of clustering solutions the data sets
were analysed by different non hierarchical clustering methods. The purpose of the paper
was to present the performance and the ability of an index to detect the proper number of
clusters in a binary data set under various conditions and different difficulty levels. The
indices reported in this section were all analysed in [183] and are those used in this thesis
work.
TraceW Validity Index
In 1965, Edwards and Cavalli-Sforza [46] found that the analysis of variance provided
an excellent criterion for testing the goodness of a particular cluster division. Using the
analysis of variance technique, data points may be divided into the two most-compact
clusters (clusters as dense as possible), and the process repeated sequentially so that a
‘tree’ diagram may be formed. When points are divided into two clusters the sum of
the squared distances from their mean could be partitioned into the sum of the squared
distances of the points of one cluster from their mean, the similar sum for the other clu-
ster, and the between-clusters sum of squares [46]. Thus, Edwards and Cavalli-Sforza
suggested that the natural criterion for division was clearly the between-cluster sum of
squares and, to obtain the best split, this sum should be maximised (and the within-clusters
sum of squares consequently minimised). The last criterion could also be presented as
the minimisation of the ‘Trace of W ’, where W is the pooled-within groups scatter ma-
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trix [61], and it is defined in the following way. Suppose that data are given in the form of
a matrix (X)n×p with the ith row given by the (l× p) vector Pi = (xi1, . . . ,xip) representing
the observation vector of the ith object. Suppose also to have a partition of n objects into
g groups with n1,n2, . . . ,ng objects in each group and n= ∑
g
i=1 ni. Then for the kth group
the row vectors Plk for l = 1, . . . ,nk represent the objects in group Gk. The scatter matrix
of each group Gk with centre of gravity vectorCk is
Wk =
nk
∑
l=1
(Plk−Ck)T (Plk−Ck).
The sum over all k
W =
g
∑
k=1
Wk
defines what is called the pooled-within groups scatter matrix [61].
Friedman and Rubin Validity Indices
Friedman and Rubin [61] criticized the method proposed by Edwards and Cavalli-
Sforza arguing that although TraceW was invariant under an orthogonal transformation,
it was not invariant under any non-singular linear transformation. In addition, Friedman
and Rubin defined the between groups scatter matrix by
B=
g
∑
k=1
nkC
T
k Ck,
where notation is the same as above. For each partition of the n objects into g groups the
following matrix identity can be defined
T =W +B (2.8)
where T is the total scatter matrix of the n points and it is given by
T = XTX =
n
∑
i=1
PTi Pi.
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Using Equation (2.8) Friedman and Rubin stated that, since T is constant over all the
partitions, minimising TraceW is equivalent to maximising Trace B, because Trace T =
TraceW + Trace B [61].
Then, two possible scenarios were considered, p= 1 (one variable) and p> 1 respec-
tively. For p= 1, Equation (2.8) is a statement about scalars and since the total scatter T is
fixed, a natural criterion for grouping is to minimiseW . This is equivalent to maximising
B. Also for p= 1, the following may be written T/W = 1+B/W where B/W multiplied
by the ratio of the degrees of freedom is what in statistics is called an F ratio. This ratio
is invariant under non-singular linear transformations of the data. The criterion may thus
be restated as partitioning the n objects into g groups so as to maximise the ratio B/W or
equivalently T/W .
For p> 1, Equation (2.8) is a matrix equation and the question of criteria for grouping,
which are invariant under non-singular linear transformations of the original data matrix,
is more complex. These criteria are derived from the identity T =W +B. One criterion
is to maximise the ratio of determinants
|T |
|W | = |I+W
−1B|. (2.9)
That is in principle all partitions of the n objects into g groups are considered and that
partition into g groups for which this ratio is maximum is to be chosen. As |T | is fixed, it
is sufficient to minimise |W | [61].
Another criterion function related to the basic identity (2.8) proposed by Friedman
and Rubin was the maximum of the Trace[W−1B] over all partitions into g groups. The
function Trace[W−1B] has been used as a test statistic in the same way as the ratio of the
two determinants mentioned previously. Moreover, both Trace W−1B and |T |/|W | may
be expressed in terms of the eigenvalues ofW−1B. In particular
|T |
|W | =
t
∏
i=1
(1+λi) and,
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TraceW−1B=
t
∑
i=1
λi.
These eigenvalues are solutions of the determinant equation |B−λW |= 0. All the eigen-
values of this equation are known to be invariant under non-singular linear transforma-
tions of the original data matrix. In fact they are the only invariants of W and B under
such transformations [61].
In their work Friedman and Rubin assessed that if a single criterion function with
which to explore the structure of heterogeneous multivariate data had to be chosen, they
would choose |T |/|W | since it is invariant under non-singular linear transformations and
has demonstrated on the data analysed in their work a greater sensitivity to the local
structure of data than the other criteria. In particular, groups resulting from the trace
W−1B criterion were always separable by a single discriminant function (a single direction
in space). This was not true for the |T |/|W | criterion. Moreover, from a computational
point of view, it is faster to compute |W | than W−1. As a matter of fact, the minimum
Trace W criterion, proposed by Edwards and Cavalli-Sforza [46], is much less costly in
computer time than any other criteria. However, its major fault is that it does not take into
account the within-group covariance of the measurements.
Scott and Symons Validity Index
According to Scott and Symons [154], clustering techniques seem to be applied in
two rather different situations. In one case, the purpose of the analysis is purely descrip-
tive. There are no assumptions, implicit or otherwise, about the form of the underlying
population and the grouping is simply a useful condensation of the data. In the other
case, it is felt that the population is composed of several distinct sub-categories and the
purpose of the analysis is to group together all those observations belonging to the same
sub-category. Scott and Symons preferred to consider the second type of problems [154].
As a model for this situation, the authors supposed that each observation in the sample
may arise from any one of a small number of different distributions. This would be the
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standard classification problem if the distributions were known, or there was a substantial
amount of information about them from previous samples, but little or no prior knowledge
about the component distributions is available in most situations where clustering tech-
niques are used. In either case, classification or clustering, the goal is to group together all
the observations from the same distribution. Let denote γ the set of identifying labels, i.e.,
if there are n sample observations, γ is an unknown parameter with n components, where
the ith component indicates the distribution from which the ith observation came. The
maximum likelihood (ML) estimate of γ, under the assumption that the underlying distri-
butions are multivariate normal, is derived and this turns out to be equivalent to several
standard clustering methods with different assumptions about the covariance structure.
These methods are shown to be natural extensions of standard classification rules based
on the likelihood ratio criterion [154].
Supposing that the observations are drawn independently form a mixture of multivari-
ate normal distributions leads to considering the model above with the additional assump-
tion that γ is an (unobservable) random variable whose components are the outcomes of
n independent multinomial trials. An indirect estimate of γ is obtained by estimating the
parameters of the mixture and using standard classification methods with these estimates
in place of the unknown parameter.
The model proposed by Scott and Symons is now described. The sample consists
of n observations Y = (y1, . . . ,yn), where yi represents measurements on p characteris-
tics. Suppose that the observations are independent and that each may arise from any
one of G possible p-variate normal distributions with means µ1, . . . ,µG and covariance
matrices σ1, . . . ,σG. To be as general as possible, it is allowed for the possibility of a pre-
vious sample of independent observations xg1 , . . . ,xgmg from each distribution. Then the
joint distribution of Y and the previous observations is completely determined by µg,σg
(g = 1, . . . ,G) and the grouping or classification parameter γ = (γ1, . . . ,γn), where γi = g
when yi comes from the g-th sub-population. If θ = (γ,µ1, . . . ,µG,σ1, . . . ,σG) denotes the
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collection of all the parameters, the loglikelihood function, l(θ), is given by
l(θ) =−1
2
G
∑
g=1
[mg
∑
i=1
(xgi−µg)′σ−1g (xgi−µg)
+∑
Cg
(yi−µg)′σ−1g (yi−µg)+(mg+ng) log |σg|
]
, (2.10)
where Cg is the set of yi’s assigned to the gth group or cluster by γ, ng is the number of
observations inCg, and |σg| denotes the determinant of σg [154].
The classification or clustering problem is to estimate γ and hence the clustersC1, . . .,
CG. If the means and covariances are known, or there are a large number of previous
observations from each sub-population, this is the classical model for the classification
problem. When there is little or no prior information about the components, the problem
becomes one of cluster analysis [154].
The likelihood in Equation (2.10) can be maximised by substituting the ordinary ML
estimates of µg and σg. The estimate of µg, whatever the assumption about the σg, is
µˆg(γ) = (mgx¯g+ngy¯g)/(mg+ng),
where y¯g is the mean of the ng observations in Cg. When µˆg(γ) is substituted for µg in
expression (2.10) it follows that the ML estimate, γˆ, of γ can be found by minimising
G
∑
g=1
{tr[(Wgx +Wgy +Wgxy)σ−1g ]+ (mg+ng) log |σg|} (2.11)
where
Wgx =
mg
∑
i=1
(xgi− x¯g)(xgi− x¯g)′, Wgy = ∑
Cg
(yi− y¯g)(yi− y¯g)′,
and
Wgxy =
mgng
mg+ng
(y¯g− x¯g)(y¯g− x¯g)′.
Two different situations may occur: the covariance matrices are equal or are different.
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In the first scenario, expression (2.11) reduces to
tr[(Wx+Wy+Wxy)σ
−1]+ (m+n) log |σ|, (2.12)
whereWx = ∑Wgx is the within-groups sum of squares matrix for the x’s,Wy = ∑Wgy is
the within-groups sum of squares matrix for the y’s, andWxy = ∑Wgxy is the contribution
due to the differences between the y’s and x’s. If σ is known, (2.12) reduces further and
the criterion proposed by Edwards and Cavalli-Sforza [46] may be obtained as a particular
example. If σ is not known, it follows that γˆ is the grouping that minimises
|Wx+Wy+Wxy|.
A particular case of this scenario is the criterion proposed by Friedman and Rubin in [61].
When, instead, the covariance matrices are all different and are specified, Scott and
Symons attributed little of interest about this case. On the other hand, if σ’s are not known,
γˆ is the grouping that minimises
G
∏
g=1
|Wx+Wy+Wxy|mg+ng .
It is important to realize that the maximum likelihood methods will always parti-
tion the data into the maximum number of partitions allowed without suggesting the
best number of groups. Scott and Symons suggested to rephrase the question of ‘how
many clusters are there?’ as a testing problem. For example, the fundamental question
whether there is more than one cluster can be considered as a test of the null hypothesis
H0 : γ1 = γ2 = . . . = γn against the alternative that not all the γi’s are equal. If λ denotes
the likelihood ratio statistic, then, in the case σg = σ(g= 1, . . . ,G) with σ unknown,
−2logλ = n log[max
γ
(|T|/|Wy|)], (2.13)
where T= ∑(yi− y¯)(yi− y¯)′ is the total scatter matrix [154].
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The maximisation of the quantity on the right hand side of (2.13) is today known as
the Scott and Symons criterion. The maximum likelihood approach and the assumption
that data are generated by a mixture of underlying probability distributions will be used
again in model-based clustering (see Section 2.5) where the criterion of Scott and Symons
will be derived as a particular case.
Marriott Validity Index
Starting from the criterion proposed by Friedman and Rubin [61] for clustering va-
lidity, Marriott analysed it from the point of view of a practical user, stating that certain
difficulties arise both in the computational and in the interpretation of the results [118].
According to his work, the basic question of ‘how many groups are there for a set of
observation?’ may be answered in two stages:
(a) What is the best subdivision into a given number, g, of groups?
(b) What is the best value of g?
One possible answer to (a) is that subdivision which minimises the variability within
groups. In terms of the procedure proposed by Friedman and Rubin [61] this means
minimising the determinant of the variance-covariance matrix |W|. However if one of
the variates is strongly grouped, the optimum subdivision defined by this approach may
well be entirely based on that variate. The method searches for any natural grouping, not
necessarily one based on all the measurements. According to Marriott the main advan-
tages of using |W| are that variables that are highly correlated in the whole population are
not given excessive weight and that a grouping that depends on high correlations within
groups is readily detected [118].
When an answer to the first point reported above is given for a range of values of
g, from 1 up to some preassigned maximum, it is necessary to decide which, if any, of
the subdivisions corresponds to a ‘natural’ clustering of the data. It is clear that if the
data are drawn from a population which is strongly grouped round a small number of
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modes, the optimum subdivision into the same number of groups will produce a large
reduction in |W|. If the underlying population is unimodal, or uniform, the reduction is
likely to be much smaller. It is easy to see that the optimum subdivision into g groups
of a uniformly distributed population reduces |W| by a factor g2. This suggests that the
criterion g2|W| may provide an answer to point (b) above [118] and the minimisation
of g2|W| is nowadays known as the Marriott validity index. The maximum difference
between successive levels is used to determine the best partition level [126].
As Marriott recognises in his original work, it is important to note that, although the
criterion g2|W| divides populations in a way that conforms reasonably well with intu-
itive ideas of natural clustering, if the population consists of a mixture of subpopulations
with very different dispersion matrices, it may be split into too many subdivisions and
recombination of some groups may be necessary [118].
From a theory prospective, if the observations are considered independently uniformly
distributed on (0, 1), the subdivision of a univariate rectangular distribution on (0, 1) into
g groups is optimum when the sections are equal. This reduces the standard deviation by
a factor g, and the variance by g2. Such a subdivision of any of the k covariates in the
multivariate case reduces |W| by a factor of g2. If g is prime, these are the only optimum
subdivisions. If g is composite, however, there are further cases; if g= g1g2, a division of
any two covariates into g1 and g2 equal subdivisions respectively will also reduce |W| by
g2. In fact, all possible subdivisions into ‘boxes’ of the same size, shape, and orientation
are optimum. It seems reasonable to adopt as an optimum subdivision of a distribution or
sample the one that minimises g2|W| [118].
Marriott also described those drawbacks of his criterion, especially those problems
that may arise from the data. In particular, considering the computational procedure, he
stated that, ideally, the optimum subdivision of a data set could be found by calculating
the criterion |W| for all possible subdivisions into g groups, and selecting the least value
[118]. In practice, however, this is only possible for trivially small data sets, except in the
one-dimensional case.
2.2. Clustering validation 38
Another issue concerns the way in which data are collected and recorded. If this
procedure is done with limited accuracy it may happen that the grouping will be affected.
In general, the less accurately a measurement is recorded, the more influence it is likely
to have on the grouping [118].
The most significant problem is related to a possible linear dependence between co-
variates. In particular, when many variables are measured, often there are high correla-
tions between them; in this case, the grouping procedure breaks down, and it is necessary
to reduce the dimensionality of the data. The simplest way of doing so suggested by Mar-
riott is by taking principal components. A preliminary analysis transforms the data into
principal components, and then the first k are chosen for use in the cluster analysis. The
value of k should be large enough to include virtually all the information in the original
data; the process should stop when the variance of the components becomes comparable
with the measurements error [118]. It is important to note that the actual vectors rep-
resenting the principal components are not important in the subsequent analysis. What
is important is the space they span, and any linear combination of them would give the
same optimum subdivisions. Whereas the cluster analysis is scale-independent, the prin-
cipal components are not. Provided k is sufficiently large, however, this is not important.
Different methods of standardisation may give quite different component vectors, but the
space that they span will be virtually the same. It is also worth noting that a small value of
|W| does not necessarily imply that the component groups are unimodal. High correlation
within groups may ‘hide’ a secondary grouping, and this can only be detected by further
reduction in dimensionality.
Calinski and Harabasz Validity Index
Milligan and Cooper [126] have provided a survey of several validity indices for data
sets containing distinct non–overlapping clusters while using only hierarchical clustering
algorithms. The authors recommended to use the Calinski and Harabasz procedure which,
for their experiment, was the best performing validity criterion.
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This index [20] for n data points and K clusters is computed as
[traceB/(K−1)]
[traceW/(n−K)] .
Here, B andW are the between and within cluster scatter matrices. The maximum hierar-
chy level is used to indicate the correct number of partitions in the data. The trace of the
between cluster scatter matrix B can be written as
traceB=
K
∑
k=1
nk‖zk− z‖2,
where nk is the number of points in cluster k and z is the centroid of the entire data set.
The trace of the within cluster scatter matrixW can be written as
traceW =
K
∑
k=1
nk
∑
i=1
‖xi− zk‖2
where zk is the centroid of the cluster k [120]. Therefore, the Calinski and Harabasz (CH)
index can be written as [120]
CH =
[
∑Kk=1 nk‖zk− z‖2
K−1
]
/
[
∑Kk=1∑
nk
i=1 ‖xi− zk‖2
n−K
]
.
According to Ka¨ster et al. [96], matrices B andW can be computed in the following way:
B= ∑
Ci∈G
|Ci|(mi− x¯)(mi− x¯)′
and
W = ∑
Ci∈G
∑
x∈Ci
(x−mi)(x−mi)′,
where Ci indicates a cluster of the grouping G, mi is the centroid of cluster Ci, and x¯ is
the mean of all data points in the data set under investigation.
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2.2.3 Validity indices for fuzzy clustering
In fuzzy clustering methodology, the fuzzy partition matrixU = (µi j)n×c (introduced
in Section 2.1.4), represents the membership degree of data point i to its cluster centre j.
The higher the value of µi j, the stronger the data point i belongs to cluster j.
For fuzzy clustering, several validity indices have been defined in literature and a very
simple distinction can be made separating those involving only the membership values
from those also involving the data set. Among the first group, the Partition Coefficient,
the Partition Entropy Coefficient and the Proportion Exponent were considered. All the
other indices analysed subsequently will be involving in their definition the data set too.
Partition Coefficient and Partition Entropy Coefficient
The Partition Coefficient (PC) was proposed by Bezdek et al. in 1984 [13] and was
defined as:
PC =
1
n
n
∑
i=1
c
∑
j=1
µ2i j (2.14)
where n is the number of data points and c the number of clusters. The Partition Coeffi-
cient takes values in the range [1
c
,1]. When PC = 1/c, the situation where all data points
have an equal membership to all cluster centres occurs, indicating that the clustering is the
most fuzzy. Furthermore, a value close to 1/c indicates that there is no clustering tendency
in the considered dataset or the clustering algorithm failed to reveal it. When PC = 1, all
clusters have well-defined borders, which means that each data point has a membership
to its cluster centre of one and the algorithm is actually the K-means one. Therefore, as
the clustering quality increases, the value of PC also increases [74].
The Partition Entropy Coefficient (PE) was also proposed in [13] and was defined
as:
PE =−1
n
n
∑
i=1
c
∑
j=1
µi j · loga(µi j) (2.15)
where the logarithmic base a is in (1,+∞) and PE ∈ [0, loga(c)]. Similarly to PC, there
are two extreme situations corresponding to the extreme values of PE. When PE = 0,
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the clusters are well separated and a similar situation to PC = 1 occurs. In contrast,
when PE = loga(c), the clustering is fuzzier and the adopted fuzzy algorithm is unable to
extract the clustering structure. Thus, as the clustering quality increases, the value of PE
decreases [74, 175].
According to Sun et al., these two indices are easy to compute. They are also useful
when the data contains only a small number of well-separated clusters. However, there
is a lack of direct connection to the geometrical properties of the data [162]. Further
limitations of PC and PE have been pointed out by Halkidi and colleagues in [74]:
1. they are monotonously dependent on the number of clusters. Thus, a significant
increase (for PC) or decrease (for PE) is visible when the number of clusters c
increases.
2. They are too sensitive to the fuzzifier, m. More specifically, as m→ 1, the indices
give the same values for all values of c.
3. They lack direct connection to the geometry of the data, since they do not use the
data itself.
The Proportion Exponent Validity Index
According to Windham [187], the most important question associated with the use of
a clustering algorithm is simply how well has it identified structure that is present in the
data. Windham defined a function which assigns to a collection of membership functions
a real number called the proportion exponent. It is assumed that the output of a fuzzy
clustering algorithm includes a c×n matrix,U = (ui j), where c is the number of clusters
identified and n is the number of data points and 2 ≤ c ≤ n. Each row of U is associated
with a particular cluster and each column is the membership function of a particular data
point. For each j= 1, . . . ,n define µ j =maxi(ui j) and I j to be the greatest integer in 1/µ j.
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The proportion exponent ofU , P(U), is defined in [187] by
P(U) =− log2
(
n
∏
j=1
( I j
∑
k=1
(−1)k+1
(
c
k
)
(1− kµ j)c−1
))
. (2.16)
To justify the negative logarithm, Windham stated that it spreads the values of the func-
tional over a much wider range, particularly for proportions near zero. It also implies that
large values for the proportion exponent indicate that the algorithm has worked well [187].
It is important to note that the evaluation of the proportion exponent index does not
involve the data or the algorithm used to partition them and its maximum implies the
optimal partition but without knowing what maximum is a statistically significant maxi-
mum. Moreover, 0≤ P(U)< ∞, since the [0,1] values of the argument in (2.16) explode
to [0,∞) due to the logarithm. Specifically, P = 0 when and only when U = [1/c], while
P→ ∞ when any column of U is crisp [12].
The Separation Index
This index identifies unique cluster structure with well-defined properties that depend
on the data and a measure of distance. It seeks compact and separated (CS) clusters,
but it rather seems computationally infeasible for big data sets since a distance matrix
between all the data membership values has to be calculated. It also presupposes that
a hard partition is derived from the fuzzy one. The separation index D1 was firstly
introduced by Dunn [44] and defined as
D1 = min
1≤i≤c
{
min
i+1≤ j≤c−1
{
dis(ui,u j)
max1≤k≤c{dia(uk)}
}}
,
where the diameter of the subset uk is given by
dia(uk) = max
Xi,X j∈uk
d(Xi,X j),
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the distance of two subsets ui and u j is
dis(ui,u j) = min
XI∈ui,X j∈u j
d(Xi,X j)
and d is any metric induced by an inner product on the data definition space. The CS
clustering is to be found by solving
max
2≤c≤n
{max
Ωc
D1},
where Ωc denotes the optimality candidates at fixed c [191]. It has been proved [12, 45]
that a hard c-partition of the data set contains c compact, separate clusters if and only
if D1 > 1. Furthermore, Dunn proved that if there is a partition U such that D1 > 1,
that partition U is unique [45]. This result shows that CS partitions are distinguished by
uniqueness whenever they exist. Since there is at most one such hard clustering of the
data set at each c, a validity strategy based on maximising D1 over all partitions is well
defined via this unique limit. The proof itself depends on a simple observation: since the
data set X is fixed, any pair of distinct c-partitions of X must intersect [12].
Xie Beni Validity Index
In 1991, Xie and Beni presented a fuzzy validity criterion based on a validity func-
tion which identifies overall compact and separate fuzzy c-partitions without assumptions
on the number of substructures inherent in the data [191]. This function depends on the
data set, geometric distance measure, distance between cluster centroids, and more im-
portantly on the fuzzy partition generated by any fuzzy algorithm used. The function is
mathematically justified via its relationship to the hard clustering validity function, the
separation index, just defined above.
In order to define their validity index, Xie and Beni introduced several definitions
[191]. Consider a fuzzy c-partition of the data set X = {X j; j = 1,2, . . . ,n} with Vi(i =
1,2, . . . ,c) the centroid of each cluster and µi j(i = 1,2, . . . ,c, j = 1,2, . . . ,n) as the fuzzy
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membership of data point j (also called vector j) belonging to class i.
Definition 2.1 di j = µi j‖X j−Vi‖ is called the fuzzy deviation of X j from class i. ‖.‖ is the
usual Euclidean norm and di j is just the Euclidean distance between X j and Vi weighted
by the fuzzy membership function.
Definition 2.2 ni = ∑x j µi j is the fuzzy number of vectors in or fuzzy cardinality of class
i. Summing up the nis over xi the total number of observations n is obtained.
Definition 2.3 The variation of class i, denoted by σi and defined as σi = ∑x j (di j)
2 =
(di1)
2+(di2)
2+ . . .+(din)
2, is the summation of the squares of fuzzy deviation of each
data point for each class i. The total variation of the data set X with respect to the fuzzy
c-partition is defined as σ = ∑xi σi.
It is important to note that both σi and σ depend on the fuzzy c-partition. A better c-
partition should result in smaller σ.
Definition 2.4 The ratio, denoted by pi, of the total variation to the size of the data set,
that is, pi = (σ/n), is called the compactness of the fuzzy c-partition of the data set.
The value pi measures how compact each class is. The more compact the classes are, the
smaller pi is. pi is independent of the number of data points. For a given data set, a smaller
pi indicates that a partition with more compact clusters has been reached, thus indicating
a better partition.
Definition 2.5 The quantity pii = (σi/ni) is called the compactness of class i.
Definition 2.6 The separation of the fuzzy c-partition is defined by s = (dmin)
2, where
dmin is the minimum distance between cluster centres, i.e., dmin =mini, j ‖Vi−Vj‖.
A large value of s indicates that all clusters are separated.
Definition 2.7 (Xie and Beni validity index) The Xie and Beni validity index S, also cal-
led ‘the compactness and separation validity function’, is defined as the ratio between the
compactness pi and the separation s, i.e., S= pi/s.
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A small value of S indicates that all the clusters in the partition under consideration are
overall compact, and separate to each others. Thus, the fuzzy c-partition of X which
minimises the value of S is considered as the best one for the analysis.
The Xie and Beni validity index can also be written in the following way:
SXB =
∑ci=1∑
n
j=1 µ
m
i j‖Vi−X j‖2
nmini, j ‖Vi−Vj‖2 , (2.17)
and it can be easily seen that the definition of S is independent of the algorithm used to
obtain µi j [191].
Gath and Geva Validity Index
Gath and Geva introduced three main criteria for comparing and finding optimal par-
titions based on the heuristics that a better clustering assumes i) clear separation between
the clusters, ii) minimal volume of the clusters and iii) maximal number of data points
concentrated in the vicinity of the cluster centroids. The performance measures were
based on criteria for hypervolume and density [67]. The fuzzy hypervolume, FHV was
defined as
FHV =
c
∑
j=1
[det(Fj)]
1/2,
where Fj =
∑ni=1 ui j(xi−v j)(xi−v j)′
∑ni=1 ui j
, for the case when the fuzzifier is 2, c is the number of
clusters, n the total number of data points and ui j is the degrees of membership of xi in
the jth cluster.
The second criterion, the average partition density DPA, was calculated from
DPA =
1
c
c
∑
j=1
S j
[det(Fj)]1/2
,
where S j = ∑
n
i=1 ui j.
Moreover, Gath and Geva also defined the partition density, which expresses the gen-
eral partition density according to the physical definition of density and was calculated
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by:
PD =
S
FHV
,
where S= ∑cj=1∑
n
i=1 ui j.
The hypervolume criterion is related to the within-cluster scatter, but due to its fuzzy
characteristics the FHV is not a monotone function of c (number of clusters). An optimal
partition in the data would be the one for which FHV reaches its minimum.
Rezaee et al. Validity Index
Rezaee et al. [148] introduced a new cluster validity index, which assessed the separa-
tion between clusters and the cohesion within clusters, which were generated by the fuzzy
c-means (FCM) algorithm. They noted that a reliable validation functional for the FCM
must consider both the compactness and the separation of a fuzzy c-partition because if
only the compactness requirement were considered, the best partition would be obtained
when each data point were considered as a separate cluster. On the other hand, if only the
optimal separation between clusters were considered, the best partition would be the data
itself; the distance between a cluster (the total data set in this case) and itself is zero.
In order to avoid these situations they designed the ‘Compose Within and Between
scattering’ (VCWB) index. It was defined by combining the average of the scattering (vari-
ation) within the c clusters and the total scattering (separation) between the clusters. In
particular, several definitions were needed before defining the index itself. Assume a data
set X = {x1, . . . ,xn|xi ∈Rp}with a fuzzy partition in c clusters (V= {vi, . . . ,vc} indicating
the cluster centres) and U= [ui j(i= 1, . . . ,c; j = 1, . . . ,n)].
Definition 2.8 The variance of the pattern set X is called σ(X)∈Rp with the value of the
pth dimension defined as
σpx =
1
n
n
∑
j=1
(x
p
j − x¯p)2,
where x¯p is the pth value of the grand mean of X (X¯ = ∑nj=1 x j/n,∀x j ∈ X).
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Definition 2.9 The fuzzy variation of the cluster i is called σ(vi) ∈ Rp with the pth value
defined as
σpvi =
1
n
n
∑
j=1
ui j(x
p
j − vpi )2.
Definition 2.10 The average scattering for c clusters is defined as
Scat(c) =
1
c ∑
c
i=1 ‖σ(vi)‖
‖σ(X)‖ ,
where ‖x‖= (x′ · x)1/2.
Definition 2.11 A distance functional Dis(c) is defined as
Dis(c) =
Dmax
Dmin
c
∑
j=1
(
c
∑
z=1
‖v j− vz‖
)−1
,
where Dmax = max‖vi− vk‖ ∀i,k ∈ {2,3, . . . ,c} is the maximum distance between the
cluster centres. The Dmin has the same definition as Dmax, but for the minimum distance
between the cluster prototypes.
The validation index VCWB proposed by Rezaee et al. is a combination of the last two
definitions:
VCWB(U,V) = α Scat(c)+Dis(c),
where α is a weighting factor equal to Dis(cmax) and it is needed because the two terms
of VCWB are of a different range [148].
In general, a small value for the scattering (Scat) within the clusters indicates a com-
pact partition, whereas the separation (Dis) term increased with the number of clusters.
For this reason, the authors proposed that a cluster number which minimises the valida-
tion index can be considered as an optimal value for the number of clusters present in the
data [148].
A summary of several validity indices for fuzzy clustering is reported in Table 2.2.
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Validity index Functional description
Optimal cluster
number
Partition coefficient PC =
1
n
n
∑
i=1
c
∑
j=1
µ2i j maxPC
Partition entropy PE =−1
n
n
∑
i=1
c
∑
j=1
µi j · loga(µi j) minPE
Proportion exponent P(U) =− log2
(
n
∏
j=1
( I j
∑
k=1
(−1)k+1
(
c
k
)
(1− kµ j)c−1
))
maxP(U)
Separation index D1 = min
1≤i≤c
{
min
i+1≤ j≤c−1
{
dis(ui,u j)
max
1≤k≤c
{dia(uk)}
}}
max
2≤c≤n
{max
Ωc
D1}
Xie and Beni SXB =
c
∑
i=1
n
∑
j=1
µ2i j||Vi−X j||m
nmin
i, j
‖Vi−Vj‖2
minSXB
Gath and Geva
FHV =
c
∑
j=1
[det(Fj)]
1/2 minFHV(hypervolume)
Rezaee et al. VCWB(U,V) = α Scat(c)+Dis(c) minVCWB
xk is the k-th data point, vi are cluster centres, c is the number of clusters, and uik is the membership
value of data xk of class ci.
Table 2.2: Several validation functionals for fuzzy clustering [148]
2.2.4 Principal component analysis
When a clustering algorithm is applied over a dataset, results may be displayed thro-
ugh various different methods. One of the most widely used is the biplot, which shows
information on both samples and variables emphasising the clusters by using different
colours or symbols. Samples are displayed as points while variables are displayed us-
ing vectors. Biplots were firstly introduced by Gabriel in [63]. In order to represent
multi-dimensional data, the original data space is transformed using Principal Compo-
nent Analysis (PCA) [86], and then the points are displayed at their projected position on
axes of the first kth principal components considered (usually two or three).
The main purpose of PCA is to reduce the dimensionality of a data set consisting of a
large number of correlated variables, while retaining as much as possible of the variation
present in the data set. This is achieved by transforming to a new set of variables, the
principal components (PCs), which are uncorrelated, and which are ordered so that the
first few retain most of the variation present in all of the original variables [92]. The
transformation is achieved by rotating the original axes to produce orthogonal axes that are
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uncorrelated to each other. The rotation procedure is a linear transformation of the original
dataset and, therefore, if all the variables are included in the rotation, then all information
is preserved [86]. The first component can be described as the orthogonal projection
into one dimension that maximises the variance of the projected points; removing this
dimension and its associated variance, the second component is the projection into one
dimension that maximises the variance of the projected new array of points, and so on
[46].
Suppose that x is a vector of p random variables, and that the variances of the p ran-
dom variables and the structure of the covariances or correlations between the p variables
are of interest. Unless p is small, or the structure is very simple, it will often not be very
helpful to simply look at the p variances and all of the 12 p(p− 1) correlations or covari-
ances. An alternative approach is to look for a few (≪ p) derived variables that preserve
most of the information given by these variances and correlations or covariances. Al-
though PCA does not ignore covariances and correlations, it concentrates on variances.
The first step is to look for a linear function α′1x of the elements of x having maximum
variance, where α1 is a vector of p constants α11,α12, . . . ,α1p, and
′ denotes transpose,
so that
α′1x= α11x1+α12x2+ . . .+α1pxp =
p
∑
j=1
α1 jx j.
Next, look for a linear function α′2x, uncorrelated with α
′
1x having maximum variance,
and so on, so that at the kth stage a linear function α′kx is found that has maximum variance
subject to being uncorrelated with α′1x, α
′
2x, . . ., α
′
k−1x. The kth derived variable, α
′
kx is
the kth PC. Up to p PCs could be found, but it is hoped, in general, that most of the
variation in x will be accounted for by m PCs, where m≪ p. By transforming the original
variables to PCs, a reduction in complexity is achieved [92].
The identification of PCs will be now described. Consider, for the moment, the case
where the vector of random variables x has a known covariance matrix σ. This is the
matrix whose (i, j)th element is the (known) covariance between the ith and jth elements
of x when i 6= j, and the variance of the jth element of x when i = j. The more realistic
2.2. Clustering validation 50
case, where σ is unknown, follows by replacing σ by a sample covariance matrix S. It
turns out that for k= 1,2, . . . , p, the kth PC is given by zk =α
′
kxwhere αk is an eigenvector
of σ corresponding to its kth largest eigenvalue λk. Furthermore, if αk is chosen to have
unit length (α′kαk = 1), then var(zk) = λk , where var(zk) denotes the variance of zk.
To derive the form of the PCs, consider first α′1x; the vector α
′
1 maximises var[α
′
1x] =
α′1σα1. It is clear that, as it stands, the maximum will not be achieved for finite α1
so a normalization constraint must be imposed. The constraint used in the derivation
is α′1α1 = 1, that is, the sum of squares of elements of α1 equals 1. Other constraints,
for example max j ‖α1 j‖ = 1, may be more useful in other circumstances. However, the
use of constraints other than α′1α1 = constant in the derivation leads to a more difficult
optimization problem, and it will produce a set of derived variables different from the PCs.
To maximise α′1σα1 subject to α
′
1α1 = 1, the standard approach is to use the technique of
Lagrange multipliers. Maximise
α′1σα1−λ(α′1α1−1),
where λ is a Lagrange multiplier. Differentiating with respect to α1 gives
2σα1−2λα1 = 0,
or
[σ−λIp]α1 = 0,
which is an ordinary eigenproblem where Ip is the (p× p) identity matrix. Thus, λ is
an eigenvalue of σ and α1 is the corresponding eigenvector. To decide which of the p
eigenvectors gives α′kx with maximum variance, note that the quantity to be maximised is
α′1σα1 = α
′
1λα1 = λα
′
1α1 = λ
(in the last equality the constraint α′1α1 = 1 was used). Thus, λ should be as large as
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possible and α′1x is the first principal component of x. In general, the kth PC of x is α
′
kx
and var(α′kx) = λk, where λk is the kth largest eigenvalue of σ, and αk is the corresponding
eigenvector [92].
It is well recognised [86,92] that the first papers describing principal component anal-
ysis were written by Pearson in 1901 and by Hotelling in 1933 [83], with the latter de-
scribing the general procedure as it is known today. Hotelling’s approach starts from the
idea of factor analysis, but he prefers to call the “new independent variables [...] which
determine the values of the original” ones [83] as ‘components’ to avoid confusion with
the term ‘factors’ which has already been used in mathematics [92]. Hotelling chooses
his ‘components’ so as to maximise their successive contributions to the total of the vari-
ances of the original variables, and calls the components that are derived in this way the
‘principal components’. In [83] they are obtained using Lagrange multipliers and ending
up with an eigenproblem. However, Hotelling’s procedure differs from the one described
above in three different aspects. First, he worked with a correlation, rather than covari-
ance, matrix; second, he looked at the original variables expressed as linear functions of
the components rather than components expressed in terms of the original variables; and
third, he did not use matrix notation [92].
2.2.5 Agreement between classifications
In the contest of clustering validity, when more than a single clustering technique is
used, a method for assessing the agreement between the different classifications returned
is to measure this agreement through a particular index. This measurement may be also
useful when comparing clustering results against external criteria and it may help in the
definition of a consensus clustering among the techniques used.
In 1960, Cohen introduced the kappa coefficient κ as a statistical measure of inter-
rater agreement for qualitative (categorical) items [30]. Until then, the most frequently
used index had been percentage or proportion of agreement (po), which suffers in that
it includes agreement which can be accounted for by chance. The κ index, instead, is
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generally thought to be a more robust measure since it takes into account the agreement
occurring by chance. Occasionally, the k×k table of joint categorical assignment frequen-
cies had been treated as a contingency table, and the contingency coefficient,C, based on
chi-square, χ2, had been used as a measure of agreement. The defect of χ2 in this context,
and therefore of C, is that it indexes association and not necessarily agreement, which is
the special kind of association of interest in reliability [31].
The original kappa index proposed by Cohen [30] was defined as
κ =
po− pc
1− pc (2.18)
where po is the observed proportion of agreement, and pc is the proportion of agreement
expected by chance. Cohen also presented large sample formula for the standard error of
an observed κ
σκ ∼=
√
po(1− po)
N(1− pc)2 (2.19)
used for setting confidence limits and performing two-samples hypothesis tests [31].
Kappa index yields negative values when there is less observed agreement than is expected
by chance, zero when observed agreement can be (exactly) accounted for by chance, and
unity when there is complete agreement.
Further developments of κ were presented by Cohen himself in 1968 when he in-
troduced the weighted kappa index. These were motivated by studies in which it was
the sense of the investigator that some disagreements in assignments, that is, some off-
diagonal cells in the k×k matrix, were of greater gravity than others. The κ, instead, does
not make such distinction, implicitly treating all disagreement cells equally.
The weighted kappa index κw was derived considering the following steps [31]. If
the proportion of disagreement is defined as q = 1− p, then p = 1− q. Substituting
po = 1−qo and pc = 1−qc into Equation (2.18) and simplifying, it can be obtained
κ =
qc−qo
qc
= 1− qo
qc
(2.20)
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an equation for κ expressed in terms of observed and chance disagreement. κw simply
replaces qo and qc by proportions of weighted disagreement, q
′
o and q
′
c. To find the latter,
each of the k2 cells must have a disagreement weight, vi j, where the i j subscript indexes
the cell (i, j = 1, . . . ,k). These positive weights can be assigned by means of any judg-
ment procedure set up to yield a ratio scale. It is convenient (even though not necessary)
to assign zero to the ‘perfect’ agreement diagonal (i = j), that is, no disagreement. A
weight which represents maximum disagreement (vmax) is assigned at the convenience of
the investigator. For any set of vi j, κw is invariant over any positive multiplicative trans-
formation. The weights assigned are an integral part of how agreement is defined and
therefore how it is measured with κw [31].
Proportions of weighted disagreement, observed by chance, are simply weighted func-
tions over the k2 cells of the poi j and pci j, respectively, namely
q′o =
∑vi jpoi j
vmax
(2.21)
q′c =
∑vi jpci j
vmax
(2.22)
where the poi j is the proportion of the joint judgments (N in number) observed in the i j
cell, and the pci j the proportion in the cell expected by chance. Weighted kappa is then
given by
κw = 1− q
′
o
q′c
. (2.23)
When (2.21) and (2.22) are substituted in (2.23), the vmax term drops out, and it simplifies
to
κw = 1− ∑vi jpoi j
∑vi jpci j
. (2.24)
Like the ‘unweighted’ kappa index, κw is fully chance corrected.
An interesting aspect is the relationship between κw and κ. The kappa index is simply
proportion of agreement (po) corrected for chance, and κw can readily be thought of
as a generalisation of κ, proportion of weighted agreement corrected by chance. The
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relationship may be more clearly understood if it is inverted: κ is a special case of κw.
In κw one may differentially weight, using vi j, the off-diagonal (i 6= j) cells, because it is
meant to consider the various kinds of disagreement. For κ, the k(k−1) off-diagonal cells
representing disagreement are simply treated as if they all represented the same amount
of disagreement. Thus, κ is the special case of κw where all disagreements are given the
same weight [31].
The discussion about weighted kappa index so far have implicitly assigned equal
weights to symmetric cells, that is, vi j = v ji. This is appropriate to the frame of reference
of reliability, where the two sources of data are conceived as being of equal status, that is,
as alternate forms. Some reflection suggests that the formal difference between reliabil-
ity and validity lies in the contrast between equal status of the sources in the former and
their differing status in validity, where one is a predictor and the other a criterion. When
validity is being assessed, it may (but need not) be eminently reasonable for vi j 6= v ji [31].
Another widely used measure to assess the agreement between classifications is the
Rand index [146]. Given a set of n objects S = {O1, . . . ,On}, let U = {u1, . . . ,uR} and
V = {v1, . . . ,vC} represent two different partitions of the objects in S such that ∪Ri=1ui =
S = ∪Cj=1v j and ui∩ui′ = ∅ = v j ∩ v j′ for 1 ≤ i 6= i′ ≤ R and 1 ≤ j 6= j′ ≤C. One of the
partition may be the external criterion and the other a clustering result or both of them
may be clustering results. Let a be the number of pairs of objects that are placed in the
same element in partitionU and in the same element in partition V , and d be the number
of pairs of objects in different elements in partitions U and V [194]. b and c equal the
number of pairs of objects which are not co-clustered, as reported in Table 2.3.
U/V co-clustered not co-clustered
co-clustered a b
not co-clustered c d
Table 2.3: Contingency table for two partitions [57]
The Rand index [146] is defined simply as the fraction of agreement, i.e.
R(U,V ) = (a+d)/
(
n
2
)
.
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The Rand index lies between 0 and 1, as, by definition, it is normalised. When the two
partitions are identical, the Rand index is 1 [194].
A problem with the Rand index is that the expected value of the Rand index of two
random partitions does not take a constant value. For this reason, Hubert and Arabie [85]
defined the adjusted Rand index which corrects for this by assuming the general form
index - expected index
maximum index - expected index
.
In this general form the index is bounded above by 1, and takes the value 0 when the
index equals its expected value [193]. As for the Rand index, a higher adjusted Rand
index means a higher correspondence between the two partitions. The adjusted Rand
index proposed by Hubert and Arabie was recommended by Milligan and Cooper [127]
as the measure of agreement even when comparing partitions having different number of
clusters.
Filkov and Skiena [57] defined the complementary measure of the Rand index, and
called it the Rand distance. The authors defined it as the frequency of pairwise disagree-
ments betweenU and V
1−R(U,V ) = (b+ c)/
(
n
2
)
.
2.2.6 Summary
At the beginning of this section, three general questions about cluster validation were
presented. To answer the first one, ‘How many clusters should be considered?’, it is
possible to run several times a clustering algorithm (each time with a different number of
groups as input) and store, after each run, the value of the chosen index for that specific
configuration. Then, the decision rule for a specific index can be used to select the best
set of clusters for the problem under investigation.
A similar approach may be used to answer the second question (‘How good are the
partitions?’): as the majority of the indices are built considering the dispersion of data
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points within and between clusters, a good grouping will be the one where clusters are
compact and well separated, i.e. the one for which indices express a low dispersion of
points within clusters and a high one between groups. This internal property makes the
validity indices suited to the problem of selecting the proper number of groups in classical
cluster analysis.
The problem of evaluating a better partition than the one found, which answers the
last question reported at the beginning of this section, may be addressed considering the
different scores for measuring the agreement between classifications. When more than a
single clustering algorithm is used, the concordance between different groupings returned
may be assessed resorting to agreement scores like Cohen’s kappa or Rand index. These
may be also helpful when clustering results need to be compared with external criteria
(such as partitions obtained with completely different approaches).
All these approaches have been described in this section, analysing in detail several
validity indices for both hard and fuzzy clustering methods, and presenting scores for
assessing the concordance between different partitions.
2.3 Clustering for breast cancer data
After the seminal paper of Eisen and colleagues [47], proposing hierarchical clustering
and the visual inspection of the dendrogram to discover unknown pattern of gene associa-
tions, the use of clustering has become more and more popular, especially for discovering
profiles in cancer with respect to high-throughput genomic data. Important applications
of the Eisen et al. method are the work of Bittner et al. [15] on clustering of cutaneous
melanoma and the works of van’t Veer et al. [170] and Perou et al. [137] on breast can-
cer. In particular, Perou et al. [137] characterised variation in gene expression patterns
in a set of 65 surgical specimens of human breast tumours from 42 different individuals,
using complementary DNA (cDNA) microarrays representing 8102 human genes. Sets of
co-expressed genes were identified for which variation in messenger RNA levels could be
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related to specific features of physiological variation. The tumours could be classified into
subtypes distinguished by pervasive differences in their gene expression patterns [137].
Authors identified four molecular distinct breast cancer groups based on gene expression
profiles using a hierarchical clustering algorithm: luminal epithelial/estrogen (ER) posi-
tive, HER2 positive, basal-like and normal breast-like.
A subsequent study by Sørlie et al. [158] extended Perou and colleagues’ work by im-
proving the breast cancer classification. In particular, a total of 85 cDNA microarray tis-
sue samples representing 84 individuals were analysed to classify breast carcinomas and
to correlate tumour characteristics to clinical outcome [158]. A novel finding compared
to previous Perou’s work [137], was that the luminal epithelial/estrogen receptor-positive
group could be divided into at least two subgroups, each with a distinctive expression pro-
file and different prognosis. Using a hierarchical clustering, the breast samples were sep-
arated into two large branches. One contained three subgroups previously defined [137],
while the luminal/ER+ group was separated into three distinct subgroups, which were
called luminal-A, B and C [158]. A difference in outcome was observed for tumours
classified as luminal A versus luminal B + C. The latter group of tumours, according to
Sørlie et al., might represent a clinically distinct group with a different and worse disease
course, in particular with respect to relapse [158].
In an additional work of 2003, Sørlie et al. refined their previous classification [158]
by analysing a total of 122 breast tumours using hierarchical clustering based on patterns
of expression of 534 “intrinsic” genes [159]. The genes used for classification were se-
lected based on their similar expression levels between pairs of consecutive samples taken
from the same tumour separated by 15 weeks of neoadjuvant treatment. The samples fell
into five major subgroups, characterised by distinct variation in gene expression pattern,
which were quite similar to the original ones and differed from them by the elimination of
the luminal-C group [159]. These five breast cancer subtypes were also associated with
significant difference in clinical outcome. The authors once again addressed the point that
gene expression studies have emphasised a considerable diversity among breast tumours,
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both biologically and clinically [137,158,159].
In a work published in 2003, Sotiriou and colleagues analysed gene expression pat-
terns generated from cDNA microarrays in an unselected group of 99 node-negative and
node-positive breast cancer patients [161]. Using unsupervised hierarchical cluster anal-
ysis on the 706 probe elements, selected as exhibiting high variability across all tumours,
two main groups based on their ER status were identified, which correlated well with basal
and luminal characteristics. This finding corroborated Perou’s previous analysis [137] that
the major factor discriminating the expression phenotype is ER status [161].
Analysing the results more in detail, it could be seen that the dendrogram further
branched into smaller subgroups within the ER+ and ER- classes. Within the ER negative
cluster were tumours with ‘basal’-like expression characteristics (basal 1 subgroup and
basal 2 subgroup). Furthermore, a subgroup distinct from the basal-like groups in the
ER- subset was defined by a high rate of HER-2/neu overexpression. The ER+ subgroup
showed differential expression of genes associated with ER activation. These were also
genes that defined the ER positive cluster as having ‘luminal’ characteristics as defined
in [137, 158]. Moreover, according to Sotiriou and colleagues [161], the ER+ cluster
could have been further segregated into three smaller subclasses, namely luminals 1, 2
and 3, similar to the luminals A, B and C identified by Sørlie et al. [158].
The authors underlined the importance of their results, since a concordance with those
of the earlier studies were shown despite the differences in patient populations, treatments
used, and technology platforms used [161].
Whilst numerous studies have reported the above and other novel molecular subtypes,
and assigned a prognostic significance to the proposed classes [22,170,184], they remain
varied in their detailed classification [84]. However, the following breast cancer groups,
identified in recent literature [158, 161], became a sort of gold-standard in cancer char-
acterisation: three luminal-epithelial groups, a HER2 positive cluster, and one or two
basal-like groups. On the other hand, more recent studies [72,95] began to criticize these
groups. In particular, Gusterson [72] addressed some of the negatives and positives gen-
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erated by the term basal-like breast cancer, and questioned its existence as an entity. He
argued that in such a rapidly advancing field like the breast cancer research, it is essential
that initial and thought-provoking results do not become established as ‘facts’ without
question. Furthermore, Gusterson stated that the identification of basal-like breast cancer
on the basis of gene-expression profiling data has been misleading in some respect and
that a clear, basic understanding of breast cancer biology is needed to fully interpret gene-
expression profiling data, in particular to improve the treatment of patients with triple
negative cancers [72].
It is also worth noting that the visual inspection of the dendrogram suggested by Eisen
et al. [47] is an informal method to determine the number of clusters. Such a procedure
was firstly criticized byMarriot [118], who stated that the hierarchical methods may detect
a natural grouping if it is sufficiently obvious, but do not appear to be primarily directed
to doing so. Also Goldstein and colleagues [70] questioned the hierarchical approach, as,
they said, it can cause difficulty in assessing the validity of the grouping. In particular,
in [70] authors aimed to highlight some of the issues that arise when hierarchical clus-
tering techniques are used in the analysis of cDNA microarray data. To illustrate these
issues, the work of Bittner et al. [15] on cutaneous melanoma was considered. It was
reported that results of the various clustering algorithms yielded different sets of clus-
ters that grouped together. For example, while average linkage cluster analysis yielded a
cluster of 19 melanoma samples for Bittner et al. [15] data, a cluster analysis using com-
plete linkage yielded a cluster of 22 melanomas, as opposed to 19 [70]. Another criticism
raised by Goldstein and colleagues was that there is not a standard criterion or algorithm
for choosing a cutoff point for a dendrogram. Rather, this choice is often made by visual
inspection. These, undoubtedly, leads to a certain degree of subjectivity being introduced
in the analysis. The last criticism introduced in [70] was related to the choice of samples
to be included in the clustering. The authors stated that finding genes which are differen-
tially expressed across arrays is a major aim of microarray analysis. Genes with very low
expression levels in some samples but not in others could be expected to be the basis of
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an unknown subclass of tumours; their removal from the data set may contribute to false
negative results, and could also encourage false positive results [70].
An alternative approach to gene expression profiling is to use established robust lab-
oratory technology, such as immunocytochemistry on formalin fixed paraffin embedded
patient tumour samples. Protein biomarker panels with known relevance to breast cancer
have been applied to large numbers of cases using tissue microarrays, exploring the exis-
tence and clinical significance of distinct breast cancer classes [1,5,21,39,40,87,100,115].
In particular, in [5] tumour biological profiles were explored on 633 archival tissue
samples analysed by immunohistochemistry. Five validated markers were considered,
namely, estrogen receptor (ER), progesterone receptors (PgR), Ki-67/MIB1 as a prolifer-
ation marker, HER2/NEU, and p53. For ER, PgR and HER2/NEU, the percentage of their
expression values tended to distribute around the values of 0%, 10%, 25%, 50%, 75%,
and 100%, and were therefore discretised on these values. The results obtained were
analysed by three different clustering algorithms. A hierarchical agglomerative algorithm
with Ward’s generalised criterion and two non-hierarchical techniques, K-means and Par-
titioning Around Medoids, were applied on the dataset considered. Four different validity
indices, applicable to both hierarchical and non-hierarchical techniques, were then used to
select the different profiles (number of clusters) [5]. The best classification was obtained
resorting to four clusters. In particular, three of them were identified according to low,
intermediate and high ER/PgR levels. A further subdivision into two biologically distinct
subtypes was determined by the presence/absence of HER2/NEU and of p53. As previ-
ously noted [158, 159], the cluster with high ER/PgR levels was characterised by a better
prognosis and response to hormone therapy compared to that with the lowest ER/PR val-
ues. Notably, the cluster characterised by high HER2/NEU levels showed intermediate
prognosis, but a rather poor response to hormone therapy [5]. Significant achievements of
this study were the consistency on the number of identified clusters with results of similar
studies [115] and a partial difference with earlier works [137, 140, 170], were a tendency
to identify only two profiles using hierarchical clustering was evident [5]. However, the
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authors were well aware that the suggested four-clusters solution did not imply that the
correct number of tumour subtypes was truly four. Increasing the number of investigated
markers might lead to an increase of the clusters number and to finer subdivisions.
Another study involving immunohistochemistry on tumour samples was the one of
Abd El-Rehim et al. [1] in which five breast cancer classes were defined. A sixth group
of only four cases was also identified but considered too small for further detailed assess-
ment. Groups 1 and 2 contained cancer that were luminal epithelial cell and hormone
receptor positive; two additional groups (3 and 6) were characterised by high c-erbB-2
positivity and negative or weak hormone receptors expression but showed differences in
MUC1 and E-cadherin expression. The fifth group (group 5) was characterised by strong
basal epithelial characteristics, p53 positivity, absent hormone receptors and weak to low
luminal epithelial cytokeratin expression. The final group (group 4), consisting of only
four tumours, was difficult to describe; however, it appeared to be characterised by a basal
phenotype with negative hormone receptor expression and strong expression of c-erbB2,
p53 and nuclear BRCA1. This dataset will be described more in detail in the next chapter.
Existing studies have also not addressed the stability of the proposed classifications
across different case sets, assay methods and data analysis procedures. Such an issue
appears of critical relevance considering the increase in the number of features involved
in bionformatics analyses. Moreover, especially in breast cancer studies, it is important
to resort to different clustering techniques rather than focusing the attention on a single
one, as diverse unsupervised classification methods usually return different groupings. To
combine the classifications returned by several algorithms, many approaches have been
proposed in the past. In the following section, a literature review on consensus clustering
will be presented.
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2.4 Consensus clustering
From a methodological perspective, to deal with the stability of classifications and in
particular of clustering techniques, several studies focused on the comparison and con-
cordance among different clustering methods defining what is now known as ‘consensus
clustering’.
Monti and colleagues in 2003 [130] presented a new methodology of class discov-
ery and clustering validation tailored to the task of analysing gene expression data. The
method can best be thought to guide and assist in the use of any of a wide range of avail-
able clustering algorithms. They call the new methodology consensus clustering, and in
conjunction with resampling techniques, it provides for a method to represent the con-
sensus across multiple runs of a clustering algorithm and to assess the stability of the
discovered clusters. The method can also be used to represent the consensus over mul-
tiple runs of a clustering algorithm with random restart (such as K-means, SOM, etc.),
so as to account for its sensitivity to the initial conditions. Cluster analysis, which aims
to discover distinct and non-overlapping sub-populations within a larger population, is of
particular significance in the field of gene expression data analysis. One of the fundamen-
tal issues to be addressed when clustering data (and especially in gene expression data
analysis) includes how to assign confidence to the selected number of clusters, as well
as to the induced cluster assignments, since the clustering results are especially sensitive
to noise and susceptible to over-fitting. The basic assumption of the method proposed by
Monti et al. was the following: if the data represent a sample of items drawn from distinct
sub-populations, and if a different sample drawn from the same sub-populations were to
be observed, the induced cluster composition and number should not be radically differ-
ent. Therefore, the more the attained clusters are robust to sampling variability, the more
one can be confident that these clusters represent real structure. To this end, perturbations
of the original data can be simulated by resampling techniques. The clustering algorithm
of choice can then be applied to each of the perturbed data sets, and the agreement, or con-
sensus, among the multiple runs can be assessed. Consensus clustering simply formalizes
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this procedure.
In a work of Swift and colleagues [163], consensus clustering was used to improve
confidence in gene-expression analysis as authors stated that microarray analysis using
clustering algorithms can suffer from lack of inter-method consistency in assigning related
gene-expression profiles to clusters. In this paper it was recognised that many different
heuristic algorithms, from the representative statistical ones (like K-means, Hierarchical
and PAM) to the artificial intelligence techniques (such as genetic algorithms, neural net-
works and simulated annealing), have been used for partitioning gene-expression data
with notable success [47]. To assess gene-expression cluster consistency, the use of the
weighted-kappa metric was analysed by Swift et al. This metric is generally used as a
comparison between two data partitions as it rates the agreement between the classifica-
tion decisions made by two or more observers (see Section 2.2.5 for details). In this case
the two observers are the clustering methods. The weighted-kappa compares clusters to
generate score within the range -1 (no concordance) to +1 (complete concordance). How-
ever, the weighted-kappa metric shows that, even for highly correlated gene-expression
profiles no two clustering algorithms have complete agreement. Overall this emphasizes
that no single analysis method will identify all patterns in the gene-expression data; there-
fore multiple analyses should be performed and compared. Robust clustering and consen-
sus clustering were suggested by the authors to achieve this goal.
Filkov and Skiena, in 2003 [57], proposed a methodology for consensus clustering as
an approach to integrating diverse sources of similarly clustered microarray data. They
proposed to exploit the popularity of cluster analysis of biological data by integrating
clusterings from existing data sets into a single representative clustering based on pair-
wise similarities of the clusterings. Under reasonable conditions, the consensus cluster
should provide additional information to that of the union of individual data analyses.
The goals of consensus clustering are to integrate multiple data sets for ease of inspec-
tion, and to eliminate the likely noise and incongruencies from the original classifica-
tions. An investigation of the use of consensus clustering for increasing the reliability
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of microarray gene expression data was performed by Filkov and Skiena [57]. It was
shown that the consensus clustering is a robust approach, even when derived from small
numbers of independent observations. Before studying the consensus clustering, Filkov
and Skiena introduced the comparison of clusters by resorting to the Rand index and by
defining the Rand distance. These two measures are complementary, as already shown
in Section 2.2.5. The un-normalised form of the Rand distance was accepted as measure
of choice. The consensus clustering was introduced by the authors by assessing that a
consensus set-partition should be representative of the given set partitions. In terms of
similarity it should be close to all given ones, or in terms of distance, it must not be too
far from any of them. One way to do this is to find a partition that minimises the distance
to all the other partitions. So, given k different partitions, Filkov and Skiena named the
sought one as the ‘consensus partition’.
Another approach has been used by Kellam and colleagues [98] where robust clusters
were identified by the implementation of a new algorithm called by the authors ‘Cluster-
fusion’. ‘Clusterfusion’ takes the results of different clustering algorithms and generates
a set of robust clusters based upon the consensus of the different results of each algo-
rithm. Firstly, an agreement matrix was generated with each cell containing the number
of agreements amongst methods for clustering together the two variables represented by
the indexing row and column indices. This matrix was then used to cluster variables based
upon their cluster agreement. In essence, the authors applied a clustering technique to the
clustering results.
2.5 Model-based clustering
In previous sections, a review of different clustering algorithms was presented. All
those techniques find clusters following a heuristic approach, i.e. by optimising some
criteria that depend on a distance between case pairs or between pairs of centroids of case
collections [123]. It is important to realise that there is another big group of clustering
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algorithms, called model-based clustering, which are based on probability models and that
offer a principled alternative to heuristic algorithms. In particular, model-based clustering
assumes that data is generated by a finite mixture of underlying probability distributions
such as multivariate normal distributions. The Gaussian mixture model has been shown
to be a powerful tool for many applications [9]. With the underlying probability model,
the issues of selecting a good clustering method and determining the correct number of
clusters are reduced to model selection problems in the probability framework [58]. This
provides a great advantage over heuristic clustering algorithms, for which there is no
established method to determine the number of clusters or the best clustering method
[192]. Model-based clustering has recently gained widespread use both for continuous
and discrete domains [9] mainly due to the fact that it allows one to identify clusters
based on their shape and structure rather than on proximity between data points [123].
With respect of standard heuristic clustering, the model-based approach has a couple
of advantages. Firstly, at each stage of hierarchical clustering, the splitting or merging is
chosen so as to optimize some criterion. In model-based methods, instead, a maximum-
likelihood criterion is used for merging groups [9]. Secondly, relocation methods move
observations iteratively from one group to another, starting from an initial partition. The
number of groups has to be specified in advance and typically does not change during
the course of the iteration. The most common relocation method (k-means) reduces the
within-group sums of squares. For clustering via mixture models, relocation techniques
are usually based on the EM algorithm (see Section 2.5.1) [58].
In model-based clustering it is assumed that data are generated by a mixture of G un-
derlying probability distributions in which each component represents a different group
or cluster. Given n observations x= (x1, . . . ,xn), let fk(xi|θk) be the density of an obser-
vation xi from the kth component, where θk are the corresponding parameters [58]. The
likelihood for the mixture model is
LMIX(θ1, . . . ,θG;τ1, . . . ,τn|x) =
n
∏
i=1
G
∑
k=1
τk fk(xi|θk), (2.25)
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where τk is the probability that an observation belongs to the kth components (τk ≥
0;∑Gk=1 τk = 1). These τk are also called mixing parameters [14]. In the Gaussian mix-
ture model, i.e. when fk(xi|θk) is multivariate normal, each component k is modeled by
the multivariate normal distribution with parameters µk (mean vector) and σk (covariance
matrix):
fk(xi|µk,σk) =
exp{−12(xi−µk)Tσ−1k (xi−µk)}√
det(2piσk)
. (2.26)
Clusters are ellipsoidal and centred at means µk. The covariances σk determine their other
geometric characteristics, like shape, volume and orientation [192].
Banfield and Raftery [9] developed a model-based approach for clustering based on
the parametrisation of the covariance matrix σk in terms of eigenvalue decomposition in
the following form:
σk = DkΛkD
T
k . (2.27)
In (2.27), Dk is the orthogonal matrix of eigenvectors, Λk is a diagonal matrix with the
eigenvalues of σk on the diagonal. The orientation of the principal components of σk is
determined by Dk, while Λk specifies the size and shape of the density contours. Λk may
be factorised as Λk = λkAk, where λk is the first eigenvalue of σk, Ak = diag{α1k, . . . ,αpk},
and 1= α1k ≥ α2k ≥ . . .≥ αpk > 0. Thus, the orientation of the kth cluster is determined
byDk, while λk and Ak determine, respectively, its size (in terms of volume occupied in the
p-space) and its shape [9]. From this parametrisation, several previously developed cri-
teria for maximising Equation (2.25) may be retrieved: σk = λI gives the sum of squares
criterion [71], in which clusters are spherical and have equal volume [58]. Instead, when
σk = σ(k= 1, . . . ,G), the criterion of Friedman and Rubin [61] is given, where all clusters
have the same shape, volume and orientation. Finally, the most general criterion of Scott
and Symons [154], which assumes all the components to be different, is obtained when
σk = λkDkAkD
T
k .
The model parameters may be estimated resorting to the Expectation Maximisation
(EM) algorithm of Dempster, Laird and Rubin [35].
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2.5.1 EM algorithm
The EM algorithm [35] is a general approach to find maximum likelihood solutions
in the presence of incomplete (latent) data [58]. The goal of EM is to maximise the
likelihood function with respect to the parameters (comprising the means and covariances
of the components and the mixing coefficients) [14]. In maximum likelihood estimation,
one wishes to estimate the model parameter(s) for which the observed data are the most
likely [16]. The algorithm will be motivated here by giving an informal treatment in the
context of the Gaussian mixture model. When a maximum of the likelihood function
is found, the condition that must be satisfied is the null value of the derivative of the
natural logarithm of LMIX(θ,τ|x) in (2.25) with respect to the means µk of the Gaussian
components:
n
∑
i=1
τk fk(xi|µk,σk)
∑Gj=1 τ j f j(xi|µ j,σ j)︸ ︷︷ ︸
γ(zik)
σ−1k (xi−µk) = 0 (2.28)
where Equation (2.26) has been used for the Gaussian distribution [14]. γik represent
the posterior probabilities (also called responsibilities) in contrast with the prior τks .
Assuming σk not to be singular, it can be multiplied by it and obtained
µk =
1
Nk
n
∑
i=1
γ(zik)xi,
where Nk is defined as Nk =
n
∑
i=1
γ(zik) and can be interpreted as the effective number of
points assigned to cluster k.
Setting to zero the derivative of lnLMIX(θ,τ|x) with respect to σk, and performing
similar calculations as above, the following relation is obtained:
σk =
1
Nk
n
∑
i=1
γ(zik)(xi−µk)(xi−µk)T .
Finally, when maximising lnLMIX(θ,τ|x) with respect to the mixing coefficients, the con-
strains underlying τk definition have to be taken into account. With a little bit of algebra
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(see [14] for details) it can be obtained
τk =
Nk
n
.
The results so far suggest an iterative scheme for finding a solution to the maximum
likelihood problem. At the beginning some initial values for the means, covariances and
mixing coefficients have to be chosen. Then an alternation between the following two
steps (E and M) is to be performed: in the expectation step, or E step, the current val-
ues for the parameters are used to evaluate the responsibilities (posterior probabilities)
γ. Then, in the maximisation step, or M step, these probabilities are used to re-estimate
the means, covariances and mixing coefficient using the above results. It was shown [14]
that each update to the parameters resulting from the E and M steps increases the log
likelihood function and that the algorithm converges when the change in the log likeli-
hood function, or alternatively in the parameters, falls below some threshold. The EM
algorithm procedure may be described as follows:
Initialise the means µk, covariances σk and mixing coefficients τk, and evaluate the
initial value of the log likelihood.
Repeat
E step. Evaluate the responsibilities using the current parameter values
γ(zik) =
τk fk(xi|µk,σk)
∑Gj=1 τ j f j(xi|µ j,σ j)
.
M step. Re-estimate the parameter using the current responsibilities
µnewk =
1
Nk
n
∑
i=1
γ(zik)xi
σnewk =
1
Nk
n
∑
i=1
γ(zik)(xi−µnewk )(xi−µnewk )T
τnewk =
Nk
n
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where
Nk =
n
∑
i=1
γ(zik).
Evaluate the log likelihood
until convergence criteria are satisfied.
Although convergence is assured since the algorithm is guaranteed to increase the
likelihood at each iteration [16], it is worth noting that EM takes many more iterations
to reach convergence compared with the K-means algorithm, and that each cycle requires
significantly more computations. It is therefore common to run the K-means algorithm
first in order to find a suitable initialisation for a Gaussian mixture model that is subse-
quently adapted using EM [14]. Moreover, the number of conditional probabilities asso-
ciated with each observation is equal to the number of components in the mixture, so that
the EM algorithm for clustering may not be practical for models with very large numbers
of components. Finally, EM breaks down when the covariance matrix corresponding to
one or more components becomes singular or nearly singular [58].
In literature, Banfield and Raftery [9] have addressed the problem of non-Gaussian
distributions suggesting a practical framework for model-based non-Gaussian cluster-
ing. Fraley and Raftery [58] have considered the problem of determining the structure
of clustered data, without any knowledge about the number of clusters or any information
about their composition. Different models with varying geometric properties were ob-
tained through Gaussian components and they were compared among each other. In Meilaˇ
and Heckerman [123], three basic algorithms for model-based clustering were compared,
namely the EMmethod, a ‘winner take all’ version of the EM algorithm, and model-based
agglomerative clustering. The Expectation Maximisation algorithm was found to signif-
icantly outperform the other two. Yeung et al. [192] applied model-based clustering to
gene expression data, showing the advantages of this approach over heuristic clustering
algorithms also by testing the Gaussian mixture assumption for different transformations
of expression data.
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More recently, Frey and Dueck explored the combination of model-based and heuris-
tic approaches and proposed a new clustering algorithm, called Affinity Propagation [60],
which will be described in Chapter 6. This method is part of the message-passing fam-
ily of algorithms (like the max-product algorithm [103]), which are used for performing
inference through local computation [14].
2.6 Supervised classification techniques
The goal of supervised learning is to build a concise model of the distribution of class
labels in terms of predictor features. The resulting classifier is then used to assign class
labels to the testing instances where the values of the predictor features are known, but
the value of the class label is unknown [101]. If instances are given with known labels
(the corresponding correct outputs) then the learning is called supervised, in contrast to
unsupervised learning, where instances are unlabeled. By applying these unsupervised
(clustering) algorithms, researchers hope to discover unknown, but useful, classes [89].
Inductive machine learning is the process of creating a classifier that can be used to
generalize from new instances. The process of applying supervised machine learning to a
real-world problem is described in Figure 2.4.
In the remaining part of this section, three different supervised classification algo-
rithms will be reviewed, namely, the C4.5 decision tree, the Multilayer Perceptron Artifi-
cial Neural Network (ANN), and the naive Bayes classifier.
2.6.1 Decision trees
Decision trees are trees that classify instances by sorting them based on feature values.
Each node in a decision tree represents a feature in an instance to be classified, and each
branch represents a value that the node can assume. Instances are classified starting at the
root node and sorted based on their feature values. The problem of constructing optimal
binary decision trees is an NP-complete problem and thus theoreticians have searched for
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Figure 2.4: The process of supervised machine learning [101]
efficient heuristics for constructing near-optimal decision trees [101].
Perhaps the most well-know algorithm in literature for building decision trees is the
C4.5 developed by Ross Quinlan [141]. C4.5 is an extension of Quinlan’s earlier ID3
algorithm and it uses the concept of information gain to make a tree of classificatory deci-
sions with respect to a previously chosen target classification [141]. Each attribute of the
data can be used to make a decision that splits the data into smaller subsets. C4.5 exam-
ines the normalized information gain (difference in entropy) that results from choosing an
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attribute for splitting the data. The attribute with the highest normalized information gain
is the one used to make the decision. The algorithm then recurs on the smaller sublists.
The output of the system is available as a symbolic rule base. The cases, described by
any mixture of nominal and numeric properties, are scrutinized for patterns that allow the
classes to be reliably discriminated. These patterns are then expressed as models, in the
form of decision trees or sets of if-then rules, which can be used to classify new cases,
with an emphasis on making the models understandable as well as accurate [141]. For
real world databases the decision trees become huge and are always difficult to under-
stand and interpret. However, decision trees tend to perform better when dealing with
discrete/categorical features [101]. In general, it is often possible to prune a decision tree
to obtain a simpler and more accurate tree [141].
2.6.2 Multilayer Perceptron ANN
A Multilayer Perceptron is a feed-forward artificial neural network model that maps
sets of input data onto a set of appropriate output. It is a modification of the standard linear
perceptron in that it uses three or more layers of neurons (nodes) with nonlinear activation
functions, and is more powerful than the perceptron in that it can distinguish data that is
not linearly separable, or separable by a hyperplane [80]. Typically, the network consists
of a set of sensory units that constitute the input layer, one or more hidden layers of
computation nodes, and an output layer of computation nodes. The number of nodes in
the hidden layer must be large enough to form a decision region that is as complex as
required by a given problem. Feed-forward ANNs allow signals to travel one way only,
from input to output [101].
Multilayer Perceptrons have been applied successfully to solve some difficult and di-
verse problems by training them in a supervised manner with a highly popular algorithm
known as the error back-propagation algorithm. Basically, error back propagation learn-
ing consists of two passes through the different layers of the network: a forward pass
and a backward pass. In the forward pass, an activity pattern (input vector) is applied to
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the sensory nodes of the network, and its effect propagates through the network layer by
layer. Finally, a set of outputs is produced as the actual response of the network. During
the forward pass the synaptic weights of the network are all fixed. During the back-
ward pass, on the other hand, the synaptic weights are all adjusted in accordance with an
error-correction rule. Specifically, the actual response of the network is subtracted from a
desired (target) response to produce an error signal. This error signal is then propagated
backward through the network, against the direction of synaptic connections – hence the
name ‘error back-propagation’. The synaptic weights are adjusted to make the actual
response of the network move closer to the desired response in a statistical sense.
A Multilayer Perceptron has three distinctive characteristics:
1. The model of each neuron in the network includes a nonlinear activation function.
2. The network contains one or more layers of hidden neurons that are not part of the
input or output of the network. These hidden neurons enable the network to learn
complex tasks by extracting progressively more meaningful features from the input
patterns (vectors).
3. The network exhibits a high degree of connectivity, determined by the synapses of
the network. A change in the connectivity of the network requires a change in the
population of synaptic connections or their weights.
It is through the combination of these characteristics together with the ability to learn
from experience through training that the Multilayer Perceptron derives its computing
power [80].
2.6.3 Naive Bayes
A Bayesian classifier is a fast supervised classification technique which is suitable
for large-scale prediction and classification tasks on complex and incomplete datasets.
Naive Bayesian classification assumes that the variables are independent given the classes
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[128]. It is also based on another common simplifying assumption: the values of numeric
attributes are normally distributed within each class.
Let C be the random variable denoting the class of an instance and X be a vector
of random variables denoting the observed attribute values. Let c be a particular class
label and x represent a particular observed attribute value. According to the independence
assumption, attributes X1 . . .Xn are all conditionally independent of one another, given
C. The value of this assumption is that it dramatically simplifies the representation of
the conditional probability P(X |C), and the problem of estimating it from the training
data [129]. In fact, accurately estimating P(X |C) typically requires many examples. To
see why, just consider the number of parameters that must be estimated whenC is boolean
and X is a vector of n boolean attributes. In this case, the following set of parameters
should be estimated:
θi j ≡ P(X = xi|C = c j)
where the index i takes on 2n possible values (one for each of the possible vector values
of X), and j takes on 2 possible values. Therefore, approximately 2n+1 parameters need
to be estimated. To calculate the exact number of required parameters, note for any fixed
j, the sum over i of θi j must be one. Therefore, for any particular value c j, and the 2
n
possible values of xi, only 2
n− 1 independent parameters need to be computed. Given
the two possible values for C one must estimate a total of 2(2n− 1) such θi j parameters
for learning Bayesian classifiers [129]. The Naive Bayes classifier, instead, reduces this
complexity by making a conditional independence assumption that reduces the number of
parameters to be estimated, when modeling P(X |C), form the original 2(2n−1) to just 2n.
Moreover, to estimate P(C|X), the training data can be used to learn estimates of P(X |C)
and P(C). New X examples can then be classified using these estimated probability dis-
tributions, plus Bayes rule. This type of classifier is called a generative classifier, because
the distribution P(X |C) can be viewed as describing how to generate random instances X
conditioned on the target attributeC [129].
If a test case x has to be classified, the probability of each class given the vector of
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observed values for the predictive attributes may be obtained using the Bayes’ theorem:
p(C = c|X = x) = p(C = c)p(X = x|C = c)
p(X = x)
(2.29)
and then predicting the most probable class. Because the event is a conjunction of attribute
values assignments, and because of the attributes conditional independence assumption,
the following equation may be written:
p(X = x|C = c) = ∏
i
p(Xi = xi|C = c)
which is quite simple to calculate for training and test data [91].
As previously mentioned, the second standard assumption of the classifier is that,
within each class, the values of numeric attributes are normally distributed. One can rep-
resent such a distribution in terms of its mean and standard deviation, and the probability
of an observed value from such estimates can be computed. For continuous attributes it
can be written
p(X = x|C = c) = g(x;µc,σc) , where (2.30)
g(x;µ,σ) =
1√
2piσ
e
− (x−µ)2
2σ2 (2.31)
is the probability density function for a normal (or Gaussian) distribution1.
The major advantage of the naive Bayes classifier is its short computational time for
training. In addition, since the model has the form of a product, it can be converted
into a sum through the use of logarithms - with significant consequent computational
advantages [101]. However, on many real-world datasets the latter condition is strongly
violated. It might happen that, even in such situations, the naive Bayes classifier performs
1It is important to note that Equation (2.30) is not completely correct: the probability for a random
variable of being exactly equal to any value is zero. Instead it is meant to consider a variable lying within
a specific interval: p(x≤ X ≤ x+ ε) = ∫ x+εx g(x;µ,σ)dx. By the definition of derivative, limε→0 p(x≤ X ≤
x+ ε)/ε = g(x;µ,σ). Thus, for very small values of ε, p(X = x)≈ g(x;µ,σ)× ε. The factor ε then appears
in the numerator of Equation (2.29) for each class. They cancel out when the normalisation is performed,
so Equation (2.30) may be used [91].
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well, but one should always be aware that not all the hypotheses are satisfied.
According to John and Langley, methods for inducing probabilistic descriptions from
training data have emerged as a major alternative to more established approaches to ma-
chine learning, such as decision-tree induction and neural networks. However, some of
the most impressive results to date have come from the naive Bayes classifier, a much sim-
pler – and much older – approach to probabilistic induction [91]. Despite the simplifying
assumptions that underlie this classifier, experiments on real-world data have repeatedly
shown it to be competitive with much more sophisticated induction algorithms. In [91]
the assumption that data are generated by a single Gaussian distribution is abandoned be-
cause it is not always the best approximation. Authors suggest to investigate more general
methods for density estimation, introducing what they call “Flexible Bayes”, an extension
of the naive Bayes classifier which uses a kernel density estimation. This method is very
similar to the naive Bayes, but the density of each continuous variable is estimated aver-
aging over a large set of kernels. The method performs well in domains that violated the
normality assumption and, in general, this flexible Bayesian classifier generalizes better
than the version that assumes a single Gaussian.
Bouckaert [17] also assesses that naive Bayes classifiers perform well over a wide
range of classification problems, and, compared with more sophisticated schemes, they
often perform better. He proposes a comparison of the three main methods for dealing
with continuous variables in naive Bayes classifiers, namely the normal method, the ker-
nel method and discretization. The normal method is the classical method that approxi-
mates the distribution of the continuous variable using a Gaussian distribution. The kernel
method is the one cited above [91] which uses a non-parametric approximation. Finally,
the discretization method [41] first discretizes the continuous variables into discrete ones,
leaving a simpler problem without any continuous variable. In general, it is acknowledged
that the normal method tends to perform worse than the other two methods. However, ac-
cording to the simulations and experiments run by Bouckaert, none of the three methods
systematically outperforms the others on all problems that were considered [17].
2.7. Similarities with Hyper-heuristics 77
2.7 Similarities with Hyper-heuristics
According to [186] a hyper-heuristic is:
“a heuristic search method that seeks to automate, often by the incor-
poration of machine learning techniques, the process of selecting, combin-
ing, generating or adapting several simpler heuristics (or components of such
heuristics) to efficiently solve computational search problems. One of the
motivations for studying hyper-heuristics is to build systems which can han-
dle classes of problems rather than solving just one problem [19,135,149].”
There might be multiple heuristics from which one can choose for solving a problem,
and each heuristic has its own strength and weakness. The idea is to automatically de-
vise algorithms by combining the strength and compensating for the weakness of known
heuristics [134]. In a typical hyper-heuristic framework there is a high-level methodology
and a set of low-level heuristics (either constructive or perturbative heuristics). Given a
problem instance, the high-level method selects which low-level heuristic should be ap-
plied at any given time, depending upon the current problem state, or search stage [149].
A similar approach to hyper-heuristics can be thought for the framework proposed in
this thesis. By simply using the following correspondences it is possible to emphasise a
broad analogy between the hyper-heuristics and the framework.
Heuristic ←→ Clustering algorithm
Solving a problem ←→ Analysing a dataset
Hyper-heuristic ←→ This thesis framework
Using these correspondences, the first sentence of the second paragraph of this sec-
tion could be re-written as follows: “There might be multiple clustering algorithms from
which one can choose for analysing a dataset, and each algorithm has its own strength and
weakness”. The idea of the framework that will be presented in this thesis is to produce a
single approach by combining the strength and compensating for the weakness of known
clustering and classification methods.
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2.8 Summary
In this chapter, a general overview of both the clustering techniques used within the
literature and their application on breast cancer studies were provided. The purpose of
clustering is to group objects so that they have the most similarity when belonging to the
same cluster and the most dissimilarity when they are in different clusters. In particular,
through the clustering process of gene expression data or tissue microarray, diverse breast
cancer phenotypes have been defined in recent years. As one of the main objectives of this
study is to emphasise the importance of applying different clustering methods on breast
cancer studies rather than just a single one, particular consideration has been given to non-
hierarchical algorithms and to the different consensus clustering approaches developed in
the past. Moreover, it has been shown how a clear and well accepted definition of breast
cancer groups is still far from being given.
In several clustering procedures it is required that the quality of the clustering results
is verified. This might be achieved resorting to cluster validity measures. In this chapter, a
particular section was dedicated to the identification of several cluster validity indices that
have been proposed in literature to evaluate the partition results. Validation criteria are
also used when the number of cluster is not know prior to commencing the analysis. In
this way, different groupings may be analysed and the best one may be chosen, according
to some validity optimisation rules.
To complement the overview on clustering, a general description of the model-based
approach has been reported to point out other possible ways of dealing with grouping
issues. A particular technique, called Affinity Propagation have been used in this study
and a comparison between the CPU time needed for the algorithm computation and the
time requested by K-means has been performed and is presented in Chapter 6.
To develop a general framework to elucidate core classes in a dataset, several super-
vised classification approaches have to be considered too. This chapter also identified
several supervised learning algorithms, which have been used to build models of the class
distribution labels in terms of predictor features and to predict the class assignment of
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possible new objects. In Section 2.6 an overview of those techniques used in this thesis
work was presented, together with a brief literature review on one of them.
In conclusion, three main aspects remain open for further investigation. Firstly, from
the already published literature, it is clear that a range of clustering algorithms were used
in breast cancer studies, leading to different definitions of cancer subtypes. However,
it is also known that a perfect clustering method can not be defined, thus stressing the
importance of a multi-techniques approach in this type of studies.
It also seems that a comprehensive and systematic comparison of clustering tech-
niques on breast cancer data has not been carried out yet. This gap of knowledge can
be filled by analysing the effect of a multi-techniques approach on the stability of results
coming from clustering analysis for breast cancer data. Moreover, the comparison of
different techniques will answer the first research question reported in Section 1.2.
The third aspect on which more focus is needed is related to consensus clustering. In
this chapter, several approaches to address this issue were presented. For example, Monti
et al. suggested using multiple runs of the same algorithm to form the consensus cluster
[130]. Swift and colleagues proposed to measure the agreement between classifications
using the kappa index [163]. The consensus clustering proposed by Filkov and Skiena
was based on that partition which minimises the distance between all the others [57],
while Kellam et al. suggested applying a clustering algorithm on the clustering results
[98]. Despite all these different approaches for consensus clustering, an evaluation of the
agreement between different methods applied to the same data combined with a heuristic
combination of the groups derived by different techniques is still missing and leaves space
for further investigation.
In the next chapter, an overview of the medical background relevant to this thesis will
be presented in order to clarify the major aspects of the breast cancer disease, its diagnosis
and the possible treatments. A description of how data were collected will be also given.
Chapter 3
Medical Background
This research is a multi-disciplinary work which involved both the School of Com-
puter Science and the School of Molecular Medical Sciences at the University of Notting-
ham, UK. The close collaboration between the two Schools allowed the work to be con-
ducted focusing on the aims and needs of both sides. The medical information presented
in this chapter have been derived from joint publications (including several conference
papers and journal papers).
The type of tumour that has been investigated in this study was the breast cancer. In
order to examine whether a suspected patient has this type of cancer, tissue samples were
collected using microarray technology and, therefore, this chapter will also describe the
process of collecting, preparing and conducting microarray analysis on these samples.
3.1 Definition of breast cancer and treatments
Breast cancer is the most common cancer in the UK and the second most common
worldwide. The latest statistics from Cancer Research UK website (2006) shows that
each year more than 45,500 women and around 300 men are diagnosed with breast cancer
in the UK. Just under 12,000 women and around 90 men die from breast cancer every
year in the UK [181]. The ability to accurately identify the malignancy is crucial for
prognosis and preparation of effective treatment. For breast cancer, some preoperative
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imaging methodologies, such as x-ray mammography and ultrasound, can identify areas
of tumour growth in the breast based on the identification of density changes within the
tissue. The mammogram can detect small changes in breast tissue which may indicate
cancers which are too small to be felt either by the woman herself or by a doctor [181].
Additionally, the diagnosis of breast cancer can often also be achieved by assessing the
lymph nodes in the ipsilateral axilla (located on or affecting the same side of the axilla).
The presence of metastasis (cancer spread from its original location) is an indicator for
local disease recurrence and thus a method for identifying patients who are at high risk of
developing a cancer variant that could spread throughout the body. The well-established
procedure to access lymph node metastases is axillary lymph node dissection (ALND)
[175].
The introduction of mammography screening programmes, together with a greater
public awareness of breast cancer have meant that the majority of patients who do not
have axillary lymph node metastases at presentation do not have to undergo ALND [147].
Intra-operative diagnosis has become increasingly important with the recent introduction
of sentinel lymph node biopsy [168]. The sentinel node can be described as any lymph
node that has a direct lymphatic connection to the tumour, and would be the first invaded
by cancer spreading from the breast, as can be seen in Figure 3.1. Surgical studies have
clearly shown that if cancer cannot be found in the sentinel lymph node, the chance of
disease being found further down the chain of lymph nodes that drain the breast is neg-
ligible [168]. Therefore accurate analysis of the sentinel lymph node can alleviate the
necessity to remove all suspected nodes present.
Surgery and radiotherapy are used to control local disease, and systemic treatments
(chemotherapy and/or hormonal therapy) to combat frank or occult metastatic disease.
Systemic treatments may also be administered up front as a primary treatment to reduce
the size of the tumour prior to surgery.
Nearly all patients, whatever the stage of their disease, have some form of surgery.
Other tests are carried out to assess the extent of the disease [181]. The main stages of
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Sentinel lymph node
Figure 3.1: Typical location of lymph nodes that drain lymph from the breast
Stage Description
Stage I
Tumour up to 2cm
No lymph nodes affected
No evidence of spread beyond the breast
Stage II
Tumour between 2cm and 5cm and/or;
Lymph nodes in armpit affected
No evidence of spread beyond armpit
Stage III
Tumour more than 5cm
Lymph nodes in armpit affected
No evidence of spread beyond armpit
Stage IV
Tumour of any size
Lymph nodes in armpit often affected
Cancer has spread to other parts of the body
Table 3.1: The main stages of breast cancer
invasive breast cancer are shown in Table 3.1.
A patient’s treatment will depend upon a number of factors including the stage and
grade of their tumour, hormone receptor (oestrogen and progesterone) status, menopausal
status and general health. The standard treatment of lobular carcinoma in situ is surveil-
lance, whereas ductal carcinoma in situ (DCIS) is often treated by complete local excision
as there is a strong possibility that it will progress to invasive carcinoma [55].
Early breast cancer is potentially curable. Surgery is carried out to remove the tumour
with an increasing trend towards more conservative surgery and reconstruction of the
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breast.
The timing of surgery may be important: premenopausal women with early breast
cancer seem to have a significantly better prognosis if their tumours are excised during
the luteal phase I of the menstrual cycle [56]. During surgery, axillary lymph nodes are
checked to see whether cancer has spread beyond the breast. New techniques of sampling
lymph nodes may help to reduce the significant disability of lymphoedema of the arm.
Some patients, for example young patients with large tumours, may receive chemotherapy
before surgery (neo-adjuvant) to shrink the tumour, allowing more conservative surgery.
Women who have oestrogen sensitive (ER positive) tumours receive some form of hor-
monal therapy to block the cancer-promoting effect of oestrogen [188]. Chemotherapy is
usually given to women who have ER negative tumours although it may also be useful for
some premenopausal ER positive patients.
Most patients do not present with advanced breast cancer. For those that do, some
form of systemic treatment will be considered to control the cancer and improve quality
of life [181].
In general, the main treatment options for breast cancer include [182]:
• Surgery
The two most common operations for breast cancer are lumpectomy (surgery to
remove the lump and some of the surrounding tissue) and mastectomy (removal of
the whole breast). During most breast cancer operations, some lymph nodes are
removed from the armpit (axillia). This is to look for cancer cells that have spread.
• Radiotherapy
Quite often, women will have a course of radiotherapy starting two to four weeks
after lumpectomy. This is to destroy any cancer cells that may still be present.
Sometimes, women might also have radiotherapy after mastectomy. If the cancer
has spread to other parts of the body, radiotherapy may be used to relieve symptoms
such as bone pain.
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• Chemotherapy
Doctors often treat breast cancer with a combination of chemotherapy drugs. Wo-
men may receive chemotherapy before or after breast surgery. The doctor can also
use chemotherapy to treat cancer that has come back.
• Hormone therapy
The female hormone oestrogen is a major factor for the growth of many breast
cancers. Hormone therapy lowers the amount of oestrogen in the blood, or blocks
oestrogen from stimulating the cancer to grow. Tamoxifen is the most common
hormone therapy used.
3.1.1 The Nottingham Prognostic Index
Lymph node status has been regarded for many years as the main indicator of progno-
sis [64]. It is a time-dependent prognostic factor – the longer the tumour has been growing
the more likely it is to have spread to lymph nodes. Moreover, prognosis depends not only
upon the presence of distant metastases but also upon their virulence. The virulence of a
tumour depends on a number of intrinsic biological factors – some measurable, such as
growth rate or response to hormone therapies, and some not yet so, such as invasiveness
or power of tissue destruction [64]. To obtain a real power of prognostication, measures
depending on both time-dependent factors and biological factors are needed. In recent
years a new prognostic index was developed in order to assess how well treatments may
work for a person with breast cancer and how long the person may live. This index was
firstly introduced in 1982 [79] and was derived from a retrospective, multivariate study
of nine factors in 387 patients with primary, operable breast cancer. In 1992 the Notting-
ham Prognostic Index (NPI) was applied to all of the first 1,629 patients in the series of
operable breast cancer up to the age of 70 [64]. The index is defined as follows:
NPI Score= (0.2× size)+grade+ stage
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where size represents the tumour diameter in cm; grade means what the cancer cells look
like under the microscope and ranges between 1 (low grade, slow growing) to 3 (high
grade, faster growing); and stage represents the number of lymph nodes affected (1 if
there are no lymph nodes affected, 2 if up to 3 glands are affected or 3 if more than 3
glands are affected). Among these three factors, size and lymph nodes stage are time-
dependent, while histological grade is a biological characteristic. All the three factors
have been proved to remain significant on multivariate analysis [64], so justifying the
choice of considering them to define the NPI score.
Depending on the score, three groups are defined, namely a Good Prognostic Group
(NPI < 3.4), a Moderate Prognostic Group (3.4 ≤ NPI ≤ 5.4) and a Poor Prognostic
Group (NPI > 5.4). However, in other studies such as [111], five different groups of
patients were be defined:
NPI Score Prognostic Group
≤ 2.4 Excellent Prognostic Group (EPG)
2.5 - 3.4 Good Prognostic Group (GPG)
3.5 - 4.4 Moderate Prognostic Group 1 (MPG1)
4.5 - 5.4 Moderate Prognostic Group 2 (MPG2)
> 5.4 Poor Prognostic Group (PPG)
3.2 Instruments for breast cancer detection
When changes in breast shape or size are detected by a patient, it is advisable to
consult a GP. The doctor will ask questions about the woman’s medical history and about
any risk factors she might have. The doctor will also carry out an examination of the
breasts, armpits and neck and look for any lumps or suspicious changes. If necessary, a
specialist may carry out further tests. These can include:
• Mammograms
Amammogram is an X-ray of the breasts. Mammography is useful for finding early
changes in the breast, when it may be difficult to feel a lump. It is not as helpful in
younger women though. If a patient is under 35 years of age, it is more likely to
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be suggested to have an ultrasound instead. Mammography can be painful because
the breasts are put between two metal plates and a little pressure is applied. But
most women describe this as mild to moderate discomfort, and it only lasts a few
minutes. It is not harmful to the breasts [179].
• Breast ultrasound scans
Breast ultrasound is painless and takes just a few minutes. Ultrasound uses sound
waves to make a picture of the inside of the body. It is usually used for women under
35 whose breasts are too dense or solid to give a clear picture with mammograms.
It is also used to see if a breast lump is solid, or if it contains fluid. A fluid filled
lump is called a ‘cyst’ [179].
• Tissue biopsy
A breast biopsy means taking a small sample of cells or tissue from your breast and
looking at the sample under a microscope. A pathologist examines these samples
and can see if they contain areas of cancer [179].
• CT scan
CT scan (or CAT scan) stands for Computerised (Axial) Tomography scan. This
just means a scan that takes a series of X-rays and uses a computer to put them
together. The scan is painless. The CT machine takes pictures of the body from
different angles and gives a series of cross sections or ‘slices’ through the part of
the body being scanned. A very detailed picture of the inside of the body can be
built up in this way. Together these cross sections give a very accurate picture of
where a tumour is and how big it is. They also show how close major body organs
are to the area that needs to be treated or operated on [178]. This kind of test is used
for all kinds of cancers, not just for detecting breast tumours.
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3.3 Microarrays
Amicroarray is a tool for analysing gene expression that consists of a small membrane
or glass slide containing samples of many genes arranged in a regular pattern. Microar-
rays allow scientists to analyse expression of many genes in a single experiment quickly
and efficiently. They represent a major methodological advance and illustrate how the
advent of new technologies provides powerful tools for researchers. Scientists are using
microarray technology to try to understand fundamental aspects of growth and develop-
ment as well as to explore the underlying genetic causes of many human diseases [27]. A
microarray works by exploiting the ability of a given mRNAmolecule to bind specifically
to, or hybridize to, the DNA template from which it originated. By using an array contain-
ing many DNA samples, scientists can determine, in a single experiment, the expression
levels of hundreds or thousands of genes within a cell by measuring the amount of mRNA
bound to each site on the array [27]. With the aid of a computer, the amount of mRNA
bound to the spots on the microarray is precisely measured, generating a profile of gene
expression in the cell.
3.3.1 DNA microarray
DNA Microarrays are small, solid supports onto which the sequences from thousands
of different genes are immobilized, or attached, at fixed locations. The supports them-
selves are usually glass microscope slides, but can also be silicon chips (in which case
they are commonly known as gene chip) or nylon membranes. Other microarray plat-
forms, such as Illumina, use microscopic beads, instead of the large solid support. The
DNA is printed, spotted, or actually synthesized directly onto the support [27].
It is important that the gene sequences in a microarray are attached to their support
in an orderly or fixed way, because a researcher uses the location of each spot in the
array to identify a particular gene sequence. The spots themselves can be DNA, cDNA,
or oligonucleotides. An oligonucleotide is a short fragment of a single-stranded DNA
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that is typically 5 to 50 nucleotides long. DNA arrays are different from other types of
microarray only in that they either measure DNA or use DNA as part of its detection
system. DNA microarrays can be used to measure changes in expression levels or to
detect single nucleotide polymorphisms (SNPs). Microarrays also differ in fabrication,
workings, accuracy, efficiency, and cost. Additional factors for microarray experiments
are the experimental design and the methods of analysing the data.
The use of a collection of distinct DNAs in arrays for expression profiling was first
described in 1987 in [104], and the arrayed DNAs were used to identify genes whose
expression is modulated by interferon. These early gene arrays were made by spotting
cDNAs onto filter paper with a pin-spotting device. The use of miniaturized microar-
rays for gene expression profiling was first reported in 1995, in a work of Schena and
colleagues [153].
Arrays of DNA can be spatially arranged, as in the commonly known gene chip (also
called genome chip, DNA chip or gene array, see Figure 3.2), or can be specific DNA
sequences labelled such that they can be independently identified in solution. The tra-
ditional solid-phase array is a collection of microscopic DNA spots attached to a solid
surface, such as glass, plastic or silicon biochip. The affixed DNA segments are known
as ‘probes’ (although some sources use different terms such as ‘reporters’). Thousands of
them can be placed in known locations on a single DNA microarray. DNA microarrays
can be used to detect DNA (as in comparative genomic hybridization), or detect RNA
(most commonly as cDNA after reverse transcription) that may or may not be translated
into proteins. The process of measuring gene expression via cDNA is called expression
analysis or expression profiling. Since an array can contain tens of thousands of probes,
a microarray experiment can accomplish that many genetic tests in parallel. Therefore
arrays have dramatically accelerated many types of investigation [27].
Applications include gene expression profiling, which is the measurement of the ac-
tivity (the expression) of thousands of genes at once, to create a global picture of cellular
function. These profiles can, for example, distinguish between cells that are actively di-
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Figure 3.2: Two DNA chips produced by Affymetrix
viding, or show how the cells react to a particular treatment. Many experiments of this
sort measure an entire genome simultaneously, that is, every gene present in a particular
cell. Furthermore, gene expression profiling has come into use as a way of defining, at
the molecular level, the phenotypes of many kinds of tumours [159], thus leading to an
explosion of molecular profiling studies [70].
A particular kind of microarray is the so-called ‘two-channel microarray’, which is
typically hybridized with cDNA prepared from two samples to be compared (e.g. diseased
tissue versus healthy tissue) [155]. The two cDNA samples are mixed and hybridized to
a single microarray (Figure 3.3) that is then scanned in a microarray scanner to visualize
fluorescence after excitation with a laser beam of a defined wavelength [164].
3.3.2 Tissue microarray
Tissue microarrays (also TMAs) consist of paraffin blocks in which up to 1000 sep-
arate tissue cores are assembled in array fashion to allow multiplex histological analysis
(Figure 3.4). These miniaturized collections of tissue spots result in a dramatic increase
in throughput for in situ examination of gene status and gene expression from archival
specimens [142].
The technique of tissue microarray was developed to address the issues of the cumber-
3.3. Microarrays 90
Figure 3.3: Diagram of typical dual-colour microarray experiment
Figure 3.4: Process of tissue microarray construction
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Figure 3.5: Construction of formalin-fixed paraffin-embedded tissue microarray
some nature of procedures, limited availability of diagnostic reagents and limited number
of patients.
In the tissue microarray technique, an instrument built to create holes in the recipient
block and for acquiring tissue core from the donor block is set up. The instrument consists
of a thin wall stainless steel tube with an inner diameter of about 0.6 mm. The tissue cores
are transferred into the recipient block through a solid stainless steel wire. As many as
1000 such tissue cores could be placed in one 45 × 20 mm recipient paraffin block. After
the block construction is completed, 5 µm sections of the resulting tumour TMA block are
cut and transferred onto a slide using an adhesive-coated tape. The complete procedure is
described in detail in [142] and is shown in Figure 3.5.
Each microarray block can be cut into 100 – 500 sections, which can be subjected
to independent tests. Tests commonly employed in tissue microarray include immuno-
histochemistry, and fluorescent in situ hybridization. Tissue microarrays are particularly
useful in analysis of cancer samples [99].
An example of a 0.6mm core Tissue MicroArray Block is shown in Figure 3.6.
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Figure 3.6: A 0.6mm core tissue microarray block
3.4 Data collection
3.4.1 Data pre-processing and Immunohistochemistry
For the analysis described in this thesis, breast cancer TMA were prepared as de-
scribed in Section 3.3.2. Briefly, cores of 0.6 mm thickness were obtained from the most
representative areas of the tumours then reembedded in microarray blocks. Each case was
sampled twice; one core was obtained from the centre and the other from the periphery of
the tumour. TMAs of 100 cases per block were made [1].
Immunohistochemistry (IHC) refers to the process of localizing proteins in cells of
a tissue section exploiting the principle of antibodies binding specifically to antigens in
biological tissues. Immunohistochemical staining is widely used in the diagnosis of can-
cer. Specific molecular markers are characteristic of particular cancer types. IHC is also
widely used in basic research to understand the distribution and localization of biomarkers
in different parts of a tissue [1].
Immunohistochemical staining for the sections was performed using the streptavidin-
Biotin Complex method using a large panel of well-characterised commercially available
tumour markers. To avoid loss or decline of immunoreactivity of tissue sections with
increasing storage time, sections from TMA blocks were cut shortly prior to staining of
each antibody.
The modified histochemical score (H-score) [121] was used because it includes a
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semiquantitative assessment of both the intensity of staining and the percentage of posi-
tive cells. For the intensity, a score of 0 to 3, corresponding to negative, weak, moderate
and strong positivity, was recorded. In addition, the percentage of positive cells at each
intensity category was estimated. The H-score is calculated as follows [122]:
H-score= (1× % of cells stained at intensisty category 1)
+(2× % of cells stained at intensisty category 2)
+(3× % of cells stained at intensisty category 3).
The range of possible scores is thus 0 to 300, where 300 equals 100% of tumour cells
stained strongly [37]. H-score and similar semiquantitative scoring systems have been
successfully used for TMA evaluation [1]. By using such a score, it was possible to
explore rationalization of cases into biologically relevant groups depending on different
levels of expression, which could not be obtained by using simpler scoring methods (e.g.,
positive vs. negative). Two cores were evaluated from each tumour. Each core was
scored individually, then the mean of the two readings was calculated. If one core was
uninformative (either lost or contained no tumour tissues), the overall score applied was
that of the remaining core.
3.4.2 Assembling TMA and clinical data
For this research work, data were provided by pathologists and researchers of the
School of Molecular Medical Sciences at NottinghamUniversity Hospitals and University
of Nottingham in form of several large datasets. In order to recompute several studies and
to define a new version of the Nottingham Prognostic Index, there was the need to create
a larger and up-to-date dataset full with all the available information. The process of
assembling both clinical and biological information into a single resource with unique
entries took time and was carried out through several stages using the SQL language.
At the beginning, as all datasets were very heterogeneous (both in size and shape) and
some of them even contained repeated variables or different variables’ values for the same
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patient, differences between data entries were pointed out, in order to select and keep the
most recent data and to combine at least tables with the same set of patients.
Subsequently, two resources containing respectively all the clinical information and
all the biological ones were created by merging the previously ‘cleaned’ smaller tables
with those ones provided in the meantime. Each final dataset contained approximately
230 different information for almost 2,450 patients (all women).
Finally, the available data was integrated with images taken by microscopes. This
piece of work, as well as the maintenance and management of the data, were entrusted to
‘Slidepath – Digital Slide Solution’, a company dedicated to the delivery of world leading
software for digital slide and life sciences informatics applications. In particular, they de-
veloped a new software called ‘Distiller’, which is a web based information management
solution ideal for sharing files and data between distributed collaborators. Snapshots of
the software are shown in Figure 3.7 and in Figure 3.8. Once logged in, a list of available
markers and images, as well as the one of clinical information stored are displayed. By
selecting the desired variables for the subset of patients of interest, a spreadsheet with all
the information is created and downloaded on the local machine.
3.5 Summary
In this chapter, the medical background of this research work was presented, including
the definition of breast cancer and the different instruments for its detection. A widely
used prognostic measure, the Nottingham Prognostic Index was also introduced together
with different kinds of breast cancer treatments. Microarray analysis techniques, which
are used for interpreting the data generated from experiments on DNA, RNA, and protein
microarrays were also presented. They allow researchers to investigate the expression
state of a large number of genes in a single experiment. Finally, the processes followed
for data collection were reported and the immunohistochemistry technique was presented.
The next chapter will present the application of several clustering techniques over
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(a) List of patients
(b) Details for a specific patient
Figure 3.7: Snapshots of Distiller software
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Figure 3.8: Possible constraints for the Search function of the Distiller software
breast cancer data and the use of an informal consensus clustering to categorise patients
in representative classes.
Chapter 4
A Comparison of Different Clustering
Techniques
4.1 Introduction
In this chapter, a comparison between different clustering algorithms applied over the
same set of data will be described. In 2005, Abd El-Rehim et al. used a hierarchical
approach to categorise breast cancer patients in six different groups which were relevant
also in terms of clinical outcome [1]. However, it should be noted that one of these groups
consisted of only four patients and, therefore, was difficult to characterise. In addition, as
already pointed out in [70], the hierarchical approach has been criticized as it can cause
difficulty in assessing the validity of the grouping. For these reasons various clustering
algorithms were applied in an attempt to refine the previous classification.
It is worth noting that the idea of combining/comparing the results of different cluster-
ing algorithms is particularly important in order to evaluate the stability of the proposed
classification. In this research work, the stability of six breast cancer classes was evalu-
ated by comparing the different solutions provided by different algorithms. Concerning
the standard problem of consensus clustering in which the label of classes is arbitrary, in
this study a label was assigned using the six clusters characterised in the work of Abd
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El-Rehim [1], as a reference for the description of the resulting groups.
4.2 Dataset description
A series of 1076 patients from the Nottingham Tenovus Primary Breast Carcinoma
Series presenting with primary operable (stages I, II and III) invasive breast cancer be-
tween 1986-98 were used. Immunohistochemical reactivity for twenty-five proteins, with
known relevance in breast cancer including those used in routine clinical practice, were
previously determined using standard immunocytochemical techniques on tumour sam-
ples prepared as tissue microarrays [1]. Levels of immunohistochemical reactivity were
determined by microscopical analysis using the modified H-score (values between 0-300),
giving a semiquantitative assessment of both the intensity of staining and the percentage
of positive cells. The complete list of variables used in this study is given in Table 4.2.
This is a well-characterised series [1] of patients who were treated according to stan-
dard clinical protocols. Patient management was based on tumour characteristics using
Nottingham Prognostic Index (NPI) and hormone receptor status. Patients with an NPI
score ≤ 3.4 received no adjuvant therapy, those with a NPI score > 3.4 received hormone
therapy if oestrogen receptor (ER) positive or classical cyclophosphamide, methotrexate
and 5-fluorouracil (CMF) if ER negative and fit enough to tolerate chemotherapy. Hor-
monal therapy was given to 420 patients (39%) and chemotherapy to 264 (24.5%). Data
relating to survival was collated in a prospective manner for those patients presenting after
1989 only; including survival time, defined as the interval (in months) from the date of
the primary treatment to the time of death. The overall survival was taken as the time (in
months) from the date of the primary surgical treatment to the time of death. This study
was approved by the Nottingham Research Ethics Committee 2 under the title ‘Develop-
ment of a molecular genetic classification of breast cancer’.
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Variable Frequencies / Values
Age
Min 18
Mean 53.4
Max 70
Tumour size
Min 0.1
Mean 2.1
Max 10
Lymph node stage
1 654
2 332
3 87
NA 3
Grade
1 160
2 343
3 572
NA 1
NPI
Min 2.1
Mean 4.3
Max 8.0
NA 4
Tumour type
Invasive ductal / NST 649
Tubular mixed 171
Medullary 30
Lobular 112
Special types 46
Mixed NST & lobular 37
Mixed NST & special type 24
Miscellaneous 4
NA 3
Table 4.1: Distributions / frequencies of several variables in the dataset
4.3 Experiments
In this work, the starting point was the same data as in [1] and several unsupervised
clustering techniques were applied in order to evaluate the stability of results coming from
different clustering methods in terms of concordance among solutions. In the following
(Section 4.3.1), the adopted clustering techniques will be described in detail, as well as
the different methods used for characterising the classes created by the algorithms and the
consensus among the different techniques (Section 4.3.4). The four-step methodology for
elucidating core, stable classes (groups) of data from a complex, multidimensional dataset
was as follows:
1. A variety of clustering algorithms were run on the data set.
2. Where appropriate, the most appropriate number of clusters was investigated by
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Antibody, clone Short Name Dilution
Luminal phenotype
CK 7/8 [clone CAM 5.2] CK7/8 1:2
CK 18 [clone DC10] CK18 1:50
CK 19 [clone BCK 108] CK19 1:100
Basal Phenotype
CK 5/6 [cloneD5/16134] CK5/6 1:100
CK 14 [clone LL002] CK14 1:100
SMA [clone 1A4] Actin 1:2000
p63 ab-1 [clone 4A4] p63 1:200
Hormone receptors
ER [clone 1D5] ER 1:80
PgR [clone PgR 636] PgR 1:100
AR [clone F39.4.1] AR 1:30
EGFR family members
EGFR [clone EGFR.113] EGFR 1:10
HER2/c-erbB-2 HER2 1:250
HER3/c-erbB-3 [clone RTJ1] HER3 1:20
HER4/c-erbB-4 [clone HFR1] HER4 6:4
Tumour suppressor genes
p53 [clone DO7] p53 1:50
nBRCA1 Ab-1 [clone MS110] nBRCA1 1:150
Anti-FHIT [clone ZR44] FHIT 1:600
Cell adhesion molecules
Anti E-cad [clone HECD-1] E-cad 1:10/20
Anti P-cad [clone 56] P-cad 1:200
Mucins
NCL-Muc-1 [clone Ma695] MUC1 1:300
NCL-Muc-1 core [clone Ma552] MUC1co 1:250
NCL muc2 [clone Ccp58] MUC2 1:250
Apocrine differentiation
Anti-GCDFP-15 GCDFP 1:30
Neuroendocrine differentiation
Chromogranin A [clone DAK-A3] Chromo 1:100
Synaptophysin [clone SY38] Synapto 1:30
Table 4.2: Complete list of antibodies used and their dilutions
mean of cluster validity indices.
3. Concordance between clusters, assessed both visually and statistically, was used to
guide the formation of stable ‘core’ classes of data.
4. A variety of methods were utilised to characterise the elucidated core classes.
Once these core classes were obtained, the clinical relevance of the corresponding patient
groups was investigated by means of associations with related patient data. All the anal-
ysis described in this chapter, excluding the Adaptive Resonance Theory algorithm, was
done using R, a free software environment for statistical computing and graphics [114].
4.3. Experiments 101
4.3.1 Techniques considered
Five different algorithms were used for cluster analysis:
1. Hierarchical (HCA)
2. K-means (KM)
3. Partitioning around medoids (PAM)
4. Adaptive resonance theory (ART)
5. Fuzzy C-means (FCM)
Hierarchical clustering
The hierarchical clustering algorithm (HCA) begins with all data considered to be in
a separate cluster. It then finds the pair of data with the minimum value of some specified
distance metric; this pair is then assigned to one cluster. The process continues iteratively
until all data are in the same (one) cluster. A conventional hierarchical clustering algo-
rithm (HCA) was utilised in this research work, utilising Euclidean distance on the raw
(unnormalised) data with all attributes equally weighted.
K-means clustering
The K-means technique aims to partition the data into K clusters such that the sum of
squares from points to the assigned cluster centres is minimised. The algorithm repeatedly
moves all cluster centres to the mean of their Voronoi sets (the set of data points which
are nearest to the cluster centre). The objective function minimised is:
J(V ) =
k
∑
j=1
c j
∑
i=1
||xi− v j||2
where xi is the i-th datum, v j is the j-th cluster centre, k is the number of clusters, c j is
the number of data points in the cluster j and ||xi− v j|| is the distance between xi and v j.
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The j-th centre v j can be calculated as:
v j =
1
c j
c j
∑
i=1
xi, j = 1, ...,k.
K-means clustering is dependent on the initial setting of the cluster centres (which, in
turn, determines the initial cluster assignments). Various techniques have been proposed
for the initialisation of clusters [4], but for this study a fixed initialisation of the cluster
centres obtained with hierarchical clustering was used. The Euclidean metric has been
chosen to represent the distance between points and cluster centres and the maximum
number of iterations was set to 100. The default algorithm of Hartigan and Wong [78]
was used. The number of clusters is an explicit input parameter to the K-means algorithm.
Partitioning around medoids
The partitioning around medoids (PAM) algorithm (also known as the k-medoids al-
gorithm) is a technique which attempts to minimise the distance between points labeled to
be in a cluster and a point designated as the centre of that cluster. The main characteristics
of this method are described in Section 2.1.3 of Chapter 2.
There are basically two ways of entering the data in PAM. The most common way
is by means of a matrix of measurements values. The rows of this matrix represent the
objects and the columns correspond to variables, which must be on an interval scale.
Alternatively, the program can be used by entering a matrix of dissimilarities between ob-
jects. Such dissimilarities can be obtained in several ways. Often they are computed from
variables that are not necessarily on an interval scale but which may also be binary, ordi-
nal, or nominal. It also happens that dissimilarities are given directly, without resorting to
any measurement values [97].
The algorithm consists of two phases: the build phase in which an initial set of k
representative medoids is selected and the swap phase in which a search is carried out to
improve the choice of medoids (and hence the cluster allocations). The build phase begins
by identifying the first medoid, the point for which the sum of dissimilarities to all other
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points is as small as possible. Further medoids are selected iteratively through a process in
which the remaining points are searched to find that which decreases the objective func-
tion as much as possible. Once k medoids have been selected, the swap phase commences
in which the medoids are considered iteratively. Possible swaps between each medoid and
other (non-medoid) points are considered one by one, searching for the largest possible
improvement in the objective function. This continues until no further improvement in the
objective function can be found. The algorithm is described in detail in [97], pp.102–104.
The number of clusters is an explicit input parameter to the PAM algorithm.
Adaptive resonance theory
The adaptive resonance theory (ART) algorithm has three main steps [26]. First, the
data are normalised to a unit hypersphere, thus representing only the ratios between the
various dimensions of the data. Second, data allocated to each cluster are required to
be within a fixed maximum solid angle of the group mean, controlled by a so-called
‘vigilance parameter’ ρ, namely Xk ·Pi ≤ ρ. However, even when the observation profile
and a prototype are closer than the maximum aperture for the group, a further test is
applied to ensure that the profile and prototype have the same dominant covariates. This
is done in a third step by specifying the extent to which the nearest permissible prototype
allocation for the given observation must be on the same side of the data space from the
diagonal comprising a vector of ones, 1ˆ, using a pre-set parameter, λ:
Xk ·Pi ≤ λXk · 1ˆ.
The ART algorithm is initialised with no prototypes and creates them during each
successive pass over the data set. It has some, limited, sensitivity to the order in which
the data are presented and converges in a few iterations.
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Fuzzy c-means
The fuzzy c-means (FCM) algorithm is a generalisation of the K-means algorithm
which is based on the idea of permitting each object to be a member of every cluster to
a certain degree, rather than an object having to belong to only one cluster at any one
time. It is based upon the concept of fuzzy logic promulgated by Zadeh [195] and aims
to minimise the objective function
J(U,V ) =
n
∑
i=1
c
∑
j=1
(µi, j)
m‖xi− v j‖2
where n is the number of data points, xi and v j are the data points and cluster centres
and µi, j is the membership degree of data xi to the cluster centre v j (µi, j ∈ [0,1]). m is
called the ‘fuzziness index’ and the value of m = 2.0 is usually chosen. An exhaustive
description of this method can be found in [11].
For this analysis, the same initialisation technique as used for the K-means algorithm
was adopted when considering the Fuzzy c-means and the maximum number of iterations
was again set to 100. The Euclidean distance was chosen as metric and the fuziness index
was set equal to 2. As for K-means, the number of clusters is an explicit input parameter
to FCM.
4.3.2 Cluster validity
Clustering validity is a concept that is used to evaluate the quality of clustering re-
sults. If the number of clusters is not known prior to commencing an algorithm, a cluster
validity index may be used to determine the best number of clusters for the given data set.
Although there are many variations of validity indices, they are all either based on con-
sidering the data dispersion in a cluster and between clusters, or considering the scatter
matrix of the data points and the one of the clusters centres.
In this study, the following indices were applied to those algorithms for which the
number of clusters is an explicit parameter, over a range of number of clusters:
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1. Calinski and Harabasz [20]
2. Hartigan [77]
3. Scott and Symons [154]
4. Marriot [118]
5. TraceW [46,61]
6. TraceW−1B [61]
For each index, the number of clusters to be considered was chosen according to the
rule reported in Table 4.3 where in is the validity index value obtained for n clusters [183].
Index Decision rule
Calinski and Harabasz minn((in+1− in)− (in− in−1))
Hartigan minn((in+1− in)− (in− in−1))
Scott and Symons maxn(in− in−1)
Marriot maxn((in+1− in)− (in− in−1))
TraceW maxn((in+1− in)− (in− in−1))
TraceW−1B maxn(in− in−1)
Table 4.3: Different validity indices and their associated decision rules
4.3.3 Derivation of classes
Concordance among solutions was evaluated using the Cohen’s kappa coefficient
κ [30]. This coefficient is a statistical measure of inter-rater agreement for qualitative
(categorical) items. It is generally thought to be a more robust measure than simple per-
cent agreement calculation since κ takes into account the agreement occurring by chance.
To enable visualisation, the original data space (consisting of a large number of dimen-
sions) is transformed by principal component analysis (PCA) [86], and then the points are
plotted at their projected position on axes of the first and second principal components. As
PCA transforms data such that the first principal component (PC) carries the maximum
amount of variance in the data and the second PC carries the next largest variance (etc.),
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such a plot, called ‘biplot’, provides a picture in which the clusters have been ‘spread out’
as much as possible.
The previously obtained clustering results from Abd El-Rehim and colleagues [1],
the cluster validity indices (where appropriate), visualisation of the new clustering results
themselves, and the concordance among clustering solutions were then all used heuristi-
cally to guide the formulation of a set of rules to define core class membership from the
various cluster assignments.
4.3.4 Characterisation of classes
Class characterisation by visualisation
For inspection of the patient characteristics in each class, the distribution of each vari-
able in the class is compared with its distribution in the total sample, using boxplots.
A boxplot shows the median expression level (solid horizontal bar), the upper quartile
and lower quartile range (shaded grey bar), the highest non-outlier and lowest non-outlier
(smaller ticks joined by dashed lines), and any outliers (open circles). For a full descrip-
tion of boxplots, including the statistical definition of outliers see, for example, [171].
Class characterisation by OSRE (orthogonal search rule extraction)
Orthogonal Search Rule Extraction (OSRE) [52] is a computationally efficient algo-
rithm to search for hypercubes in data space, since they map directly onto Boolean rules.
This is achieved by modelling the cluster allocation index using an analytical statistical
classifier to best fit the cluster membership indicator label, followed by a structured search
for the directions in which each data point can be moved before it hits the fitted decision
surface for cluster membership. This methodology initially returns a rule for each data
point, which triggers a pruning process to keep only those rules which represent large pro-
portions of the data in the clusters, i.e. have high sensitivity for cluster membership, and
do so with minimal mixing between clusters, i.e. also have high specificity. The result is a
set of multivariate rules involving relatively few covariates, that is to say, low-order rules
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containing the covariates that characterise the sub-group of the cluster. The proposed in-
terpretation is that these rules identify the drivers for cluster allocation, which may vary
across the cluster but are, in general, well-defined [52].
Note that this method contrasts with widely used rule induction methods in two ways:
firstly, there are no univariate cut-offs for groups of data, as in OSRE a sequential uni-
variate search is carried out at the level of each individual data point which returns a
multivariate hyperbox around that point, without the need to partition the data along a
sequence of univariate covariates; and secondly, that the rules are overlapping, rather than
constrained to mutual exclusivity as is usually the case in rule tree induction. Mutually ex-
clusive trees can be readily derived from overlapping rule sets by sequential conjunctions
of each rule and the complement of the previous rule along the tree branch, but this loses
the benefit of the simplicity of interpretation that comes with the derivation of low-order
rules.
Class characterisation by ANN (Artificial Neural Networks)
A conventional multi-layer perceptron artificial neural network (MLP-ANN) model
was utilised such that individual H-scores (see Section 3.4.1) derived from the tissue mi-
croarray analysis of the clinical samples were set as inputs and the class was set as the
output using Boolean notation (i.e. 1 represented membership of a given class, 0 rep-
resented non-membership). This allowed the identification of markers that drive mem-
bership of a given class and that discriminate the class from the others. A three-layer
MLP-ANN (featuring eight nodes in the hidden layer) with a back-propagation algorithm
and a sigmoid activation function was used. Learning rate and momentum were set at 0.1
and 0.5 respectively. The approach used in this work is similar to the ones used in [125]
and [119].
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4.4 Results
4.4.1 Clustering results
HCA, K-means, PAM and ART
The HCA results from Abd El-Rehim et al. [1] were utilised, unaltered. Both the
K-means and PAM algorithms were run with the number of clusters varying from two to
twenty, as the number of clusters is an explicit input parameter of the algorithms. Given
that the K-means algorithm can be sensitive to cluster initialisation and in order to obtain
reproducible results, this technique was initialised with the cluster assignments obtained
by hierarchical clustering. For the ART algorithm, the parameters were set in order to
obtain six clusters in order to match the number of clusters previously obtained by HCA.
The best validity index obtained for repeated runs of the algorithm with 20 random ini-
tialisations was used to select the final clustering assignment.
Fuzzy C-means
Two different (independent) implementations of the fuzzy c-means algorithm were
run on the data set in an attempt to obtain clusters, but the algorithm did not perform as
hoped. When the number of clusters was set as two and three, it appeared that reasonable
results were obtained. However, from examination of the membership function of each
point assigned to these clusters, it could be seen that it was very close to either 1/2 or 1/3,
respectively. In other words, every data point was assigned to all the clusters with the
same membership. Moreover, when the number of clusters was above three, non-zero
memberships were evident for only three clusters and these memberships were similar
to the three cluster solution – i.e. for n > 3, the n = 3 cluster solution was obtained,
but with n − 3 empty clusters. These results indicated that the fuzzy c-means was not
able to obtain clear cluster partitions. The fuzziness index m was altered in an attempt
to improve the results obtained, but it was found that little difference in the results was
observed until m was close to one. Given that, when m = 1, fuzzy c-means is equivalent to
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K-means, this result was not useful. As there are many applications for which the fuzzy c-
means technique has been successful (see, for example, [176]), these results are not easy
to explain, but they may have been caused by the fact that the data under investigation
contain a lot of values close to the extremes of each variable. Although the fuzzy c-means
algorithm is widely used in literature, it was dropped from further analysis due to its poor
performance on the Abd El-Rehim et al. dataset.
4.4.2 Cluster validity
The values of the decision rule obtained for various values of the validity indices for
both K-means and PAM, for 2 to 20 clusters are shown in Figure 4.1; (a) shows the validity
decision rule values obtained for K-means and (b) shows those obtained for PAM. The
best number of clusters according to each validity index, for each clustering algorithm,
is shown in Table 4.4 This corresponds to the either the maximum or minimum decision
rule value (depending on the index), as indicated by the red point in Figure 4.1.
Index K-means PAM
Calinski and Harabasz 6 4
Hartigan 3 4
Scott and Symons 3 4
Marriot 6 4
TraceW 4 4
TraceW−1B 3 4
Minimum sum of ranks 6 4
Table 4.4: Optimum number of clusters estimated by each index for K-means and PAM
methods
It can be seen that, while there was not absolute agreement among the indices as to
which was the best number of clusters for the K-means method, there is good agreement
that the best number of clusters for the PAM method is four. Although the best number
of clusters varies according to validity index for K-means, on further inspection, it can be
seen from Figure 4.1 that there is more agreement than might be immediately apparent.
For example, the Scott and Symons index (which indicated that the best number of clusters
was three) indicated that the second best number of clusters was six. Consequently, the
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Figure 4.1: Cluster validity indices obtained for K-means and PAM clustering, for varying
cluster numbers from 2 to 20
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K-means ART PAM
HCA 0.497 0.296 0.325
K-means — 0.494 0.420
ART — — 0.224
Table 4.5: Kappa index among different classification
K-means ART PAM
HCA 0.548 0.401 0.332
K-means — 0.599 0.525
ART — — 0.376
Table 4.6: Weighted kappa index among different classification
indices were used to rank order the number of clusters and the minimum sum of ranks was
examined. It was found that the minimum sum of ranks (a form of consensus among the
indices) indicated that the overall best number of clusters was six for K-means and four
for PAM. Furthermore, careful examination of Figure 4.1(b) confirms that the six cluster
solution for PAM is of relatively poor quality.
4.4.3 Derivation of classes
The correspondence of patients assigned in the six cluster solution for each of the
methods was then examined. Cohen’s kappa and weighted-kappa indices were computed
to measure the degree of agreement among algorithms. For the weighted-kappa index,
weights were set in decreasing order from one (perfect agreement) to zero (complete
disagreement) with a 0.2 step between levels. Results are reported in Tables 4.5 and 4.6.
From these tables, a better agreement between K-means and hierarchical algorithms is
evident compared to that between ART and hierarchical. It is also evident that the PAM six
cluster solution has lower concordance with the original HCA results than either K-means
or ART, and that the concordance of PAMwith K-means and ART is also correspondingly
lower.
The cluster numbers were aligned with those obtained previously by Abd El-Rehim
et al. in [1] in order to minimise differences and to aid visualisation. Biplots of the
aligned clusters are shown in Figure 4.2 for the six cluster solution from each algorithm.
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From these plots, it can be seen that the most similar results were obtained from the
Hierarchical, K-means and ART. In fact, all these three methods obtain two clusters (1 &
2) split over the left-hand side of the biplots. A third cluster (cluster 6) is evident towards
the bottom of the biplot. Then various splits of remaining data into three clusters (3, 4 &
5) can be seen. The PAM algorithm, instead, obtains three clusters (1, 2 & 4) split over
the left-hand side, one group is visible towards the bottom (cluster 6) and one is spread in
the centre of the biplot (cluster 3). PAM places all patients on the right-hand side into a
single cluster (cluster 5).
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(a) Hierarchical clustering
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(d) PAM clustering
Figure 4.2: Biplots of clusters projected on the first and second principal component axes
The variables under investigation are displayed using vectors (arrows) and their len-
gths in the plots are related to the expression of the biomarkers. In addition, clusters may
be ‘informally’ characterised by looking at those arrows which overlap a particular set of
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points. For example from Figure 4.2(d), the fifth cluster, represented by brown circles,
can be characterised by the over-expression of the CK5/6 and p53 markers.
The biplots further confirm that the six cluster solution obtained from the PAM al-
gorithm was the most dissimilar among the considered techniques. Taking into account
the results of validity indices analysis, the concordance analysis and the visual analysis,
it was decided to remove the six clusters determined by PAM from further analysis.
The cluster distributions (number of patients in each cluster) obtained for the original
hierarchical clustering and those obtained for the K-means and ART methods are shown
in Table 4.7.
Cluster HCA K-means ART
1 336 301 238
2 180 282 408
3 139 138 111
4 4 97 96
5 183 124 35
6 234 134 188
Table 4.7: Number of cases in each cluster
Focusing on these cluster correspondences, the aim was to define core classes con-
taining the biggest possible number of patients. In a first attempt, considering agreement
among the three clustering techniques (HCA, KM and ART) and looking at those patients
assigned to the same group by different methods, a total of 382 patients were classified if
hierarchical group 4 was considered and 463 if not. After that, for each labelled group,
concordances between all pairs of methods were analysed. It was found that the sum of
the number of patients assigned to the same group ranged between 459 (pairing HCA and
ART) and 645 (pairing KM and ART). These results are again reflected in Table 4.5. Two
principles were used to guide the definition of consensus classes: (i) to consider all the
clustering techniques analysed and (ii) to get the highest number of patients assigned to
any class. These principles conflict, in that strict application of the first principle leads
to a decrease in the number of patients assigned to classes. Hence, a heuristic trade-off
between the two was employed. As a result, hierarchical group 4 was omitted (being
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replaced by group 5), and the ART assignments were not considered in a strictly conjunc-
tive manner. Consequently, a set of six core breast tumour classes was derived following
the specific rules reported in Table 4.8, in which the resultant number of patients in each
class is shown.
It was found that almost the 62% of data was assigned to these core classes; the
remaining patients were placed into a ‘not classified’ (NC) group. It must be stressed
that the derivation of class assignments was made on the basis of the clustering results
alone (which are, obviously, based on the 25 markers only) – class assignments, although
somewhat subjective, were made blind to all clinical and outcome data. It should be also
noted that around a third (actually 38%) of all patients were not assigned to any of the
core classes.
If cluster . . . Class No. of cases
H1 & KM1 & (ART1 | ART2) 1 202
H2 & KM2 & (ART1 | ART2) 2 153
H3 & KM3 3 80
H5 & KM4 & ART4 4 82
H5 & KM5 5 69
H6 & KM6 & ART6 6 77
Total number of cases assigned to classes 1–6 663
Total number of cases not classified 413
Table 4.8: Rules for determining consensus classes
4.4.4 Characterisation of classes
Biplots of the six consensus classes were produced and are reported in Figure 4.3,
which provides a visualisation of the separation of the classes. Figure 4.3(a) shows the
biplot obtained for all patients, in which the cases not assigned to any class (NC) have
been coloured grey. It can be seen that these fall mainly into the centre region of the biplot.
Figure 4.3(b) shows the biplot obtained for only patients assigned to classes 1 – 6. It can
be seen that the classes appear more spread out. The first axis was mainly determined,
on the left, by luminal markers including luminal cytokeratins (CK18, CK7/8, CK19),
hormone receptors (ER, AR, PgR), and MUC1 over-expression and, on the right, by basal
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(b) For only patients in classes 1–6
Figure 4.3: Biplots of classes projected on the first and second principal component axes
cytokeratins (CK14 and CK5/6) and partly by p53 over-expression. The second axis is
determined, on the top, partly by nuclear BRCA1 (nBRCA1) over-expression and, on the
bottom, by HER2 and E-cad over-expression (also HER3 and HER4, although these are
not shown as they overlap HER2).
Figure 4.4 shows boxplots of all 25 markers, (a) for all cases, (b) for those cases
assigned to classes 1–6, and (c-h) for each class separately. By inspection of both the
biplots and the boxplots, a description of each class could be derived. For example, classes
1 and 2 are characterised by strong expression of the luminal CK markers, as well as
moderate to strong MUC1 expression (as per the population). However, there is a distinct
difference regarding HER3 and HER4 expression. It can also be seen that, classes 4 and
5 both exhibit higher expressions of the basal CKs (CK5/6 and CK14). Triple negative
patients with high p53 levels are grouped in class 4, whereas class 5 consist of triple
negative patients with low p53 levels. A summary of the class characteristics obtained by
visual inspection of the boxplots is given in Table 4.9.
The results obtained from the automated characterisation methods (MLP-ANN and
OSRE) are reported in Table 4.10.
A proposed summary of the essential characterisations of the classes obtained is given
in Figure 4.5, according to the available bio-pathological knowledge. It is worth noting
that class 2, labelled as Luminal-N, and the split of the basal group into two different sub-
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(b) For patients in classes 1–6
l
l
ll
l
ll
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
ll l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
lll
l
l
l
CK
7/
8
CK
18
CK
19
CK
5/
6
CK
14
Ac
tin p6
3
ER Pg
R AR
EG
FR
H
ER
2
H
ER
3
H
ER
4
p5
3
n
BR
CA
1
FH
IT
E−
ca
d
P−
ca
d
M
UC
1
M
UC
1c
o
M
UC
2
G
CD
FP
Ch
ro
m
o
Sy
na
pt
o
0
50
10
0
15
0
20
0
25
0
30
0
(c) Class 1
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(d) Class 2
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(e) Class 3
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(f) Class 4
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(g) Class 5
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(h) Class 6
Figure 4.4: Boxplot for all markers, whole data and grouped by class
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Class Over-expressed Under-expressed Other
1 ER, AR, PgR, HER3, HER4
2 ER, AR, PgR, nBRCA1 HER3, HER4
3 ER, AR MUC1, MUC1co PgR normal
4 p53 ER, PgR, HER2, MUC1, MUC1co,
CK18, CK7/8, CK19
5 ER, PgR, HER2, MUC1, MUC1co, p53 absent
CK18, CK7/8, CK19
6 HER2, HER3, HER4 ER, AR, PgR absent;
p53 widely spread
Table 4.9: Description of classes as determined by statistical characterisation
Class Over-expressed Under-expressed
1 (ANN) PgR, HER3, HER4, MUC1co
1 (OSRE) PgR, HER3, HER4, CK18, CK19, MUC1co HER2
2 (ANN) PgR, nBRCA1 HER3, HER4
2 (OSRE) PgR, nBRCA1, MUC1co HER3, HER4
3 (ANN) ER MUC1
3 (OSRE) CK7/8, CK18
4 (ANN) p53
4 (OSRE) HER3, p53 ER, HER2
5 (ANN) CK5/6 CK7/8
5 (OSRE) p53; CK7/8, CK19 or HER2, HER4
6 (ANN) HER2
6 (OSRE) HER2, p53, MUC1co ER
Table 4.10: A summary of rules obtained from the automated methods for defining class
memberships
groups depending on p53 levels, appear to be novel findings which were not emphasised
in literature yet.
4.5 Clinical Evaluation
4.5.1 Patient clinical outcome
Follow-up data was available for 974 patients, with overall survival ranging from 4 to
224 months (median 123 months, mean 118 months). During this period, a total of 346
patients died, 263 from breast cancer. Patient age ranged from 18 to 72 years (median
54 years). Of the available cases, 708 (66%) cases were aged 50 years or more. At the
time of diagnosis, 160 (14.9%) tumours were histological grade 1, 343 (31.9%) grade 2
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Figure 4.5: A summary of the classes of breast cancer obtained, with indicative class
interpretations
and 572 (53.2%) grade 3. A total of 654 (60.8%) patients had lymph node-negative dis-
ease and 419 (38.9%) had positive lymph nodes (332 cases with between one and three
positive nodes, 87 cases with four or more positive). Frequencies for histological tumour
types were: 649 invasive ductal carcinomas of no special type (NST), 171 tubular mixed
carcinomas, 30 medullary carcinomas, 112 lobular carcinomas, 27 tubular carcinomas, 11
mucinous carcinomas, five cribriform carcinomas, three papillary carcinomas, 37 mixed
NST and lobular carcinomas, 24 mixed NST and special type carcinomas and four mis-
cellaneous tumours. A total of 736 (68.4%) had tumour size more than 1.5 cm and distant
metastases was observed in 111 cases.
4.5.2 Clinical characterisation of patients by class
Significant associations, as expected, were found between the classes with respect
to patient age, tumour grade, size, lymph node stage and histological tumour type (see
Table 4.11). As for grade, there was a relevant distribution of tumours among the six
different phenotypic classes: the vast majority of grade 1 tumours were in either Class
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Figure 4.6: Kaplan-Meier curves for ten years survival by class
1 or Class 2. In contrast, the majority of tumours in Classes 3-6 were of higher grade
(grade 2 or 3). Tumours with high values of grade are known to be more aggressive and
to have a shorter survival time [48]. Therefore, Classes 1 and 2 appeared to express good
prognostic factors.
Figure 4.6 shows ten year breast cancer specific survival for the six biological classes.
It can be seen that the different classes were distinct with respect to overall survival. The
highest frequency of breast cancer related mortality was seen in patients whose tumours
belonged to classes 5 (basal-p53-normal) and 6 (HER2). A lower, but still high, frequency
was seen in patients with tumours from both classes 3 (luminal B) and 4 (basal-p53-
altered). Classes 1 (luminal A) and 2 (luminal N) had the lowest frequency of death due
to breast cancer.
A boxplot of the Nottingham Prognostic Index (NPI) split by class is shown in Fig-
ure 4.7. It can be seen that the NPI for classes 1 and 2 is lower than that of classes 3–6
(overall Kruskal-Wallis p<< 0.001). It can also be seen that classes 1 and 2 have similar
NPI, and classes 3–6 have similar NPI (to each other). This is an interesting observation
for two reasons. Firstly, it confirms that the NPI is providing discriminant information
between classes 1 and 2, and classes 3–6. Secondly, it suggests that the class divisions are
providing additional information to the NPI.
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Breast Cancer Class
1 2 3 4 5 6 φ
Age
≤ 50 76 (37.6) 63 (41.2) 24 (30.0) 55 (67.1) 33 (47.8) 37 (48.1) 0.209
> 50 126 (62.4) 90 (58.8) 56 (70.0) 27 (32.9) 36 (52.2) 40 (51.9)
Total 202 153 80 82 69 77
Grade
1 58 (28.9) 43 (28.1) 2 (2.5) 0 (0) 2 (2.9) 1 (1.3)
2 81 (40.2) 89 (58.2) 18 (22.5) 1 (1.2) 7 (10.1) 12 (15.6) 0.660
3 62 (30.8) 21 (13.7) 60 (75.0) 81 (98.8) 60 (87.0) 64 (83.1)
Total 201 153 80 82 69 77
Size
≤ 1.5cm 79 (39.1) 65 (42.5) 20 (25.0) 12 (14.6) 15 (21.7) 16 (20.8) 0.225
> 1.5cm 123 (60.9) 88 (57.5) 60 (75.0) 70 (85.4) 54 (78.3) 61 (79.2)
Total 202 153 80 82 69 77
Lymph Node Stage
1 132 (65.3) 108 (70.6) 39 (48.7) 50 (61.0) 52 (75.4) 36 (46.8)
2 58 (28.7) 37 (24.2) 35 (43.8) 23 (28.0) 10 (14.5) 30 (39.0) 0.217
3 12 (5.9) 7 (4.6) 6 (7.5) 9 (11.0) 7 (10.1) 10 (13.0)
Total 202 152 80 82 69 76
Tumour type
Invasive ductal/NST 97 (48.0) 45 (29.4) 64 (80.0) 70 (85.4) 53 (76.8) 68 (88.3)
Tubular mixed 52 (25.7) 50 (32.6) 8 (10.0) 0 (0) 1 (1.5) 5 (6.5)
Medullary 0 (0) 0 (0) 0 (0) 10 (12.2) 5 (7.2) 2 (2.6)
Lobular 18 (8.9) 34 (22.2) 6 (7.5) 0 (0) 4 (5.8) 1 (1.3) 0.622
Special types 19 (9.4) 11 (7.2) 0 (0) 1 (1.2) 0 (0) 0 (0)
Mixed NST & lobular 6 (3.0) 7 (4.6) 2 (2.5) 1 (1.2) 3 (4.3) 0 (0)
Mixed NST& special type 9 (4.5) 5 (3.3) 0 (0) 0 (0) 1 (1.5) 0 (0)
Miscellaneous 0 (0) 1 (0.7) 0 (0) 0 (0) 2 (2.9) 0 (0)
Total 201 153 80 82 69 76
Table 4.11: Breast Cancer Class distribution in relation to clinicopathological parameters (NST: No Special Type)
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Figure 4.7: Boxplots of Nottingham Prognostic Index (NPI) by class
4.5.3 Comparison between the six classes and the ones identified in
previous studies
The six classes identified in this work can not be used to define breast cancer pheno-
types, as a consistent number of patients presented mixed class characteristics. However,
it was thought that a comparison with classes previously identified in similar works would
be interesting and could help for a clearer interpretation of the results. In particular, the
six classes identified in this study were compared with those defined in the previous work
of Abd El-Rehim et al. [1], and with the ones identified in Ambrogi et al. [5] and Sørlie
et al. [158]. The groups identified by consensus clustering included three luminal tumour
classes (classes 1, 2 and 3) characterised by high luminal cytokeratin expression and the
expression of hormone receptors. There were two basal tumour classes (class 4 and 5),
characterised by low luminal cytokeratin expression and a triple negative phenotype (i.e.
ER, PgR and HER2 negative). Lastly, there was the HER2 class (class 6) characterised
by high luminal cytokeratin and HER2 expression. These classes are similar to those de-
termined by gene expression profiling, but in this study the definitions of the luminal and
basal tumours were refined into further distinct classes with different clinical outcome.
Class 1 tumours are consistent with the previously identified group 1 [1] and Am-
brogi’s group 1 [5], but are more distinctly defined. These tumours have high expression
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of luminal cytokeratins (CK7/8, CK18 and CK19), hormone receptors, HER3 and HER4
and show high homology to the luminal-A type tumours, as identified in gene array stud-
ies. Class 3 tumours were also characterised by high levels of HER3 and HER4 but, in
contrast, showed relatively lower levels of PgR (levels of ER and AR were similar). This
class was not identified by the previous study using the same panel of markers [1], but is
similar to group 2 in the Ferrara series [5]. This class of tumour shows homology to the
luminal-B group of tumours [158,160].
Whilst gene expression profiling has determined two luminal tumour classes, in this
study those tumours with a luminal phenotype have been divided into a further class
(class 2). This novel class of tumours, which was designated as the luminal-N class,
whilst having high levels of ER and PgR, has negative/low expression of the EGFRs,
particularly HER3 and HER4. Interestingly, the class 1 (luminal-A) and class 2 (luminal-
N) tumours were similarly associated with good prognostic factors, including smaller
tumour size, grade 1 tumours, node-negative and tubular mixed carcinomas. The luminal-
N tumours were further distinct from the luminal-A tumours by high expression of nuclear
BRCA1 protein. In contrast, the third luminal class, luminal-B, although phenotypically
similar to the luminal-A tumours (except for PgR expression), consisted of those tumours
with poorer prognostic factors such as larger tumour size, higher stage and grade. It
is also apparent that HER3 and HER4 are important discriminators in the breast cancer
classification presented here, although there remains controversy as to their prognostic
significance [3, 190].
Previously, a basal-like subtype was identified using protein expression (Abd El-
Rehim’s group 5 [1] and Ambrogi’s group 3 [5]). However, it is now thought that the
basal-like subtype is heterogeneous [105] and, indeed, two basal-like classes (classes 4
and 5) have now been determined. These classes were characterised by high expression
of basal cytokeratins (CK5/6 and CK14), low expression of luminal cytokeratins and a
triple negative phenotype. They were, however, separated by p53 protein expression lev-
els: the basal-p53-altered tumours (class 4) expressed high p53 and basal-p53-normal
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Previous publications
Class Name Key Features Abd El-Rehim et al. [1] Ambrogi et al. [5] Sørlie et al. [158]
1 Luminal-A
luminal,
Group 1 Cluster 1 luminal A
HER3/4+
2 Luminal-N
luminal,
Group 2 —
HER3/4–
3 Luminal-B
luminal,
— Cluster 2 luminal B
PgR–
4
Basal-p53-
basal, p53+ Group 5 Cluster 3 basal
altered
5
Basal-p53-
basal, p53- Group 5 —
normal
6 HER2
luminal,
Group 3 & 6 Cluster 4 HER2
HER2+
NC — — Group 4 — —
Table 4.12: Comparison of breast cancer classes determined in this study compared to
those previously identified
tumours (class 5) had low p53. High frequency of tumour suppressor p53 mutations and
protein expression have previously been detected in the basal-like subtype [49, 138, 158].
A higher proportion of younger patients had basal-p53-altered tumours compared with
basal-p53-normal tumours and all but one were grade 3. Basal p53 altered tumours pri-
marily consisted of ductal NST and medullary tumours, whilst in basal-p53-normal, there
was a wide range of histological types. The association between medullary carcinomas,
p53 and basal tumours has been previously demonstrated [33, 158].
Those tumours with high HER2 expression were clustered into one class (class 6),
which is homologous to Sørlie’s HER2 group [158] and Ambrogi’s group 4 [5]. This
class has the worst overall survival. A summary of the new clinical phenotypes and their
relationship to those previously identified is shown in Table 4.12.
While 25 protein markers were originally used to derive the classes, not all will nec-
essarily be needed in order to adopt these classes in clinical decision making. Having
established core classes, it is currently investigating how a new patient may be reliably
assigned into a class using the minimum number of markers. As indicated in Table 4.9
and Figure 4.5, only around eight–twelve of the markers appear to be key drivers. The
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proportion of patients that would remain ‘unclassified’ in such a model-based class as-
signment is not necessarily 38%. It may well be that, for example, all patients could be
classified into one of these six classes, but with varying degrees of certainty. That is,
‘unclassified’ in this study does not necessarily mean ‘unclassifiable’ in clinical practice.
Actually, the core classes appear from the merging of results from different clustering pro-
cedures. Further studies are required to validate these classes and to enable the creation
of a clinically usable algorithm for prospective classification, taking into account current
therapeutic strategies.
4.6 Discussion
This study has extended the previous work [1], with the application of different clus-
tering techniques to address the issue of the non-existence of the ‘perfect’ clustering al-
gorithm. In particular, in this work four different clustering methods (in addition to the
hierarchical method used in [1]) were applied to a multidimensional dataset of protein
biomarker data, in order to evaluate the stability of results coming from different tech-
niques. Different clustering algorithms result in different clusters, particularly when large
multi-dimensional data sets are considered.
To explore the extent of the differences among different algorithms, an informal con-
sensus clustering was used, grouping together patients that were assigned to ‘similar’
clusters by different clustering algorithms. The consensus approach was similar to the
one used by Kellam et al. [98], but instead of building an agreement matrix, the previ-
ously published hierarchical clustering solution (and associated labelling) was used as a
fixed reference. In this way, a set of six core classes of breast cancer was elucidated. An-
other important issue that emerges when cluster analysis is performed, is the best number
of clusters to consider. Several validity indices were proposed in recent years (see, for
example, [183]) to evaluate the compactness of clusters and the separation among them.
For the algorithms which take an explicit number of clusters as an input parameter (i.e.
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K-means and PAM), cluster validity indices were used to guide the choice of the ‘best’
number of clusters. Note that cluster validity indices would have been applied to the
fuzzy c-means algorithm had it not been dropped from analysis for the reasons outlined
in Section 4.4.1.
Furthermore, this study confirmed, as already highlighted in [5], that cluster analysis
should be treated with caution, as different clustering algorithms will lead to different
groupings of tumours. As reported in [192], most of the proposed clustering algorithms
are largely heuristically motivated, but the issue of determining the ‘correct’ number of
clusters and choosing a ‘good’ clustering algorithm are not yet rigorously solved. In par-
ticular, in this study, the PAM algorithm, when run with six clusters as an input, provided
groups that were different from those obtained using the other techniques. In addition, the
hierarchical algorithm, commonly used in standard bioinformatics applications of cluster
analysis, such as [137] or [170], seems to provide a dissimilar and skewed classification
with respect to the others, thus reducing the degree of overall concordance and the number
of subjects assigned to the core classes.
In conclusion, it has been clearly demonstrated that different clustering algorithms
can produce quite different solutions on such multi-dimensional data. A methodology for
reaching consensus from the various results that may be obtained from clustering algo-
rithms has been shown, together with the illustration of this consensus methodology on
a well-known set of breast cancer data. In doing so, possible new sub-classes of breast
cancer which warrant further investigation have been identified. It must be emphasised
that this consensus methodology, by its heuristic nature, should be considered as an ex-
ploratory technique, and must not be considered as providing any form of definitive an-
swer. Further work exploring, for example, the statistical properties of the considered
algorithms may provide relevant information on the structure on this complex biological
problem.
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4.7 Triple-negative note
Clinically, breast cancer patients fall into three main groups: those with estrogen (ER)
and progesterone (PR) receptor-positive tumours, who are cured with anti-hormone treat-
ments with/without chemotherapy; those with HER2 positive tumours, who can receive
a HER2-targeted therapy; those with ER, PR and HER2 negative tumours, for whom the
lack of tailored therapies makes chemotherapy the only available modality of systemic
care [185].
Genome-wide DNA microarray analysis were used to classify breast cancers into five
main expression profile groups, two of them ER-positive (luminal A and B) and three ER
negative (normal breast-like, ERBB2 [also known as HER2] and basal-like) [137, 158,
159]. Consistently, single nucleotide polymorphism-association studies indicated that
different genetic risk factors can be associated to ER-positive or ER-negative tumours,
and that they may also vary according to the expression of HER2 or of basal cancer
markers [65].
The basal-like cancer group includes tumours that lack both steroid hormone receptors
and HER2 expression, the so-called triple-negative cancers [29, 132, 158, 169]. However,
despite the clinical similarities between basal-like and triple-negative tumours, including
higher incidence in younger patients [36, 166], higher histologic grade [36, 143, 166],
aggressive clinical behaviour and poor prognosis [18, 62], triple-negative and basal like
breast cancers are not synonymous. Indeed, not all basal-like cancers are negative for ER,
PgR and HER2 expression [132] and the triple negative group also encompasses non-
basal-like tumours, namely normal breast like cancers [36]. Notably, although normal
breast-like tumours have a somewhat better prognosis than basal-like cancers [158, 159,
161], they do not respond to neoadjuvant chemotherapy as well as basal-like cancers
do [25, 151].
Salient features of triple-negative breast cancers include overexpression of EGFR and
c-KIT, high proliferative rates, frequent genomic alterations, phenotypic similarity to
BRCA1-associated cancers and frequent mutations of TP53 [29, 106, 139]. In particu-
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lar, p53 appears heterogeneously expressed in triple-negative tumours, suggesting that it
may be associated with specific subgroups. Hence, two independent breast tumour case
series for p53 expression in triple-negative breast cancers were comparatively analysed.
A series of 633 patients who underwent surgery for primary infiltrating breast cancer
between 1983 and 1992 at the University of Ferrara was studied [5]. Immunohistochem-
istry (IHC)-determined ER, PR, Ki-67/MIB-1 proliferation index (Ki-67), HER2 and p53
levels were analysed. Percent expression values of ER, PR and HER2 tended to distribute
around discrete values (0%, 10%, 25%, 50%, 75% and 100% of tumour cells) and were
categorized accordingly. Percentages of Ki-67 and p53 expressing cells were analysed
without discretization (Table 4.13), but they were reported in categories for convenience
(Table 4.14).
Applying non-hierarchical algorithms, Ambrogi et al. [5] previously identified four
breast tumour clusters distinguishing distinct tumour profiles according to the expression
of traditional markers: cluster 1, characterised by high values of ER/PR; cluster 2, with
intermediate ER/PR values; cluster 3, with low-to-nil ER and high p53 and cluster 4 with
low-to-nil PR and high HER2 values.
In the present analysis, p53 protein expression was shown to be able to subdivide the
triple negative Ferrara cases into two distinct subsets, that were tightly associated to clus-
ters 2 and 3, respectively [5]: low to nil p53 levels were only observed in cluster 2 while
overexpression of p53 was only seen in cluster 3 (Tables 4.13, 4.14). These findings
support the hypothesis that the triple-negative cancers group de facto includes two dif-
ferent biological entities: basal-like (p53-positive) and normal breast-like (p53-negative)
tumours. Owing to this dichotomy, p53 expression may critically help identifying the cor-
responding patient subclusters, and may possess a specific biological/prognostic value.
Looking for additional evidence, the triple-negative tumours of an independent dataset
of 1076 patients from the Nottingham Tenovus Primary Breast Carcinoma Series [1],
which were evaluated by IHC for 25 markers including p53, were also analysed for basal
cancer-related biological markers. Levels of IHC reactivity were categorized using a mod-
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Ki 67/MIB-1 P53 Cluster
4.21 0.00 2
75.00 0.00 2
12.10 0.00 2
45.00 2.50 2
72.69 0.00 2
16.11 0.01 2
14.78 8.40 2
4.82 0.00 2
48.98 0.00 2
10.60 3.75 2
18.70 0.00 2
73.38 0.00 2
20.00 0.00 2
1.28 0.00 2
69.61 0.00 2
90.77 0.00 2
54.93 0.00 2
45.39 2.00 2
40.20 75.79 3
14.50 98.00 3
75.00 97.00 3
20.00 81.00 3
14.80 95.00 3
18.23 55.21 3
65.31 98.00 3
45.00 98.00 3
47.60 98.00 3
50.00 98.37 3
75.04 65.00 3
62.62 35.20 3
85.00 95.00 3
42.30 98.00 3
33.93 40.93 3
Table 4.13: Values of Ki-67/MIB-1 and p53 expression levels in triple-negative patients
(Ferrara case series). The third column shows the cluster defined in Ambrogi et al. [5]
p53 Cluster 2 Cluster 3
0 14 0
1-10 4 0
11-75 0 4
76-100 0 11
Table 4.14: Distribution of p53 expression levels in triple-negative patients
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ified Hscore (values between 0-300) that integrates staining intensity and percentages
of positive cells. As expected, a decreased expression of luminal phenotype-associated
markers (MUC1, CK7/8, CK18, and CK19) and a concomitant increased expression of
markers associated with the basal-like phenotype (EGFR, CK5/6, CK14 and p53) were
observed (Figure 4.8). Consistently with the Ferrara data, p53 was markedly overex-
pressed in only a subset of triple-negative cases (Figure 4.9).
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Figure 4.8: Boxplots for Nottingham data
Missense TP53 mutations often lead to higher stability of p53 proteins, that become
detectable by IHC [136]. Mutant p53 proteins can become functionally dominant-negative
and are characterised by gain-of-function properties. In contrast, truncated p53 pro-
teins are largely unstable, and cannot be revealed by IHC analysis, similarly to wild-
type p53. As a consequence, missense TP53 mutations are predominantly IHC positive
(92.9%), whereas truncating TP53 mutations are predominantly IHC negative (88.5%)
[136]. Breast cancer patients carrying missense TP53 mutations show worse disease-free
survival than those with wild-type TP53, whereas women carrying cancers with truncat-
ing TP53 mutations do not [136]. Consistently, Langerod et al. [108] demonstrated that,
among the five breast cancer subgroups identified by Perou et al. [137], the basal-like
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Figure 4.9: Distribution of p53 expression levels in Nottingham case series
and ERBB2+ phenotypes show the highest TP53 mRNA expression while the normal
like phenotype has the lowest TP53 mRNA levels. These findings were confirmed at
the protein level. Since IHC detection of p53 protein largely identifies missense TP53
mutations, p53 IHC positivity may represent a useful biological marker to discriminate
more aggressive triple-negative basal-like tumours from triple-negative tumours with a
normal-like phenotype. In addition, as TP53 gene mutations are predictive of response
to taxanes in reconstituted model systems [28] and in patients [38, 76, 174], knowledge
of p53 status may also provide powerful information to select, among the triple-negative
tumours, those more likely to benefit from taxane versus anthracyclines/alkylating agent-
based chemotherapy [25, 38, 151]. Taken together, these findings suggest that analysis
of p53 expression may help selecting patient subgroups with different biological history
among triple-negative breast cancers. This may be associated with powerful predictive
information for differential care and clinical trials planning.
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Figure 4.10: Distribution of p53 expression levels in Ferrara case series
4.8 Summary
In this chapter, a comparison between several unsupervised clustering techniques
which were run in the attempt to define a set of core breast cancer classes was reported.
Through an informal consensus clustering, a set of six groups was identified and several
statistical methods have been used to characterise each group. The relationship between
several clinical information and the core classes was also studied resulting in some novel
findings which have not been emphasised in literature yet. The chapter was concluded by
a short note on the role of p53 on triple-negative patients.
In the next chapter supervised classification techniques will be analysed and a novel
algorithm, which does not assume any particular distribution for the variables under in-
vestigation, will be presented and validated over different data sets taken from the UCI
Machine Learning Repository.
Chapter 5
Supervised Classification Techniques
5.1 Background and motivation
The classification of breast cancer patients is of great importance in cancer diagnosis.
During the last few years, many algorithms have been proposed for this task and modern
machine learning techniques are progressively being used by biologists to obtain proper
tumour information from the databases. In this chapter, a review of different supervised
machine learning techniques for classification of data sets and a methodological compar-
ison of these are reported.
For the first part of this analysis, the same data on breast cancer [1] used in previous
chapter will be considered. The full list of variables is reported in Table 4.2 in Chapter 4.
Over this dataset, a C4.5 tree classifier, a Multilayer Perceptron Artificial Neural Network
and a naive Bayes classifier will be applied. The same machine learning techniques were
already used in literature: in particular, Bellaachia and Guven in [10], revising a study
of Delen et al. [34], used the above methods to find the most suitable one for predicting
survivability rate of breast cancer patients. This study was instead motivated by the ne-
cessity to find an automated and robust method to validate the previous classification of
breast cancer markers (see Chapter 4). In fact, six classes were obtained using agreement
between different clustering algorithms. Starting from these groups, the aim was to re-
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produce the classification keeping into account the high non-normality of the data (see
Figures 5.1 and 5.2). For this reason, the C4.5 and the Multilayer Perceptron classifiers
were used and then the results were compared with the naive Bayes ones. It is important
to note that out of the 1076 patients, only 62% (663 cases) were classified into one of the
six core groups presented in Chapter 4, while the remaining 38% presented indeterminate
or mixed characteristics. In this part of the study, the focus was only on the subset of the
‘in-class’ cases to run the classifiers on in order to find an automated way to justify and
reproduce the classification obtained before. This subset represents a novel clinical cate-
gorisation of breast cancer which is interesting in its own right and presents a challenging
classification task. Further understanding of undetermined cases is left open for future
investigation.
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Figure 5.1: Histogram of variable ER
In the second part of the chapter, different case series taken from the UCI Machine
Learning Repository [8, 156] will be considered to cope with non normal data. On these
data sets, the performance of the naive Bayes classifier will be compared with the Lo-
gistic Regression approach for classification. Moreover, as the naive Bayes assumption
of normality of the data is strongly violated in many real-world problems, a new method
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Figure 5.2: Histogram of variable CK18
for the implementation of a Bayesian classifier was developed and will be presented in
the last part of this chapter. This method deals with continuous and non-normal variables
which, as in the cases presented here, do not follow normal distributions (see Figure 5.3).
The algorithm has the same structure as the naive Bayes one, considering the ratio be-
tween areas under curves of the variables distribution. The results obtained with the new
method will be compared with both those found by the naive Bayes algorithm (variables
approximated by a Gaussian distribution) and those obtained by applying a multinomial
Logistic Regression model.
The chapter is structured as follows: in Section 5.2, the technical details of the three
classifiers considered are reported (a general description of each technique has already
been presented in Chapter 2). A short description of the Logistic Regression approach
and of the data sets used are also present in Section 5.2. Then in Section 5.3 the results
obtained applying classifiers are presented and the differences among them pointed out.
Section 5.4 is reserved for the description of the new method developed to cope with the
non-normality of the data.
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Figure 5.3: Histogram of sample variables
5.2 Experiments settings
The performances of the naive Bayes classifier, the C4.5 decision tree and the Multi-
layer Perceptron Neural Network were evaluated using the WEKA software [189]. It is
a popular suite of machine learning free software written in Java and developed at the
University of Waikato in New Zealand. Instead logistic regression and the new method
were run using R [114]. All the techniques analysed were run 10 times using the 10-
fold cross validation option and the accuracy of the obtained classification was evaluated
simply by looking at the percentage of the correctly classified instances. The mean of the
returning results was then computed.
As C4.5 can handle continuous attributes, there was no need to discretise any of the
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attributes and in this work experiments the default values for the parameters were used,
with the minimum number of object in each leaf being set as 2. The default version does
perform some pruning (using the subtree raising approach), but does not perform error
pruning.
For the Multilayer Perceptron classifier the default parameters were again used, leav-
ing the number of neurons in the hidden layer as 15, which is the sum of the number
of attributes and classes divided by two. The default backpropagation learning algorithm
was used. Comparison of alternative learning algorithms is outside the scope of this work.
The default options were also used when running the naive Bayes algorithm, accepting
the option of a normal distribution estimator for numeric attributes.
5.2.1 Logistic Regression
Logistic Regression is an approach to learning functions of the form f : X → C, or
P(C|X) in the case where C is discrete-valued, and X = 〈X1 . . .Xn〉 is any vector con-
taining discrete or continuous variables [129]. Logistic Regression assumes a parametric
form for the distribution P(C|X), then directly estimates its parameters from the training
data. In this way, the ‘two-steps’ approach for estimating P(C|X) used by the naive Bayes
may be avoided. In this sense, Logistic Regression is often referred to as a discriminative
classifier, because the distribution P(C|X) can be viewed as directly discriminating the
value of the target C for any given instance X . As shown in [129], if C is boolean and
the Gaussian Naive Bayes (GNB) assumptions hold, then asymptotically (as the number
of training examples grows toward infinity) GNB and Logistic Regression converge to-
ward identical classifiers. However, as demonstrated in detail in [131], GNB parameter
estimates converge toward their asymptotic values in order logn examples, where n is
the dimension of X . In contrast, Logistic Regression parameter estimates converge more
slowly, requiring order n examples.
When the response variable C is boolean (0 or 1), the Logistic Regression, fitted by
a generalised linear model, may be used to model P(1|X) (and then P(0|X) is equal to
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1−P(1|X)); a multinomial logistic regression model is instead needed when there are
more than two classes.
Measures for predictive accuracy
There are many different measures for assessing the accuracy of a model [75]; two of
them are calibration and discrimination. When a fraction of about P of the events that are
predicted with probability P actually occur, it can be said that the predicted probabilities
are well calibrated and a suitable model for P(C|X) has been found [172]. Discrimination,
instead, measures a predictor’s ability to separate patients with different responses [75].
When the outcome variable is dichotomous and predictions are stated as probabilities
that an event will occur, calibration and discrimination are more informative than other
indices (like, for example, the expected squared error) in measuring accuracy [75]. The
calibration plot is a method that shows how well the classifier is calibrated and a perfectly
calibrated classifier is represented by a diagonal on the graph [173]. In this work, these
plots were produced following the procedure described in [172], plotting the fitted values
versus the actual average values.
A c concordance index is a widely applicable measure of predictive discrimination
and it applies to ordinary continuous outcomes, dichotomous diagnostic outcomes and
ordinal outcomes. This index of predictive discrimination is related to a rank correlation
between predicted and observed outcomes. The c index is defined as the proportion of
all patient pairs in which the predictions and outcomes are concordant. For predicting
binary outcomes, c is identical to the area under a receiver operating characteristic (ROC)
curve [75].
A ROC curve is a tool to measure the quality of a binary classifier independently from
the variation in time of the ratio between positive and negative events [173]. In other
words, it is a graphical plot of the sensitivity versus (1 - specificity) for a binary classi-
fier system as its discrimination threshold is varied. The ROC can also be represented
equivalently by plotting the fraction of true positives (TPR = true positive rate) versus the
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fraction of false positives (FPR = false positive rate). A completely random guess would
give a point along a diagonal line (the so-called line of no-discrimination) from the left
bottom to the top right corners. Usually, one is interested in the area under the ROC curve,
which gives the probability that a classifier will rank a randomly chosen positive instance
higher than a randomly chosen negative one. A random classifier has an area of 0.5, while
an ideal one has an area of 1.
5.3 Results
As stated previously, in this first part of the study, the classifiers were applied in order
to get an automated way to justify and reproduce the classification previously obtained.
The results obtained from the C4.5 were quite good, precisely 582 cases were correctly
classified (87.8%) and just 81 (12.2%) incorrectly classified. The main concern in using
this classifier came from the set of rules that were produced: they appear to be quite
numerous and not straightforward, especially if they should be used by scientists not
familiar with computational analysis.
The Multilayer Perceptron (MLP) neural network was then considered. This method
performed better than the C4.5 succeeding in correctly classifying 647 instances (97.6%)
out of 663; just 16 cases (2.4%) were misclassified.
Finally, the naive Bayes (NB) classifier was applied. This method performed worse
than the previous ones, classifying properly a smaller amount of cases (576, correspond-
ing to 86.9%). A summary of the above results can be found in Table 5.1.
Whole data
Method Classified Misclassified
C4.5 582 (87.8%) 81 (12.2%)
MLP 647 (97.6%) 16 (2.4%)
NB 576 (86.9%) 87 (13.1%)
Table 5.1: Comparison of results on three classifiers using 25 markers
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Still based on previous research (Chapter 4), 14 ‘important’ markers candidates were
selected. The strategy was to select those markers that were discriminant in the categori-
sation process and whose distribution was very different among the six classes. These
14 markers were selected on the basis of clinical importance as indicated by pathologists
involved in previous studies. An exhaustive search of the best combination of 10 markers
out of these 14 was then performed based on the naive Bayes classification results. This
was done as reducing the number of markers used for classification is a clinical aim, as
this would both simplify and reduce the costs of a clinical test based on these markers.
This ‘new’ smaller dataset was used to repeat previous experiments applying the above
classifiers on it. For the C4.5 decision tree a particular difference could not be seen,
having 581 cases (87.6%) correctly classified. Also for the Multilayer Perceptron an
increased number of misclassified instances was obtained, this time being 34 (5.1%). The
naive Bayes, instead, performed very well compared to the previous run. Now 617 cases
(93.1%) were classified properly and just 46 (6.9%) were misclassified.
A summary of the latter results is reported in Table 5.2.
Ten Markers
Method Classified Misclassified
C4.5 581 (87.6%) 82 (12.4%)
MLP 629 (94.9%) 34 (5.1%)
NB 617 (93.1%) 46 (6.9%)
Table 5.2: Comparison of results on three classifiers using only 10 markers
The 10 accuracies of each algorithm were compared using t-tests, after checking for
normality using the Shapiro test [152]. It was found that, for both the whole data and the
10-markers datasets, the Multilayer Perceptron classifier performed significantly better
than the other two (p<< 0.01). The C4.5 decision tree algorithm was significantly more
accurate than the naive Bayes (p < 0.01) when the whole data was considered, but was
not when the number of features was reduced. Table 5.3 summarizes these findings.
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Average accuracies
C4.5 MLP NB
Whole data 87.8 (6.3) 97.6 (1.8) 86.9 (2.5)
10 Markers 87.6 (6.6) 94.9 (2.6) 93.1 (2.5)
Table 5.3: Average accuracies on 10×10 cross validation experiments for the three clas-
sifiers (standard deviation in brackets)
5.4 Derivation of a new algorithm
From the results, all classifiers achieved a reasonable performance. They all are suit-
able for large-scale prediction and classification tasks on complex datasets. However,
each of them has weaknesses. The C4.5 classifier may be considered what is called ‘a
white box model’: the reason for arriving at the classification can be explicitly deter-
mined by examining the model. It also achieves good classification accuracy with large
data in a short time. On the other hand, for real world datasets, the decision tree may
become huge. In particular, for scientists not familiar with computational analysis, the set
of rules coming from a decision tree may not be straightforward. Multilayer Perceptrons,
using a back-propagation algorithm, are a standard algorithm for any supervised-learning
pattern recognition process. However, like the majority of neural networks, it is a good
example of a ‘black box model’, since explanation of the results is not available in an
easily comprehended form. If one tries to write down the network model and the function
representing the entire process, this might take a long time and in some cases it might
be extremely complicated. Naive Bayes is a fast-supervised classification technique and,
in general, it is a good approach for a classification problem. It is easy to understand
and reproduce manually, being basically based on a product of conditional probabilities.
However, one must be aware that naive Bayes relies on two fundamental assumptions:
the first one is the complete independence of features (which is largely satisfied in the
data under investigation), and the second is that the attributes should follow a normal dis-
tribution, which is not always true. Considering the latter assumption, it is immediately
apparent that the ‘Nottingham data’ do not have a normal distribution. However, despite
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the violation in its assumptions, the naive Bayesian classifier is remarkably effective on
the dataset considered, showing a good performance.
Given the violation of the naive Bayes hypothesis of normality, other methods to repre-
sent features’ distributions and to classify data were explored. A ‘non-parametric’ version
of the naive Bayes classifier was implemented, with the aim of being able to categorize
instances independently from their distribution.
5.4.1 A ‘non-parametric’ Bayesian classifier
The main idea of the new algorithm is that the closer a variable value is to its median
in a particular class, the higher is the probability to be assigned to that specific group.
At the beginning of the algorithm the median value of each feature in every class was
computed as well as the priors probabilities, which were defined as the ratio between
each class numerosity and the total number of cases.
The following step is the main part of the method in which the single probabilities are
calculated.
For each variable, it is checked whether the single variables’ values are smaller or
bigger than the median of that variable distribution in each class. If the value is smaller,
the area under the histogram which remains on the left with respect to the value being
analysed is calculated (Figure 5.4a). If the amount is bigger, the area on the right side is
computed, taking in consideration the portion of the histogram delimited by the value and
the maximum (Figure 5.4b). To compute the area under the histogram, the sum of each
bar’s area should be taken, and the latter has to be calculated as the product of bar’s width
and height. The amount returned is then divided by half of the total observations, as it is
assumed that the total area under the histogram is equal to one.
In the next step, for each patient and each class, the product of all the features proba-
bilities times the priors ones is computed.
p[i,k] = priors[k]×
p
∏
j=1
prob[ j,k] for k = 1, . . . ,K
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(a) If the value is smaller than the median
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Figure 5.4: Area under the histogram
where j runs over the p variables, i represents patients and K is the number of groups.
The final step of the algorithm is the calculation of the prediction for each instance: it
is defined as the class number which gives the highest p[i,k] (argmaxk p[i,k]).
With a little abuse of notation, this proposed algorithm can be summarised in the
following way: calling m, min and Max the median, minimum and maximum values of
each feature in each class, and, for similarity with the naive Bayes, g(x,m) the function
that represents each variable distribution, the value of k for which p[i,k] is maximised has
to be found, where
p[i,k] = priors[k]×


∏
j
1
N/2
∫ x
min
g(x;m) x< m
,
∏
j
1
N/2
∫ Max
x
g(x;m) x> m
j represents one of the features, x is the particular variable’s value under investigation and
i runs over the instances set.
In the following, the acronyms NB (naive Bayes) and NPBC (non-parametric Baye-
sian classifier) will be used to indicate, respectively, the usual naive Bayes classifier and
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the new method.
5.4.2 Data sets considered
Breast Cancer Data Set
To validate the algorithm just described, the original 25 well-characterised biomarkers
from Abd El-Rehim et al. data [1] will be used. In this data set, several clinical informa-
tion were also available, including the Nottingham Prognostic Index (NPI) score and its
defining factors (tumour size, grade, and stage of disease). The NPI was defined in [64]
as a prognostic index which may be used to categorise patients affected by breast cancer
according to its value. In particular, the index is calculated according to the following
formula:
NPI Score= (0.2× size)+grade+ stage
and five different groups may be defined depending on its value.
NPI Score Prognostic Group
≤ 2.4 Excellent Prognostic Group (EPG)
2.5 - 3.4 Good Prognostic Group (GPG)
3.5 - 4.4 Moderate Prognostic Group 1 (MPG1)
4.5 - 5.4 Moderate Prognostic Group 2 (MPG2)
> 5.4 Poor Prognostic Group (PPG)
The 25 biomarkers were used to predict the NPI groups.
UCI Machine Learning Repository Data Sets
The other datasets used to validate the new method were taken from the UCI machine
learning repository [8]: vehicle, glass, and haberman.
For the vehicle dataset, the purpose is to classify a given silhouette as one of four
types of vehicle, using a set of features extracted from the silhouette. Each vehicle may
be viewed from one of many different angles. The original purpose was to find a method
of distinguishing 3D objects within a 2D image by application of an ensemble of shape
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feature extractors to the 2D silhouettes of the objects. Measures of shape features ex-
tracted from example silhouettes of objects to be discriminated were used to generate a
classification rule tree by means of computer induction. This object recognition strategy
was successfully used to discriminate between silhouettes of model cars, vans and buses
viewed from constrained elevation but all angles of rotation. The features were extracted
from the silhouettes by the HIPS (Hierarchical Image Processing System), which extracts
a combination of scale independent features utilising both classical moments based mea-
sures such as scaled variance, skewness and kurtosis about the major/minor axes and
heuristic measures such as hollows, circularity, rectangularity and compactness. Four
‘Corgie’ model vehicles were used for the experiment: a double decker bus, Cheverolet
van, Saab 9000 and an Opel Manta 400. This particular combination of vehicles was
chosen with the expectation that the bus, van and either one of the cars would be readily
distinguishable, but it would be more difficult to distinguish between the cars [156].
The glass dataset is taken from the USA Forensic Science Service and six types of
glass, defined in terms of their oxide content (i.e. Na, Fe, K, etc), are considered. The
study of classification of types of glass was motivated by criminological investigation: at
the scene of the crime, the glass left can be used as evidence, if it is correctly identified [8,
54].
The haberman dataset contains cases from study conducted between 1958 and 1970
at the University of Chicago’s Billings Hospital on the survival of patients who had un-
dergone surgery for breast cancer [8, 73].
Table 5.4 gives the description of the three UCI benchmark problems. Each variable in
each dataset was tested for normality using the Shapiro test [152]. Since no test data sets
were provided in the benchmark sets, the ten-fold cross validation option was again used
to evaluate the performance of the proposed algorithm. That is, each dataset was split
randomly into ten subsets and one of those sets was reserved as a test set; this process was
repeated ten times and the mean of the results was used.
Since two of the UCI datasets (namely vehicle and glass) had been also analysed by
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name vehicles glass haberman
#pts 846 214 306
#ats 18 9 3
#cls 4 6 2
#pts: the number of training data;
#ats: the number of attributes of patterns;
#cls: the number of classes.
Table 5.4: Three benchmark datasets from UCI
Bouckaert [17], comparing three main methods for dealing with continuous variables in
naive Bayes classifiers, a comparison with Bouckaert’s results will be performed simply
by looking at the average accuracies reported in the original work [17]. As a matter of
fact, in [17], the kernel method and the discretisation one have been used in comparison
with the original naive Bayes. The kernel method approximates P(X |C) for a continuous
variable X (see Equations 2.30 and 2.31 in Section 2.6.3) by a sum of so called kernels,
which are functions centered around data points [17, 91]. The discretization method [41]
instead, first discretises the continuous variables into discrete ones, leaving a simpler
problem without any continuous variables.
5.4.3 Results
First of all, four cases for which the NPI value was missing were deleted from the
breast cancer data. Then, the experiments were started running the naive Bayes clas-
sifier in WEKA using the 10-fold cross validation option and evaluating the accuracy of
the obtained classification simply by looking at the percentage of the correctly classified
instances. Also when using the new method in R, the 10-fold cross validation option was
utilised.
It was found, for the breast cancer dataset, that only 249 (23.2%) patients were
correctly assigned to their particular class, while the remaining 823 (76.8%) were mis-
classified. For the Statlog vehicle dataset, instead, naive Bayes properly classified 381
instances (45.0% of the total amount), leaving 465 cases (55.0%) incorrectly assigned
to their group. When considering the glass dataset, the algorithm correctly classified
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almost just half of the cases (48.6% which corresponds to 104 data points), leaving the
other half (110 cases, equal to 51.4%) not properly classified. For the last dataset analysed
(haberman), naive Bayes assigned 229 patients (74.8%) to the proper group, and just 77
(25.2%) were misclassified.
With the new algorithm, a substantial improvement in the amount of cases that were
correctly classified was obtained when considering the breast cancer dataset and more
cases were also correctly assigned to their group when the UCI datasets were analysed.
For the breast cancer data, the number of patients which were assigned to their orig-
inal class was 416 (38.8%), and 656 (61.2%) were wrongly classified. For the vehicle
data, NPBC was able to properly classify 503 cases (59.5%), 122 more than with the
naive Bayes. The remaining 343 instances (40.5%) were misclassified even with the new
algorithm. When moving to the glass dataset, it was obtained that 121 (56.5%) types
were correctly assigned to their group, while the remaining 93 (43.5%) were not. The
last dataset considered, haberman, had 240 (78.4%) data points properly classified and
66 (21.6%) misclassified.
When using a multinomial Logistic Regression model (MLR) the number of cases
correctly classified was higher with respect to previous techniques for the vehicle and
glass data sets, but not for the breast cancer one. Concerning the haberman data,
for which a generalised linear model (GLM) was fitted, the same results obtained with
the naive Bayes classifier were returned: a total of 229 (74.8%) patients were correctly
assigned to their class, while the remaining 77 (25.2%) were not.
A summary of the results is reported in Tables 5.5 to 5.8. In Tables 5.6 and 5.7
average accuracies of different naive Bayes methods computed by Bouckaert [17] are
also reported.
Calibration plots (see Section 5.2.1) for the breast cancer, vehicle and glass
data sets are reported in Figures 5.5, 5.6, and 5.7. If the curve is above the diagonal
line (which represents a perfectly calibrated classifier), it means that there is an over-
estimation of the class membership probabilities by the classifier. It can be seen that,
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breast cancer data
Method Classified Misclassified
NB 249 (23.2%) 823 (76.8%)
NPBC 416 (38.8%) 656 (61.2%)
MLR 332 (31.0%) 740 (69.0%)
Table 5.5: Comparison of results over the breast cancer dataset. NB: Naive Bayes,
NPBC: Non-Parametric Bayesian Classifier, MLR: Multinomial Logistic Regression
vehicle data
Method Classified Misclassified
NB 381 (45.0%) 465 (55.0%)
NPBC 503 (59.5%) 343 (40.5%)
MLR 678 (80.1%) 168 (19.9%)
BK [17] (60.9%) (39.1%)
BD [17] (61.1%) (38.9%)
Table 5.6: Comparison of results over the Statlog vehicle dataset. BK: Bouckaert’s
Kernel method, BD: Bouckaert’s Discretisation method
glass data
Method Classified Misclassified
NB 104 (48.6%) 110 (51.4%)
NPBC 121 (56.5%) 93 (43.5%)
MLR 134 (62.6%) 80 (37.4%)
BK [17] (51.1%) (48.9%)
BD [17] (71.9%) (28.1%)
Table 5.7: Comparison of results over the glass dataset
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haberman data
Method Classified Misclassified
NB 229 (74.8%) 77 (25.2%)
NPBC 240 (78.4%) 66 (21.6%)
GLM 229 (74.8%) 77 (25.2%)
Table 5.8: Comparison of results over the haberman survival dataset. GLM: Generalised
Linear Model
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Figure 5.5: Calibration plots for multinomial logistic fit to the breast cancer data
for the breast cancer dataset, the Logistic Regression model probabilities are less cali-
brated than the ones obtained by the proposed method. For the other data sets considered,
Logistic Regression performed slightly better than the new algorithm.
For the haberman data set a plot of the ROC curves for both the GLM and the new
method was produced and is reported in Figure 5.8. From the values of the areas under the
curves, reported in the plot, a slightly better accuracy of the GLM is evident with respect
to the new method, which, in any case, seems to be a quite good predictive model for the
haberman data. Although similar plots could have also been produced when considering
the other data sets, it was decided to use only those data where the response variable was
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Figure 5.6: Calibration plots for multinomial logistic fit to the vehicle data
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Figure 5.7: Calibration plots for multinomial logistic fit to the glass data
binary (0 or 1) and not multinomial.
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Figure 5.8: ROC curves for haberman survival data
5.5 Discussion of results
In the experiments presented in this chapter, several different results were obtained
from the classifiers. Using the whole Nottingham ‘in-class’ dataset (25 markers × 663
instances), the best performance was obtained from the Multilayer Perceptron classifier:
in fact just 16 cases were incorrectly classified. The naive Bayes and C4.5 decision tree
returned similar results (but worse than the MLP), with the latter being ‘only marginally’
more accurate than the naive Bayes.
When just the 10 ‘most important’ markers were considered, a substantial improve-
ment in the naive Bayes performance was found: even though it did not return the highest
number of correctly classified instances, it performed much better than with all the mark-
ers, decreasing the number of misclassified instances from 87 to 46. Again, the best
results were obtained using the Multilayer Perceptron, but this time the network did not
perform as well as before: there were 18 more cases of misclassification. Finally, the C4.5
decision tree was the worst classifier among the three used, performing almost identically
as with all markers.
Starting from these results, a ‘non-parametric’ approach of the naive Bayes classifier
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to deal with continuous and non-normal covariates was developed. The method was pre-
sented and its performance over four particular data sets was compared to the original
naive Bayes one as well as to Logistic Regression.
The naive Bayes method did not perform well on all data considered in this part of
the work, and, focusing on the breast cancer one, this reflects a sort of independence
between biological markers and clinical information. Moreover, all datasets’ features
strongly violated the normality assumption, so proving the reason of a ‘non-parametric’
approach.
For each class and each variable, the median value and the histogram of its distribution
were computed. Different situations that might occur were then considered: if, fixing a
particular class and a particular data point, the value of a generic variable was lower
or greater than the extreme values of the same variable in the class considered at that
stage, then a probability close to zero to belong to the specified class was assigned to
that data point; if the value was identical to the median the probability was set to be one;
finally, if the data point was smaller than the median, the area between the distribution’s
minimum and the actual value was calculated (or between the value and the distribution’s
maximum if value was greater than the median). The value obtained was then divided by
half number of observations. As for the naive Bayes classifier, it was calculated, for each
case, the product of probabilities of all features given the classes. Data were classified
looking at the class number for which the above reached the maximum.
With the method just described, a bigger amount of data points was correctly classi-
fied, raising the percentage from 23.2% to 38.8% for the breast cancer dataset, from
45% to almost 60% for the vehicle Statlog dataset, from 48.6% to 56.5% for the glass
data, and from almost 75% to more than 78% for the haberman dataset. However,
when using Logistic Regression, different results were obtained. For the breast cancer
dataset, the proposed new model seemed to be more accurate (in terms of percentages
of patients correctly classified) and more calibrated with respect to the Logistic Regres-
sion. This was not true when considering the UCI data sets, for which the new algorithm
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slightly appeared to be less calibrated and less accurate. However, for the haberman
dataset, when a GLM was fitted to the data, the number of patients correctly assigned
to their class was identical to the one obtained when using naive Bayes and the ROC
curve associated to the method presented here was very similar to the one produced by
the GLM, providing two close values for the areas under the curve.
It is important to note that a couple of data sets presented in this work were also used
in [17] to compare naive Bayes normal method with the kernel and the discretization ones
obtaining both better and worse results compared to ours (Tables 5.6 and 5.7). Bouckaert
considered those three methods to deal with continuous variables when using the naive
Bayes classifier. Instead the ‘non-parametric’ method was developed to deal with the
non-normality of several dataset variables and, moreover, it outperformed all the ones
proposed in [17] when applied over the breast cancer dataset (results not reported).
It is also worth noting that the new developed method is not meant to be applicable
over all available datasets. In this chapter several situations were presented, for which
a classical approach, the naive Bayes classifier, was outperformed by a more general
algorithm that does not assume any particular distribution of the analysed features. In
general, according to the experience, the classical naive Bayes classifier outperforms the
new method when datasets with categorical features are considered or when the majority
of them follows a normal distribution. In these situations it is advisable to use the original
naive Bayes approach.
5.6 Summary
In this chapter, supervised learning was applied over several case studies. In particular,
three different classifiers, the C4.5 decision tree, the MLP-ANN and the naive Bayes
were reviewed and used over the ‘in-class’ patients of the Abd El-Rehim et al. [1] breast
cancer dataset in order to validate the previous classification derived and characterised in
Chapter 4. Surprisingly, the naive Bayes classifiers performed quite well, especially when
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just the 10 ‘most-important’ markers were considered. This happened even though one
of the underlying assumptions of the NB was strongly violated by the data: as a matter
of fact, all the features did not follow a normal distribution. A non-parametric version
of the naive Bayes was then developed and validated over known data sets. These latter
results were presented in this chapter together with their comparison with the Logistic
Regression approach.
In the next chapter, a novel clustering technique, called Affinity Propagation, will be
presented. This algorithm combines properties of both heuristic and model-based ap-
proaches and it was shown to be feasible with very large data sets. Its application over
several data set of cancer will be reported and discussed.
Chapter 6
The Affinity Propagation Method: Is It
Computationally Efficient?
In this chapter, the clustering technique Affinity Propagation (AP, [60]) will be pre-
sented and adopted for grouping tumours with similar biological characteristics. This
method combines properties of both hierarchical and model-based clustering. A particu-
lar feature of AP is that the number of clusters should not be passed as an input parameter.
Instead, a measure of preference, as described later, has to be chosen. By iterating the al-
gorithm over a set of preferences, it is possible to obtain an indication about the number
of clusters present in the data.
The Affinity Propagation was analysed in this study to find out whether it could en-
hance the proposed framework (described in the next chapter) by using a different ap-
proach to discover the best classification in a dataset. In the next sections, the AP al-
gorithm will be described in details, together with motivations for its use. Then, results
obtained by applying this method to cancer case series will be reported. In the end, the
evaluation of the computational complexity of AP and its comparison with the ones of
‘traditional’ algorithms will be presented to address the real efficiency of the algorithm
over the case studies analysed.
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6.1 Background and motivation
Genomic analysis renewed interest in clustering techniques. After the seminal paper
of Eisen and colleagues [47], proposing hierarchical clustering and the visual inspection
of the dendrogram to discover unknown pattern of gene associations, the use of clustering
has become more and more popular especially to discover profiles in cancer with respect
to high-throughput genomic data. Important applications of the Eisen method are the
work of Bittner et al. [15] on clustering of cutaneous melanoma and the works of Perou et
al. [137] and of van’t Veer et al. [170] on breast cancer. More recently, a classification of
breast carcinoma using traditional tumour markers was proposed [5]. Different clustering
algorithms were used in [5] to choose a stable solution across different clustering methods.
At last a classification in four clusters was preferred and suggested a possible separation
of high risk profiles. This classification [5] was in agreement with those obtained with
c-DNA microarray data [137,170].
One of the main problems connected with cluster analysis is the choice of the number
of clusters. The visual inspection of the dendrogram suggested by Eisen et al. [47] is
an informal method to determine the number of clusters. Such a procedure was indeed
criticized by Goldstein et al. [70] as it can cause difficulty in assessing the validity of
the grouping. In classical cluster analysis it is customary to use indexes to compare one
cluster solutions to other cluster solutions and to choose the one suggested as optimal.
In a recent study [5], different indexes were used to select an optimal partition. Namely
the indexes proposed by Calinski and Harabasz [20], Krzanowski and Lai [102], Hartigan
[77] and Tibshirani et al. [165], were considered. According to Getz et al. [68], the
number of clusters should be determined internally by the clustering algorithm and should
not be externally prescribed.
In this chapter, a recently developed clustering algorithm, the Affinity Propagation
[60], will be used to cluster cancer patients in order to evaluate its performance with
respect to the traditional approaches. Although this algorithm does not determine auto-
matically the number of clusters, it provides a consistent method to suggest the number
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of groups to be created which can be useful to detect different levels of association pat-
tern. Several datasets, already published in literature were considered in this study: the
melanoma data of Bittner et al. [15], and four different breast cancer data: namely, the
studies of Ambrogi et al. [5], Perou et al. [137], van’t Veer et al. [170] and the ‘Not-
tingham dataset’ presented in [1]. In addition, the computational complexity of AP was
analysed and compared to the one of K-means. These two methods were applied over
the ‘Nottingham dataset’, and a comparison of the required CPU times was performed in
order to evaluate whether it was worth including AP in the proposed framework.
6.2 The Affinity Propagation algorithm
As other clustering algorithms, Affinity Propagation uses data to find a set of cen-
tres such that the sum of squared errors between data points and their nearest centre is
small. Like other traditional clustering techniques, the Affinity Propagation algorithm de-
termines the centres from real data points (which, for this method are called ‘exemplars’).
These exemplars correspond, for instance, to the medoids in the algorithm PAM [97]
(Partitioning Around Medoids, a more robust version of K-means), that is k representa-
tive objects among the observations of the dataset that should represent the structure of
the data. As a technical detail, it is worth noting that K-means algorithm does not use ex-
emplars, as the centres are not generally actual data points but are computed as the means
of data points belonging to clusters.
Affinity Propagation combines the properties of different classes of clustering algo-
rithms. On one hand, algorithms like hierarchical clustering are based on grouping pairs
of objects with high affinity. On the other hand model-based clustering uses a proba-
bility model based on a mixture of class conditional distributions. Affinity Propagation
uses both pairs comparison and a probability model to determine the optimal grouping.
According to a more technical point of view, Affinity Propagation can be derived as the
sum-product algorithm in a graphical model describing the mixture model [59].
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AP is a method that recursively transmits messages (that will be defined subsequently)
between pairs of data points until a good set of exemplars and corresponding clusters
emerges.
The first step for the algorithm implementation is to choose a measure of similarity,
s(i,k), between all pairs of data points. In AP terminology, s(i,k) quantifies how well the
data point with index k is suited to be the exemplar for data point i. In cluster analysis,
the negative Euclidean distance is generally used as a similarity measure. When dealing
with c-DNA data, however, it is common to use the Pearson correlation [15]. The same
choices can be made when using Affinity Propagation [60].
Rather than requiring the number of clusters to be prespecified, AP assigns a common
value (called preference) to all data points. The second step relates to the choice of these
values of preference which are indicated as p(i). The preferences represent a measure
of how much data point i is candidate to be an exemplar. In general, data points with
larger values of p(i) are more likely to be chosen as exemplars. At the beginning, the
AP simultaneously considers all data points as potential exemplars (so the preferences
being the same for all data points). The number of identified exemplars is influenced by
the values of the input preferences, but also emerges as a result of the message passing
structure that is illustrated subsequently. For very small value of input p(i), for every i, all
data points are grouped in one large cluster with a single exemplar; in the opposite case
of large p(i) for every i, each data point prefers to be its own exemplar. In general, the
initial value of the preferences is set equal to the median of all input similarities (resulting
in a moderate number of clusters) or to their minimum (resulting in a small number of
clusters).
The algorithm is named Affinity Propagation because at any point in time, each mes-
sage reflects the current affinity between a data point and its exemplars. In practice, during
the message-passing algorithm, each data point i furnishes a measure to suggest another
data point k to be selected as cluster centre, taking into account other potential exemplars
for point i. There are two kinds of message being passed between each pair of data points
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Figure 6.1: Message exchange between data points
that represent the relationship between data points:
• “responsibility”: sent from data point i to candidate exemplar k. It is a measure
that quantifies how well-suited point k is to be the exemplar for point i, taking into
account other potential exemplars for point i. This message is represented by r(i,k)
and is computed using this formula:
r(i,k) = s(i,k)− max
k′: k′ 6=k
{a(i,k′)+ s(i,k′)};
• “availability”: sent from candidate exemplar point k to point i. It is a measure that
reflects the evidence for point i to choose point k as its exemplar, considered that
other points may have k as an exemplar. This message is represented by a(i,k) and
is computed using this formula:
a(i,k) =min{0,r(k,k)+ ∑
i′: i′ /∈{i,k}
max{0,r(i′,k)}}
An illustration of the responsibilities and availabilities is reported in Figure 6.1. A
particular measure is the “self-responsibility”, that is r(k,k); it reflects accumulated ev-
idence that point k is an exemplar and how it would be unsuitable to be integrated in a
group of another cluster centre.
At the beginning of the algorithm, the availabilities are initialized to zero, so r(i,k) is
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set to the input similarity between point i and its potential exemplar k minus the largest
of the similarities between point i and other candidate exemplars. After the computation
of all the responsibilities, the availabilities are worked out using the previous formula.
Only the positive portions of responsibilities between the candidate exemplar k and other
data points i′ are added because it is only necessary for a good exemplar to explain some
data points well ( r(i′,k) > 0 ) regardless of how poorly it explains other data points
( r(i′,k) < 0 ). In fact, if r(i′,k) < 0, k is not suited to be the exemplar for point i′. So in
this case, the point i′ will not contribute to the message passing from candidate exemplar
k to point i.
After that, the messages are recursively updated for a fixed number of iterations or
until a stable clustering result. At any stage, the availabilities and responsibilities can be
combined to identify exemplars. For point i, the value k that maximises a(i,k)+ r(i,k)
identifies point i as exemplar if k = i or identifies the data point that is the exemplars
for point i. In other words, as suggested in [43], after exchanging messages, Affinity
Propagation identifies a set of exemplars K so as to maximise the net similarity, which is
defined as
∑
i/∈K
max
k∈K
s(i,k)+ ∑
k∈K
p(k)
where p(k) is the a priori preference that point k would be chosen as an exemplar. At the
end of the message passing, the number of clusters is obtained together with the labels for
each data point of its exemplars. All the equations shown above are derived and explained
in detail in the Supporting Online Material for [60].
An illustration of how Affinity Propagation works is reported in Figure 6.2. Affin-
ity Propagation is illustrated for two-dimensional data points, where negative Euclidean
distance was used to measure similarity. Each point is coloured according to the current
evidence that it is a cluster centre (exemplar). The darkness of the arrow corresponds to
the strength of the transmitted message.
AP differs from other clustering algorithm like K-means in several aspects. Firstly,
K-means is based on the minimisation of the Euclidean distance between data points and
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Figure 6.2: How Affinity Propagation works [60]
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cluster centres, which are computed as mean points within a cluster, while AP uses general
dissimilarities and actual data points as centres. Secondly, K-means begins with an initial
set of randomly selected centroids and iteratively refines this set so as to decrease the
sum of squared error. AP, instead, simultaneously considers all data points as potential
exemplars [60]. Finally, the use of squared Euclidean distance as measure of dissimilarity
between data points and centroids in K-means not only limits the type of data variables
that can be considered, but it can also make the determination of the cluster means non-
robust to outliers [14]. Furthermore, as the K-means algorithm can be thought as an
EM algorithm, it is worth noting that the use of a general dissimilarity measure in such a
context implies an increased complexity in the maximisation step which is generally faced
by considering as possible cluster centres actual data points. By doing so, the algorithm
can be implemented for any choice of similarity measure [14].
An advanced characteristic of Affinity Propagation is that it determines the number of
clusters on the basis of the message passing architecture and of the points that are most
representative, given an initial common preference. It is possible to see the effect of the
value of the input preference on the number of clusters by a graphic with the value of
the common initial preference on the x-axis and the respective number of clusters on the
y-axis. In this way, the value to adopt in the analysis can be established in correspondence
with plateaus that are observable in this graphic. Given an initial preference, AP defines
a unique solution.
One of the strong points of AP is its computational efficiency, as described in [109].
Leone and colleagues, indeed, state that AP seeks at maximising the overall similarity
of all data points to their exemplars under the hard constraint which forces each data
point in a cluster to refer to its exemplar and each exemplar to refer to itself as a self-
exemplar. The solution of this hard combinatorial task is approximated following the
ideas of belief-propagation [103]. Whereas an implementation of belief propagation for
n data points leads to O(n3) messages which have to be determined self-consistently, the
formulation of Frey and Dueck [60] allows to work with O(n2) messages only. There-
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fore, the algorithm is feasible even for very large data sets [109], such as a collection
of 75,066 segments of DNA (60 bases long) corresponding to putative exons [60]. This
last assumption was actually also confirmed in the original work of Frey and Dueck [60],
where the authors compared the AP performance on four different scenarios with the one
of the K-means algorithm. When dealing with the problem of clustering images of faces
using standard optimisation criterion of squared-error, Frey and Dueck used both AP and
K-means to identify exemplars among 900 grayscale images extracted from the Olivetti
face database1. The authors claimed that AP found exemplars with much lower squared
error than the best of 100 runs of K-means clustering, which took about the same amount
of computer time [60].
Considering the time complexity of the affinity propagation, Zhang et al. [196] stated
that, while the message passing algorithm converges with n logn complexity, the simi-
larity matrix is computed with quadratic complexity, thus hindering the scalability of the
approach. As a matter of fact, in Frey and Dueck [60] the similarity matrix was assumed
to be given beforehand, or to involve a small fraction of the item pairs [196]. Algorithms
like K-means or PAM, instead have an overall complexity of O(nkt) or O(tk(n− k)2)
(where n is the dimension of the dataset, k is the number of clusters and t the number of
iterations), as already reported in Table 2.1 of Chapter 2.
6.3 Application of AP over known datasets
The Affinity Propagation was applied over several case studies of both breast and
cutaneous cancers. In the following, each dataset will be presented in detail and sub-
sequently results obtained by AP will be compared with those presented in the original
papers. Finally, a comparison between the CPU times required to perform AP and K-
means algorithms is reported.
1The Olivetti dataset, along with the similarities used to obtain the results described in [60] are available
at www.psi.toronto.edu/affinitypropagation.
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6.3.1 Case studies considered
This section includes a description of the case series considered in the work.
1. The information on 633 patients operated on for primary infiltrating breast cancer
between 1983 and 1992, archived at the Pathology department of the University of
Ferrara, was retrospectively analysed in the work of Ambrogi et al. [5]. The avail-
able data concerned patient age, pathological tumour size, histologic type, patho-
logic stage, and number of metastatic axillary lymph nodes; as well as immunohis-
tological determinations of oestrogen receptor status (ER), progesterone receptors
status (PgR), Ki-67/MIB-1 proliferation index (MIB1), c-ErbB-2/NEU (HER2) and
the p53 oncosuppressor gene (p53). Values of ER, PgR and HER2 tended to be
grouped on the following values: 0%, 10%, 25%, 50%, 75% and 100%; they were
consequently discretized on those values. Values of MIB1 and p53 were used as
originally measured.
2. The melanoma dataset of Bittner et al. [15] was also analysed. These data consist
of gene expression profiles obtained on a collection of 38 samples, comprised of
31 melanoma tumours and 7 controls. For the analysis described in Section 6.3.2,
the data from the seven control specimens were excluded and only the ratios for
the 3613 genes that were considered ‘well measured’ (that is their intensities were
sufficiently high) were used. These ratios were converted to log2 ratios.
3. Another dataset on breast cancer that was considered for investigation was that of
Perou et al. [137]. Variation in gene expression patterns in a set of 65 surgical
specimens of human breast tumours from 42 different individuals have been char-
acterised, using complementary DNA representing 8102 human genes. According
to the authors, these patterns provided a distinctive molecular portrait of each tu-
mour [137]. Sets of co-expressed genes were identified for which variation in mes-
senger RNA levels could be related to specific features of physiological variation.
The tumours could be classified into subtypes distinguished by differences in their
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gene expression patterns. In their paper, Perou et al. focused on a set of 1,753
genes in 65 experimental tissue samples. In each sample, the ratio of the abun-
dance of transcripts of each gene to its median abundance across all tissue samples,
is reported. Data and original analyses of both Bittner and Perou studies are fully
described in the book “Design and Analysis of DNA Microarray Investigations” by
Simon and colleagues [157].
4. The dataset analysed in van’t Veer et al. [170] was also considered in this study:
they used DNA microarray analysis on primary breast tumours of 117 patients, and
applied supervised classification to identify a gene expression signature strongly
predictive of a short interval to distant metastases in patients without tumour cells
in local lymph nodes at diagnosis. All patients were lymph node negative and under
55 years of age at diagnosis. Unsupervised clustering detected two subgroups of
breast cancer, which differ in ER status and lymphocytic infiltration.
5. The last case study considered was the data set originally analysed in Abd El-Rehim
et al. [1]. As already mentioned, these data consist of tumours of an independent set
of 1076 patients from the Nottingham Tenovus Primary Breast Carcinoma Series,
which were evaluated by Immunohistochemistry (IHC) for 25 markers. Levels of
IHC reactivity were categorized using a modified H-score (values between 0-300).
Further description of these data can be found in [1] as well as in previous chapters
of this thesis.
6.3.2 Results
In this section, results obtained by the application of AP over known case studies will
be reported in order to compare them with those obtained by hierarchical or partitional
algorithms. Al last, the CPU time needed for the computation of affinity propagation over
a single dataset was evaluated. Its comparison with the time requested by ‘traditional’
methods will be presented and discussed in order to evaluate the inclusion of this novel
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algorithm in the proposed framework for the elucidation of core classes in a dataset.
Ambrogi et al. breast cancer biomarkers data
AP was applied to the breast cancer data analysed in [5] in which the final cluster-
ing was obtained using a K-Medoids algorithm to generate four clusters. The negative
Euclidean distance was chosen as the similarity measure, in accordance with the original
paper [5]. A graphical evaluation of the effect of the value of preference on the number
of clusters for the breast cancer data is reported in Figure 6.3. The presence of three main
plateaus in correspondence with two, four and five clusters is shown.
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Figure 6.3: The effect of the value of the input preference on the number of clusters for
the Ambrogi et al. data
When doing the analysis with two clusters, by using an input preference value in
correspondence with that plateau, results consistent with knowledge from the literature
were obtained. Indeed, one cluster was associated with low values of ER and PgR, while
the other with high values of these biological markers, as reported in Figure 6.4.
The message-passing algorithm was then run with an input preference to obtain 4
clusters. The results are reported in Figure 6.5. From these plots, the resulting clusters
could be characterised as follows. Cluster 1 was associated with highest values of ER and
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(b) Distribution in AP cluster 2
Figure 6.4: Distribution of variables in two clusters for the Ambrogi et al. data
PgR, so it seemed to represent subject with characteristics known to be good prognostic
factors. Cluster 2 seemed to be associated with intermediated values of PgR and ER
and null values of HER2; so also this cluster was associated with less aggressive tumour
features. Null values of ER, highest values of p53, HER2 and MIB1 were associated with
Cluster 3. Null values of PgR and high values of HER2 were associated with Cluster 4.
Therefore, Cluster 3 and Cluster 4 represent groups that are associated with characteristics
known to be poor prognostic factors. As for the triple negative patients, null values of
PgR, ER and HER2 associated with positive values of p53 were grouped in Cluster 3.
The distribution of subject between the classification using K-Medoids (PAM) and the
classification using AP is reported in Table 6.1. If these results were compared with those
of the previous work, null values of PgR, ER, HER2 and p53 were grouped in original
Cluster 2, which was the cluster most similar to the characteristics of total sample. Instead,
in this new classification null values of PgR, ER and HER2 associated with null values
of p53 lay in Cluster 4, a cluster that is not similar to total sample for the distribution of
biological markers and represents groups with poor prognostic factors.
Afterwards, the AP algorithm was applied again to obtain a division of subjects in 5
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(e) Distribution in AP cluster 4
Figure 6.5: Boxplots for the whole data and grouped by AP cluster for the Ambrogi et al.
data
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AP CLUSTERS
PREVIOUS
1 2 3 4
High ER 253 1 0 2
WORK’S Intermediate ER 1 122 0 84
CLUSTERS
Low ER / High p53 0 1 88 2
Low ER / High HER2 1 25 1 52
Table 6.1: The distribution of subjects between new and old classification (Ambrogi et al.
data)
groups and to compare these results with the four clusters obtained in the previous run.
This comparison is reported in Table 6.2, from where it is visible that the solution with
five clusters is very similar with the one with four groups. There is just a subdivision in
groups 4 and 5 of the last group determined in the previous run. However, this distinction
into two separate groups is somehow significant, as it is shown in Figure 6.6. (a) shows
the distribution of the five markers in cluster 4 for the AP with four groups, while (b) and
(c), respectively, show the distributions of markers in clusters 4 and 5 for the AP solution
with five groups. When the dataset is divided in five clusters, the fourth and the fifth differ
by the presence or absence of HER2.
AP 5 CLUSTERS
AP 4 CLUSTERS
1 2 3 4 5
1 210 41 0 2 2
2 1 125 0 23 0
3 0 0 86 1 2
4 1 0 1 49 89
Table 6.2: The distribution of subjects between AP 4 and 5 groups (Ambrogi et al. data)
Bittner et al. melanoma data
Bittner and colleagues [15] attempted to determine if c-DNA microarray data could
be used to identify distinct subtypes of cutaneous melanoma, a malignant neoplasm of the
skin. In particular they were able to identify two major cancer profiles with different bio-
logical characteristics. Results were based on the application of a hierarchical algorithm
and on cutting the dendrogram by visual inspection [70]. In Figure 6.7 the dendrogram
resulting from the application of a hierarchical algorithm with average linkage and a sim-
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Figure 6.6: Boxplots of markers for different AP groups
ilarity matrix based on Pearson correlation is reported. The two clusters were obtained
by cutting the tree as shown in Figure 6.7. In this way the 31 melanomas were divided in
a single group comprising 20 melanomas while the remaining 11 (actually grouped in 4
clusters) were considered together.
AP algorithm was applied to the melanoma data using a distance matrix based on
correlations. The resulting plot of the cluster number for different preference levels is
reported in Figure 6.8. The plot suggests solutions with 2, 4 and 5 clusters. An interesting
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Figure 6.7: Dendrogram resulting from the application of hierarchical algorithm to Bittner
et al. dataset
issue which can be raised from this plot is related to the correspondence between the
number of clusters and the preference values. Frey and Dueck, in a FAQ webpage for
Affinity Propagation2, state that “the number of clusters is close to being monotonically
related to the preference” but they do not investigate further on this. In Figure 6.8 it can
be seen that, after the plateau at four clusters, the blue line decreases and then increases
again to reach the following plateau at five clusters. Increasing the number of the possible
values of preference, the plot reported in Figure 6.9 can be obtained. It can be seen that a
small plateau is also found in correspondence of three clusters, while, if a fewer number
of values of preference is considered, the relationship between the number of clusters and
the preferences becomes monotonous (see Figure 6.10). This behaviour was not evident
in any other similar plot reported in this chapter, thus leaving the issue of the monotonicity
of this kind of plot open for future investigation.
The solution with 5 clusters is the one more similar to the one obtained by Bittner and
colleagues. The 3-dimensional principal component plot in Figure 6.11 shows the two
groups of the 31 melanomas. The red crosses correspond to the “interesting” cluster iden-
tified by Bittner and colleagues. The four black squares are tumours classified differently
2Available at http://www.psi.toronto.edu/affinitypropagation/faq.html
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Figure 6.8: The effect of the value of input preference on the number of clusters for the
melanoma data
Figure 6.9: The effect of the value of input preference on the number of clusters for the
melanoma data (‘zoom in’)
Figure 6.10: The effect of the value of input preference on the number of clusters for the
melanoma data (‘zoom out’)
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Figure 6.11: Principal component plot of the gene expression profiles obtained for the 31
melanoma tumours
by AP and the hierarchical algorithm. The concordance between the two methods appears
satisfying.
Perou et al. breast cancer data
In the work of Perou and colleagues [137], an average-linkage hierarchical clustering
method, as implemented in [47], was used to group the experimental samples on the basis
of similarity in their patterns of expression. In the dendrogram derived from the hierarchi-
cal clustering, two large branches were apparent separating the tumour samples into those
that were clinically described as ER positive and those that were ER negative. Within
these large branches there were smaller branches for which common biological themes
could be inferred, namely basal-like, Erb-B2+, normal-like and luminal epithelial/ER+
cancers.
As done in Lama et al. [107], missing values were imputed with the average values of
neighbour genes resulted from a k Nearest Neighbours (k-NN) algorithm, setting k = 10
(R software package EMV, see [167]). The 10 genes ‘more similar’ to the one with missing
value were selected on the basis of the sample correlation: a measure which conforms well
to the intuitive biological meaning of ‘co-expression’. In this way, all the unavailable data
could be recovered and a 1753 x 65 matrix obtained, where rows represented genes and
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AP CLUSTERS
PREVIOUS 1 2
WORK’S ER positive 26 22
CLUSTERS ER negative 8 4
Table 6.3: The distribution of subjects between new and old classification (Perou et al.
data)
columns represented samples.
The AP algorithm was run using 1−Pearson correlation as a similarity measure and
the effect of the value of preference against the number of clusters is shown in Figure 6.12.
By the inspection of plateaus, two, three, four and six may be considered as numbers of
clusters determining stable solutions.
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Figure 6.12: The effect of the value of input preference on the number of clusters for the
Perou et al. data
When considering two clusters a clear correspondence with the ER positive and ER
negative groups was not evident. In particular the distribution shown in Table 6.3 was
obtained (please note that for 5 patients information about their ER status was missing).
Considering three clusters, the ER negative group was basically identified by the first
cluster, which, on the other hand, contained also several ER positive patients (see Ta-
ble 6.4 for details).
For four clusters a comparison with the four groups determined by the authors was
done: from Table 6.5 it can be seen that all the basal-like tumours were captured by
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AP CLUSTERS
PREVIOUS 1 2 3
WORK’S ER positive 8 17 23
CLUSTERS ER negative 10 2 0
Table 6.4: The distribution of subjects between new and old classification (Perou et al.
data)
Cluster 1 and the normal-like tumours were assigned to Cluster 2. Clusters 3 and 4 seem
to be characterised by the luminal/epithelial cancers. Instead, the Erb-B2 group was not
captured by a single cluster by the AP. It is important to note that in their work, Perou and
colleagues assigned three samples to the ER negative group without specifying which of
the four subgroups they are part of.
AP CLUSTERS
PREVIOUS
1 2 3 4
Basal 8 0 0 0
WORK’S Erb-B2 3 2 1 1
CLUSTERS
Normal 0 11 0 0
Luminal 7 3 16 10
Table 6.5: The distribution of subjects between new and old classification (Perou et al.
data)
Finally, when Perou et al. dataset was divided in six clusters it was found what is
reported in Table 6.6. Also with this classification in six groups, the basal-like patients
were assigned to Cluster 1. Instead the Normal ones were divided in Clusters 2 and 5.
Clusters 3, 4 and 6 seemed to be three Luminal groups. Moreover, the Erb-B2 group was
not captured by a single cluster by the AP.
AP CLUSTERS
PREVIOUS
1 2 3 4 5 6
Basal 7 0 0 0 1 0
WORK’S Erb-B2 2 2 0 1 0 2
CLUSTERS
Normal 0 5 0 0 6 0
Luminal 2 2 15 10 1 6
Table 6.6: The distribution of subjects between new and old classification (Perou et al.
data)
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AP CLUSTERS
PREVIOUS 1 2
WORK’S ER positive 64 11
CLUSTERS ER negative 5 37
Table 6.7: The distribution of subjects between new and old classification (van’t Veer et
al. data)
van’t Veer et al. breast cancer data
In the work of van’t Veer et al. [170], an unsupervised hierarchical clustering algo-
rithm allow the authors to cluster 117 tumours on the basis of thousands of genes. For
clustering, the ‘one minus correlation’ distance was used by the authors as described in
the Supplementary Information for [170]. In this way two subgroups of breast cancer
were detected, differing in ER status (ER-positive and ER-negative) and lymphocytic in-
filtration (see Figure 1a in [170]).
In this dataset, 293 genes had missing information for all 117 patients. These genes
were excluded for the analysis. Other missing values were detected in the remaining data
and, as done for the Perou et al. data, they were imputed with k-NN algorithm. In this
way, the data matrix had 117 tumours and 24188 genes of log ratio of the intensities of
the red and green channels.
Over van’t Veer et al. dataset, the affinity propagation algorithm was applied in order
to verify the two ER groups, obtaining the plot in Figure 6.13 showing the effect of the
value of preference on the number of clusters. From this plot, looking at the plateaus,
solutions with two, three, five, six and seven clusters were suggested. It is worth noting
that AP was not able to indicate a solution with four clusters but one in six groups was
evident in accordance with results previously obtained with the Perou et al. data.
When considering two clusters a very good concordance with the two groups obtained
separating the ER positive and ER negative patients could be seen. In fact, just 16 over
117 cases did not show such a correspondence (see Table 6.7).
As reported in Table 6.8, the split in three clusters is nothing more than a subdivision
of the previously determined cluster 1 into two subgroups.
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Figure 6.13: The effect of the value of input preference on the number of clusters for the
van’t Veer et al. data
AP CLUSTERS
PREVIOUS 1 2 3
WORK’S ER positive 30 35 10
CLUSTERS ER negative 1 4 37
Table 6.8: The distribution of subjects between new and old classification (van’t Veer et
al. data)
Nottingham breast cancer data
On the same data described in [1], where a hierarchical algorithm was used to classify
patients in six different groups, the AP technique was applied and a plot of the effect
of preference value on the number of cluster is reported in Figure 6.14. Looking at the
plateaus, several solutions were proposed, dividing the dataset in two, three, four, five, six
and eight clusters.
The solution with two clusters corresponded to the well known grouping of breast can-
cer in ER positive and negative tumours [137]. From the boxplots reported in Figure 6.15
this distinction is very well marked.
The solution with three clusters was very similar to the previous one, with a simple
subdivision into two subgroups of the ER positive cluster.
The most interesting solution, in terms of comparison with the original work, was the
one obtained using a preference value to get six clusters. The original groups determined
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Figure 6.14: The effect of the value of input preference on the number of clusters fo the
Abd El-Rehim et al. data
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Figure 6.15: Boxplots of ER and PgR in AP clusters
in [1] can be described as two luminal and ER positive groups, two HER2 positive groups,
which show differences in MUC1 and E-cadherin expressions, and a strong basal epithe-
lial cluster. The last group, which contains only four patients, appears to be characterised
by a basal phenotype with high p53. The distribution of patients assigned to the six clus-
ters by AP and by the original hierarchical clustering is reported in Table 6.9. Labels to
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the AP groups were assigned resorting to the weighted kappa index for the agreement
between classifications [30] and the ordering for which the highest index was obtained
was considered (weighted kappa = 0.302). Although there is not a good agreement be-
tween the two classifications, a couple of AP groups can also be described in terms of the
original work. In particular, AP cluster 1 and 2 seem to express luminal characteristics,
while AP group 5 appears to be a basal group.
AP CLUSTERS
1 2 3 4 5 6
PREVIOUS
Luminal A 140 54 4 126 0 12
Luminal B 58 113 3 5 1 0
WORK’S HER2 / MUC1- 38 10 40 24 5 22
CLUSTERS
Basal 1 0 0 2 0 0 2
Basal 2 2 22 59 0 94 6
HER2 / MUC1+ 28 78 31 27 2 68
Table 6.9: The distributions of subjects between new and old classifications (Abd El-
Rehim et al. data)
On a more detailed analysis, the following results emerged. From Table 6.9, it is
possible to see that also AP cluster 3 seems to express basal characteristics. Plotting
the distributions of the main markers for patients assigned to groups 3 and 5 by AP, the
Figure 6.16 is obtained. From this plot it is evident that the main difference between these
two groups is the under/over expression of the p53 marker. These two groups seem to
express characteristics which are typical of triple-negative patients. Considering only this
subset of patients, it could be found that the 91% of them was assigned to either cluster 3
or cluster 5. These results once again confirm what it was recently found about p53 and
triple negative patients (see Section 4.7 for details).
When using a preference value to get 4 AP groups, the distribution of patients was
compared with the one obtained by the application of the PAM algorithm in the analysis
described in Chapter 2 of this thesis. This comparison was chosen because, for the data
analysed, PAM was the technique that produced the most stable and separated clusters,
and for which there was an overall agreement between all the computed validity indices on
the number of groups to consider. Results of this comparison are reported in Table 6.10.
The overall agreement between the two classifications was once again calculated using
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Figure 6.16: Boxplots of main markers for AP clusters 3 and 5
AP CLUSTERS
1 2 3 4
PAM
1 196 133 52 1
CLUSTERS
2 37 254 24 9
3 26 2 108 17
4 30 8 58 121
Table 6.10: The distributions of subjects between new classification and PAM grouping
(Abd El-Rehim et al. data)
the weighted kappa index, which in this case had a score of 0.56.
When using preference values for AP to obtain five and eight clusters, the groups that
emerged were simply subdivisions of previously obtained groups.
6.3.3 Evaluation of CPU time
The affinity propagation algorithm is a novel approach also for what concerns the
choice of the appropriate number of clusters. Rather than iterating the method using each
time a different number of groups, the AP can be run iterating on the values of preference.
However, these different approaches are also reflected on their time complexities. In
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order to evaluate whether AP should or should not be included in the proposed framework
for the identification of representative groups in a generic dataset (described in the next
chapter), a comparison of the CPU time requested to perform both AP and K-means on
the ‘Nottingham dataset’ was carried out.
To perform the experiments, the dataset of 25 biomarkers available for 1076 patients
presented in [1] was used. The analysis consisted of several steps: at each of these,
a bigger amount of data was considered, starting from 100 patients (randomly selected
from the whole dataset) and increasing the size by adding 100 more patients (always
selected at random from the remaining ones) at each step. The whole process terminated
with the whole data being analysed. During each of these steps, data was clustered using
K-means and AP. The former algorithm was run with the number of clusters varying from
two to twenty, while AP using different preference values in order to get the same range
of groups. The CPU time needed for each run was recorded and the average value then
considered for the comparison. It is important to note that, the CPU time requested by
AP was only compared with that of K-means because, as shown in Figure 6.17, the CPU
times for K-means and PAM were quite similar. Results are shown in Figure 6.18, from
which it can be seen how the CPU time needed for AP seems to follow an exponential
behaviour, compared to a more linear one associated with the K-means. Based on this
result, it was decided not to consider the AP algorithm in the proposed framework for
elucidating core classes in a dataset.
The interesting outcome shown by Figure 6.18 is in contrast with the claim made by
Frey and Dueck in [60], where the affinity propagation technique is described as feasible
for large data sets and faster than hundreds of runs of the K-means method. The difference
between the results shown in Figure 6.18 and those reported by Frey and Dueck in their
original paper [60] may be due to the size of the data used not being big enough. However,
the choice of not including the AP in the proposed framework was taken only considering
its effective speed on the problem under investigation.
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Figure 6.17: Comparison of CPU time between K-means and PAM
Figure 6.18: Comparison of CPU time between AP and K-means
6.3.4 Discussion of results
Cluster analysis is a powerful technique to explore complex diseases and improve
prognosis. The recent literature on omic data is rich of new methods of cluster analysis
able to deal with huge datasets. Moreover techniques of visualisations are usually adopted
to suggest the number of clusters [47]. At the same time many papers warn against the
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possible misuse of clustering techniques [70]. One of the main problems is the subjectiv-
ity of the analysis and the ability of clustering algorithms to create clusters even in absence
of real structure. The choice of the number of clusters is one of the main problems to be
faced when applying this kind of analysis. The possibility to use algorithms that incor-
porate a criterion for the choice of the optimal partition is one of the achievement of the
recent developments in this research field.
The Affinity Propagation algorithm is characterised by a simple software implemen-
tation and it has the ability to suggest the cluster number. In addition, this algorithm has
the advantage of taking into account real data points as exemplars; in this way, also cate-
gorical data may be analysed using, as similarity, a different distance from the Euclidean
one. By looking for a set of exemplars, and not for a set of centroids, the search space is
restricted, improving the computational efficiency of the Affinity Propagation.
The range of the suggested solutions reported in this chapter gives insights in the hier-
archical structure of the data highlighting different levels of information for the treatment
of cancer patients well in accordance with previous knowledge. For example, the solution
with two clusters for Ferrara breast cancer data, evidenced in Figure 6.3, reflects the well
known separation between tumours ER positive and negatives, as shown in Figure 6.4.
This is a very important distinction and, in fact, in a number of papers of the pre-genomic
era the number of clusters considered was in fact two [124, 140]. The solution with four
clusters is in agreement with the solution selected in the previous work and the four clus-
ters obtained are similar to that created by the PAM algorithm in [5]. The clustering
obtained by AP on the melanoma data is able to reproduce the interesting findings of Bit-
tner and colleagues having the advantage of avoiding any arbitrary choice due to the visual
inspection of the dendrogram. Over Perou et al. the AP could almost reproduce previ-
ous classification: the basal-like tumours were captures by Cluster 1, and the normal-like
ones were assigned to Cluster 2; Clusters 3 and 4 represent the luminal-epithelial tumours,
while the Erb-B2 group was not identified by AP in a single cluster. The solution with two
clusters for van’t Veer et al. data reflects with a few number of exceptions, the separation
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between ER+ and ER- groups evidenced in the original work. Finally, when considering
Nottingham dataset, AP identified six groups as in the original work [1], and, in addition,
reproduced the very important distinction within triple-negative patients. Two subgroups
were identified, one over-expressing the p53 marker and the other being characterised by
its absence.
The Affinity Propagation algorithm is claimed to be faster and more reliable than the
K-means [60] when considering large data sets such as thousands of segments of DNA.
For the problems under investigation in this study, however, this last assumption was
not confirmed. As shown in Figure 6.18, the CPU time requested by the AP follows an
exponential behaviour when increasing the problem size. K-means, instead, seems to
have a linear trend.
6.4 Summary
In this chapter the Affinity Propagation clustering technique was described and its ap-
plication over several known cancer data sets was presented to investigate the reliability
of the algorithm in order to evaluate whether to include it in the proposed guideline for
the elucidation of core classes. AP results were compared with those obtained with tradi-
tional algorithms. For two case studies the APmethod suggested novel possible groupings
which were not studied yet and that represent very interesting directions for future inves-
tigation. Moreover, it would be interesting to characterise the AP groups also in terms
of clinical outcome and response to treatments. The computational complexity of the AP
was also considered in this chapter and a comparison of the CPU times required for the
AP and K-means computations over the ‘Nottingham dataset’ was reported. It was found
that, for the problem under investigation, the AP algorithm required more CPU time. For
this reason, this model-based technique was not included in the proposed framework for
core classes elucidation.
The next chapter presents a step-by-step guideline to identify representing core classes
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within any kind of data. By the application of different clustering techniques and using
a consensus among the resulting groups a set of characteristic classes may be defined.
These core patterns can be described using several statistical approaches and resorting to
visualisation techniques and may be validated utilising different supervised algorithms.
Chapter 7
A Framework to Elucidate Core Classes
in a Dataset
This chapter will provide a proposed algorithmic framework for elucidating a set of
core groups in a general case study dataset. This proposed strategy will be explained in
detail and validated over a novel set of breast cancer histone markers provided by the
Division of Molecular and Cellular Sciences, Centre for Biomolecular Sciences, School
of Pharmacy at the University of Nottingham.
7.1 Background and motivation
Clustering for real world problems and case studies has become a widely used ap-
proach to extrapolate important information from data and to separate different groups
that share similar characteristics within them. Cluster analysis may be thought of as
the discovery of distinct and non-overlapping sub-partitions within a larger population
[130]. Different clustering techniques are known today, but, especially in breast can-
cer studies, researchers tend to focus on a single algorithm, usually the hierarchical
one [137, 158, 159, 161, 170]. Choosing which method to use is not an easy task, as
different clustering techniques return different groupings. When using more than one
algorithm, it is then common to define a consensus across the results [98] in order to
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integrate diverse sources of similarly clustered data [57].
At the same time, supervised classification techniques are widely used to learn a clas-
sification rule from a set of labeled cases (called the training set) to label new cases in
a test set. Many different supervised classification methods have been developed in re-
cent years, such as Neural Networks, Classification Trees, Bayesian Classifiers and many
more.
Using machine learning algorithms and following similar approaches used in the past,
a guideline to elucidate core classes in a general dataset was developed, in order to de-
termine the fundamental characteristics of data expressed by different groups. At the
beginning of this step-by-step guide, different clustering algorithms are applied and thro-
ugh a consensus clustering a set of common classes is defined. These core groups are then
assessed using supervised classification techniques. In the next section this algorithmic
framework is presented in detail and it will then be validated over a novel dataset.
7.2 Strategy
The proposed framework needs several input sets of methods and parameters, and it
is formed by different steps which will be described below. The framework F has the
following input arguments:
• The dataset under investigation Ω.
• The set of preliminary data analysis techniques and pre-processing algorithms P.
• The collection of several clustering techniques C which may be applied.
• The collection V of several validity indices which may be used to assess the group-
ing returned by cluster analysis.
• The set K of concordance measures (like kappa or rand indexes).
• The collection B of visualisation techniques to characterise the groupings.
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• The set of several supervised learning techniques S.
• The statistical coefficient a to assess the association between groups and variables
of interest.
Therefore, in its most general parameterisation, the framework may be written as
F(Ω, P, C, V, K, B, S, a).
An organisation chart showing the overall approach and the logical steps used in this
proposed pipeline is reported in Figure 7.1. Following this structure, each step of the
framework is now presented.
1. In the first step, data preprocessing is performed. Rows which contain entries with
missing values have to be deleted in order to run the clustering algorithms, and vari-
ables need to be ‘homogeneous’, which means that it is not convenient to have both
numerical and categorical entries as part of the same variable distribution. If this
happens, then clustering techniques may group together all numerical instances in
one cluster and the categorical ones in another group, without emphasising other
possible structures within the dataset. In this ‘data preprocessing’ step, several de-
scriptive statistics (minimum, maximum, mean, median, quartiles, etc.) need to be
checked as well, in order to have a complete picture of the data under investigation
and to immediately spot any inconsistencies within them.
2. The second step is about clustering. Various unsupervised classification algorithms
may be applied. In this work, four techniques are proposed to categorise cases into
groups, namely the hierarchical (HCA), K-means (KM), Fuzzy C-means (FCM)
and Partitioning Around Medoids (PAM). Given that K-means method is sensitive
to cluster initialisation and in order to obtain reproducible results, this technique is
initialised with the cluster assignments obtained by hierarchical clustering. All of
the above techniques have been previously analysed and used (see Chapters 2 and
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Figure 7.1: Organisation chart of the proposed framework
4 for details). This does not mean that these four are the best techniques to use, but
they are among the most widely used clustering methods in machine learning and
data mining. It is however a matter of fact that they performed quite well on the
problems that were previously considered in this study.
3. In this step, validity indices are applied to clustering results. If the number of
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clusters is not known before starting the analysis it is often convenient to resort
to some external validation criteria. Several validity indices have been proposed
in literature, but in this framework only six have been considered. The indices of
Calinski and Harabasz [20], Hartigan [77], Scott and Symons [154], Marriot [118]
and the two proposed by Friedman and Rubin [61] are used. According to specific
rules, they indicate the appropriate number of groups to consider in the analysis.
When indices indicate different numbers, it is possible to use them to rank in order
the suggested groupings and then take the minimum sum of ranks as a form of
agreement between indices.
4. When clusters are returned, a general characterisation of them can be obtained thro-
ugh visualisation techniques. Biplots, which are built considering the first two prin-
cipal components and representing clusters projected on them, are a useful tool.
This principal component (PC) technique is also used to reduce the dimensionality
of a problem, as PCs account for as much of the variability in the data as possible.
Another used technique for visualisation is the boxplot. It shows the distribution of
each variable, computing its median value and lower and upper quartiles. Through
the computation of the boxplots of all variables divided by clusters and using the
biplots as well, it is possible to obtain a first ‘informal’ description of the group-
ing obtained by the clustering techniques. In addition, the agreement between the
classifications obtained by different algorithms is, in this guideline, assessed either
using the Cohen’s kappa (κ) and weighted kappa (κw) indices [30, 31], or the Rand
and adjusted Rand indices [85, 146], which also take into account the agreement
occurred or corrected by chance. For the weighted-kappa index, weights are set
in decreasing order from one (perfect agreement) to zero (complete disagreement)
and all levels disagreement between raters are weighted according to their distance
from perfect agreement. In any case, the length of the vector of weights must equal
the number of rating categories. The adjusted Rand index corrects for the expected
value of the Rand index of two random partitions not taking a constant value [194].
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All these indices also give an indication about how likely will be to get a good
consensus between classifications.
5. The following step reported in Figure 7.1 is related to classes definition. This is
done via a consensus clustering which may be performed in several ways. In this
proposed framework, the classifications obtained by different clustering algorithm
are used and, looking at the biplots, the cluster labels are aligned in order to have the
same patient assigned to the cluster named in the same way by different algorithms.
Looking then at the same cluster number / label across all methods, core classes
are defined by taking into consideration those cases assigned to the same group by
different methods. These classes are aimed to include as many instances as possible.
6. To assess and verify the classes defined by the consensus clustering, several su-
pervised classification techniques may be used. Among them, the C4.5 classifier
(C4.5), the MultiLayer Perceptron Artificial Neural Network (MLP-ANN) and the
naive Bayes classifier are considered in this framework. When data do not follow a
normal distribution, the ‘non-parametric’ version of the naive Bayes (presented in
Chapter 5) is used.
7. In the last step, the identified core classes are described resorting again to biplots
and boxplots. When computing the biplots of classes, the ‘not classified’ cases
usually are concentrated in the middle of the region. In addition, the correlation
between classes and particular features of interest is computed resorting to the Phi
(φ) statistics [53].
7.3 Validation over a novel dataset
To validate the approach presented in the previous section, the framework was applied
in the following configuration: (Ω1, P1, C1, V1, K1, B1, S1,φ) where each input set is
now described.
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• Ω1 = particular dataset provided by the School of Pharmacy at the University of
Nottingham.
• P1 = {Missings deletion, descriptive statistics computation}.
• C1 = {KM, PAM}.
• V1 = {The same six validity indices as in Section 4.3.2}.
• K1 = {κ,κw}.
• B1 = {Biplots, boxplots}.
• S1 = {C4.5}.
• φ as the index to assess the association between classes and clinical variables avail-
able.
It is important to note that what follows is still an ongoing work, so not all of the
techniques previously mentioned and reported in Figure 7.1 have been applied yet.
The dataset Ω1 used to validate the proposed approach was a collection of 1254 con-
secutive breast tumours diagnosed from 1986 to 1998 included in the Nottingham Ten-
ovus Primary Breast Carcinoma Series. Full details of the characterisation of the tissue
microarray and the cohort of the patients are described elsewhere [50, 51]. Survival data
were maintained on a prospective basis. Breast cancer specific survival was taken as the
time (in months) from the date of the primary surgical treatment to the time of death from
breast cancer [51]. Grading score was also available in this dataset. Breast cancer tissue
microarrays were prepared as described in [2]. Each case was sampled twice from both
the centre and the periphery of the tumour. Arrays of 150 cases per block were prepared.
Breast cancer tissue microarray slides were prepared and immunohistochemically stained
to detect the five histone markers as described in [1–3, 145]. The histone markers se-
lected for this study were hMOF, SIRT1, H4K16ac, H3K9Me3 and SUV. They all have
different functions: hMOF and SIRT1 are histone acetyltransferase and deacetylases in
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orderly; they are responsible for H4K16ac acetylation. Later in this study, the SIRT1
marker will be dropped from the analysis. H4K16ac is a marker of active gene, while
H3K9Me3 is a marker of silenced gene. Finally, SUV is the main factor responsible for
H3K9 tri-methylation [113].
This collection of data presented many missing values; for the analysis described be-
low, the five histone markers were only considered as well as those patients for which all
the informations were present, thus reducing the number of patients to 301. The basic de-
scriptive statistics like minimum, mean and maximum values for each feature were com-
puted and together with the deletion of all missing values they formed the pre-processing
techniques of the P1 input set.
To assess the grouping, the K-means and PAM algorithms (see Sections 2.1.2 and
2.1.3) were applied with the number of clusters varying between two and twenty (the
number of clusters is an explicit input parameter for both algorithms).
The same set of validity indices described in Section 4.3.2 was used for these experi-
ments, as well as the same decision rules reported in Table 4.3 of the same section. The
values of the indices for both K-means and PAM, for 2 to 20 clusters are shown in Fig-
ure 7.2; (a) shows the validity decision rule values obtained for K-means and (b) shows
those obtained for PAM. The best number of clusters according to each validity index, for
each clustering algorithm, is shown in Table 7.1 This corresponds to either the maximum
or the minimum decision rule value (depending on the index), as indicated by the red
point in Figure 7.2.
Index K-means PAM
Calinski and Harabasz 4 4
Hartigan 4 3
Scott and Symons 4 3
Marriot 4 4
TraceW 4 3
TraceW−1B 4 3
Minimum sum of ranks 4 4
Table 7.1: Optimum number of clusters estimated by each index for K-means and PAM
methods
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Figure 7.2: Cluster validity indices obtained for K-means and PAM clustering, for varying
cluster numbers from 2 to 20
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From Table 7.1 it can be seen that all indices applied to the K-means results suggested
to consider four groups, while such an agreement was not evident in the case of PAM
algorithm. However, resorting once again to the minimum sum of ranks for the indices, it
could be observed that both methods indicated four as the best number of clusters.
To visualise the results, biplots of the clusters were produced, where the same colours
across different methods were used to minimise differences and to aid visualisation. Bi-
plots for the solutions from each algorithm are reported in Figure 7.3. As reported in
Section 4.4.3, the arrows in the plots represent the variables (markers) and their directions
indicate in which group they are more expressed. From these plots, it can be clearly seen
that for both algorithms cluster 3 seems to be characterised by low values of all the five
markers, while cluster 2 appears to contain those patients with high values of covariates.
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(b) PAM clustering
Figure 7.3: Biplots of clusters projected on the first and second principal component axes
To verify the last assumption, boxplots of the markers divided by cluster were pro-
duced and are shown in Figure 7.4. (a) shows the boxplot of the whole dataset, while (b)
and (c) show, respectively, those obtained for K-means and PAM algorithms.
The cluster distributions (number of patients in each cluster) obtained for the K-means
and PAM methods are shown in Table 7.2.
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(c) PAM
Figure 7.4: Boxplots for all markers, whole data and grouped by cluster for K-means and
PAM methods
7.3. Validation over a novel dataset 196
Cluster K-means PAM
1 49 55
2 67 68
3 72 72
4 113 106
Table 7.2: Number of cases in each cluster
The correspondence of patients assigned in the four clusters solution for each of the
methods was then examined. Cohen’s kappa and weighted-kappa indices were computed
to measure the degree of agreement among the two classifications derived by the two
algorithms. Results for kappa and weighted kappa were, respectively, 0.882 and 0.870,
showing a very good agreement between the two techniques used.
Focusing on the cluster correspondences, the aim was to define core classes containing
the biggest possible number of patients. Considering the agreement among the clustering
techniques and looking at those patients assigned to the same group by different methods,
it was found that the sum of the number of patients assigned to the same group was
275 over 301 (91.4%). These results are again reflected in the kappa index values. The
remaining patients (26, equal to the 8.6%) were placed into a ‘not classified’ (NC) group.
As already pointed out for the analysis presented in Chapter 4, it must be stressed that
the derivation of class assignments was made on the basis of the clustering results alone
(which are, obviously, based on the five markers only). The distribution of patients in the
four ‘common’ classes is reported in Table 7.3, together with the rule applied to define
each class.
Class No. of cases
1 (KM1 ∧ PAM1) 44
2 (KM2 ∧ PAM2) 61
3 (KM3 ∧ PAM3) 69
4 (KM4 ∧ PAM4) 101
Total number of cases assigned to classes 1 – 4 275
Total number of cases not classified 26
Table 7.3: Distribution of patients in the ‘common’ classes
7.3. Validation over a novel dataset 197
−0.15 −0.10 −0.05 0.00 0.05 0.10 0.15 0.20
−
0.
10
−
0.
05
0.
00
0.
05
0.
10
0.
15
0.
20
Comp.1
Co
m
p.
2
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
SUV
hMOF
ACH4K16
SIRT1
H3K9Me3
°
°
°
°
°
common n.1
common n.2
common n.3
common n.4
N.C.
(a) For all patients
−0.15 −0.10 −0.05 0.00 0.05 0.10 0.15 0.20
−
0.
10
−
0.
05
0.
00
0.
05
0.
10
0.
15
0.
20
Comp.1
Co
m
p.
2
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
SUV
hMOF
ACH4K16
SIRT1
H3K9Me3
°
°
°
°
common n.1
common n.2
common n.3
common n.4
(b) For only patients in classes 1–4
Figure 7.5: Biplots of classes projected on the first and second principal component axes
Biplots of the four consensus classes were produced and are reported in Figure 7.5,
which provides a visualisation of the classes projected on the first two principal compo-
nents.
Figure 7.5(a) shows the biplot obtained for all patients, in which the cases not assigned
to any class (NC) have been coloured grey. It can be seen that these fall mainly into the
centre region of the biplot. Figure 7.5(b) shows the biplot obtained for only patients
assigned to classes 1 – 4. The first axis was mainly determined, on the left, by markers
like ACK4H16 and H3K9Me3, while the second one is determined, on the bottom, by
SIRT1 over-expression (although it can be seen from the boxplots that this marker is not
characterising any particular group).
Figure 7.6 shows boxplots of all 5 markers, (a) for all cases, (b) for those cases as-
signed to classes 1 to 4, and (c-f) for each class separately.
By inspection of both the biplots and the boxplots, a ‘manual’ description of each class
could be derived. First of all, it can be noticed that the distribution of SIRT1 remains
almost identical throughout each class, thus suggesting that this marker is not playing
any role in classes definition and characterisation. Then it appears evident that class 3 is
mainly characterised by low expression of ACH4K16 and of H3K9Me3. Compared to
the overall distribution of markers, class 2 seems to express high values for all the five
covariates under investigation.
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Figure 7.6: Boxplot for all markers, whole data and grouped by class
Starting from this consensus/common data, it was investigated whether it was possible
to establish a set of rules to determine in which group a patient is more likely to be
assigned starting from its variables values. To do so, the decision tree classifier C4.5 was
used, in order to get some visual results too. This part of experiments was run using
WEKA software [189]. The data set loaded was only formed by those patients that were
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classified in one of the four groups previously defined, i.e. the 26 NC cases were not
considered, thus leaving 275 instances to analyse. The C4.5 classifier was run ten times
using the 10-fold cross validation option and the accuracy of the obtained classification
was evaluated simply by looking at the percentage of the correctly classified instances
and then averaging over the ten runs. The mean accuracy of C4.5 was 84.73%, such that
233 of the 275 patients were assigned to the proper class. A tree can be drawn from
this classifier, with each node representing a variable and each leaf the class membership
and the number of instances in it. The values reported on the connecting lines are the
decision rules which are applied during the classification process. The tree generated by
C4.5 algorithm is reported in Figure 7.7, where the minimum number of objects per leaf
was left equal to 2 (default value).
Figure 7.7: Decision tree generated by C4.5 for histone data
As it can be seen from Figure 7.7, the tree is very large and quite complicated to
interpret. In such a situation it is possible to prune the tree, running again the algorithm
and setting a higher number for the minimum number of objects per leaf. By doing so,
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and increasing the minimum number to 8, the tree shown in Figure 7.8 was obtained.
Figure 7.8: Decision tree generated by C4.5 for histone data (minimum number of objects
per leaf = 8)
As previously noted, the SIRT1 marker does not play any relevant role in the classes
definition. This is also confirmed by Figure 7.8, in which it can be seen that SIRT1 is not
present as a node of the tree. For this reason, and following the clinical interpretation of
this aspect, the SIRT1 marker was subsequently dropped from the analysis (see below for
details).
As mentioned at the beginning of this section, several items of clinical information
were also available for this study. In particular, the overall survival of patients was con-
sidered, and using the Kaplan-Meier estimator [94] the curves of the predicted survival
against time were produced. The Kaplan-Meier estimator (also known as the product
limit estimator) estimates the survival function from life-time data. In medical research,
it might be used to measure the fraction of patients living for a certain amount of time
after treatment [93]. A plot of the Kaplan-Meier estimate of the survival function is a
series of horizontal steps of declining magnitude which, when a large enough sample is
taken, approaches the true survival function for that population. The value of the survival
function between successive distinct sampled observations is assumed to be constant. For
more technical details about Kaplan-Meier survival estimator see [93, 94].
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The Kaplan-Meier curves obtained for this study are reported in Figure 7.9. It is
important to note that several missing information about survival time and recurrence
were deleted for the curves computation, leaving the total number of patients equal to
254.
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Figure 7.9: Kaplan - Meier curves for months of survival divided by class
The best overall survival is visible for patients grouped in classes 1 and 2, while classes
3 and 4 have the worst one. This somehow reflects what is shown in the boxplots (Fig-
ure 7.6), as class 2 presented high values for almost all the covariates, while class 3 had
the lowest values.
As a last analysis, the association between tumour grade and classes was assessed,
resorting to the Phi (φ) statistics [53]. Grading score is one of the components of the
NPI score (Section 3.1.1 and [64]) and is determined by the Nottingham Grading System
(NGS) which is based on the microscopic evaluation of tumour cells by pathologists [48,
144]. Grading is based on Mitotic Count, Tubule Formation and Nuclear Pleomorphism.
Each of these indices can be scored between 1 and 3, therefore grading has its values in the
range from 3 to 9. However, to simplify and to make grade comparable to other indices,
the final values are scaled back from 1 to 3, according to rules reported in Table 7.4 [24].
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Grade Combined Score
Low Grade (1) 3 – 5
Intermediate Grade (2) 6 – 7
High Grade (3) 8 – 9
Table 7.4: Overall breast cancer grade by summation of all scores
The high grade patients are considered critical and their chances of survival are also poor
[48].
In statistics, the phi coefficient φ is a measure of association for two binary variables.
The phi coefficient is also related to the chi-square statistic for a 2×2 contingency table
φ =
√
χ2
N
where N is the total number of observations. The coefficient has a maximum value of one
and the closer its value to one, the stronger the association between the two variables [53].
The association between grade and the common classes is reported in Table 7.5 (the total
number of patients here is 273, as there were 2 missing information for Grade).
Common classes
1 2 3 4 φ
Low Grade 8 19 7 26
Interm. Grade 11 30 21 20 0.343
High Grade 25 12 40 54
Table 7.5: Common classes distribution in relation to grading score
This table proves what is know from literature. As a matter of fact, it can be seen
that the majority of high grade patients, which are known to have a poor prognosis [48],
are grouped in classes 3 and 4, which, according to the Kaplan-Meier curves reported in
Figure 7.9 are the groups with the worst overall survival.
As previously reported, SIRT1 did not play any role in the classification decision mak-
ing. In accordance with researchers in the School of Pharmacy, after presenting them the
above results, it was agreed to reconsider the whole problem without taking into account
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the SIRT1 marker. In this way, several missing information could also be retrieved, having
now a dataset with 347 patients, 46 more than previously.
The same steps as before were followed to perform the analysis, starting with the
application of unsupervised clustering techniques and the definition of a consensus clus-
tering to end with some correlation analysis. Running the K-means and PAM algorithms
over this new dataset and computing the same set of validity indices as before, the plots
shown in Figure 7.10 were obtained.
As it can be seen, all indices for PAM algorithm indicate three as the best number of
clusters, while there is not such an agreement for the K-means method. The suggested
number of clusters for each index in each method is reported in Table 7.6.
Index K-means PAM
Calinski and Harabasz 14 3
Hartigan 3 3
Scott and Symons 3 3
Marriot 14 3
TraceW 3 3
TraceW−1B 3 3
Minimum sum of ranks 3 3
Table 7.6: Optimum number of clusters estimated by each index for K-means and PAM
methods
Resorting once again to the minimum sum of ranks for the indices, it can be observed
that both methods indicated three as the best number of clusters.
For the visualisation of the results, biplots of the clusters were produced and are re-
ported in Figure 7.11. From these plots, by looking at the overlap between arrows and
circles, it can be seen that for both algorithms cluster 3 (in red) seems to be characterised
by low values of all the four markers, while cluster 2 appears to contain those patients
with high values of covariates.
To verify the last assumption, boxplots of the markers divided by cluster were pro-
duced and are shown in Figure 7.12. (a) shows the boxplot of the K-means groups, while
(b) shows those obtained for the PAM algorithm.
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Figure 7.10: Cluster validity indices obtained for K-means and PAM clustering, for vary-
ing cluster numbers from 2 to 20
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(b) PAM clustering
Figure 7.11: Biplots of clusters projected on the first and second principal component
axes
The cluster distribution (number of patients in each cluster) obtained for the K-means
and PAM methods is reported in Table 7.7.
Cluster K-means PAM
1 144 161
2 105 96
3 98 90
Table 7.7: Number of cases in each cluster
The correspondence of patients assigned in the three clusters solution for each of the
methods was then examined resorting to both the unweighted and weighted kappa index κ.
Results were, respectively, 0.911 and 0.906, showing almost a perfect agreement between
the two techniques used.
Focusing on the cluster correspondences, core classes containing the biggest possible
number of patients were defined. Considering the agreement among the clustering tech-
niques and looking at those patients assigned to the same group by the different methods,
three common classes were found containing the 94.2% of the overall population. In
practice, 20 patients were not assigned to any of these three classes and were placed into
a ‘not classified’ (NC) group. The distribution of patients in the three ‘common’ classes
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Figure 7.12: Boxplots for all markers grouped by cluster for K-means and PAM methods
is reported in Table 7.8, together with the rule applied to define each class.
Biplots of the three consensus classes were produced and are reported in Figure 7.13.
Again, Figure 7.13(a) shows the biplot obtained for all patients, in which the cases not
assigned to any class (NC) have been coloured grey. It can be seen that these fall mainly
into the centre-top region of the biplot. Figure 7.13(b) shows the biplot obtained for only
patients assigned to classes 1 – 3. The first axis was mainly determined, on the left, by
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Class No. of cases
1 (KM1 ∧ PAM1) 143
2 (KM2 ∧ PAM2) 95
3 (KM3 ∧ PAM3) 89
Total number of cases assigned to classes 1 – 3 327
Total number of cases not classified 20
Table 7.8: Distribution of patients in the ‘common’ classes
ACK4H16 and H3K9Me3 markers, while the second one is determined, on the bottom,
by hMOF over-expression.
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(b) For only patients in classes 1 – 3
Figure 7.13: Biplots of classes projected on the first and second principal component axes
Figure 7.14 shows boxplots of all four markers, (a) for those cases assigned to classes
1 to 3, and (b-d) for each class separately.
By visual inspection of both the biplots and the boxplots, a ‘manual’ description of
each class could be derived. It seems quite evident that class 3 is mainly characterised
by low expression of all the four markers. Compared to the overall distribution, class 2
appears to express higher values while class 1 is quite similar, especially with respect to
hMOF and ACH4K16.
Starting from this consensus/common data, it was again investigated whether it was
possible to establish a set of rules to determine in which group a patient is more likely
to be assigned starting from its variables values. To do so, the decision tree classifier
C4.5 was used, running this algorithm in WEKA. The data set loaded was only formed by
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(d) Class 3
Figure 7.14: Boxplot for all markers grouped by class
those patients that were classified in one of the three groups defined above, i.e. the 20 NC
cases were not considered, thus leaving 327 instances to analyse. The C4.5 classifier was
run ten times using the 10-fold cross validation option and the accuracy of the obtained
classification was again evaluated using the percentage of the correctly classified instances
and averaging over the ten runs. The mean accuracy of C4.5 was 90.8%, which means
that 297 of the 327 patients were assigned to the proper class by this classifier. The tree
generated by C4.5 algorithm is reported in Figure 7.15, where the minimum number of
objects per leaf was left equal to 2 (default value). As it can be seen from Figure 7.15, also
this tree is very large and quite complicated to interpret. So it was decided to prune the
tree, running again the algorithm and setting a higher number for the minimum number
of objects per leaf. By doing so, and increasing the minimum number to 8, the tree
shown in Figure 7.16 was obtained. To obtain a smaller tree and simplify the rules for
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Figure 7.15: Decision tree generated by C4.5 for histone data
Figure 7.16: Decision tree generated by C4.5 for histone data (minimum number of ob-
jects per leaf = 8)
classification, a third tree was computed by running the classifier with 16 as the minimum
number of objects per leaf. The result is visible in Figure 7.17. It is important to realise
that, by pruning the tree, the accuracy of the classifier decreases, thus leaving one to
decide whether a simple set of rules or a high accuracy is preferable for the analysis.
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Figure 7.17: Decision tree generated by C4.5 for histone data (minimum number of ob-
jects per leaf = 16)
The same clinical information as before were available for this study. Again, the
attention was focused on the overall survival of patients, and using the Kaplan-Meier
estimator [94] the curves of the predicted survival against time were computed. These
curves are reported in Figure 7.18. It is important to note that several missing information
about survival time and recurrence were deleted for the curves computation, leaving the
total number of patients equal to 319. The best overall survival is visible for patients
grouped in class 2, while classes 1 and 3 have the worst similar survival. Once again,
the class with the highest values of covariates (class 2) appears to have the overall best
survival.
As a last analysis, the association between tumour grade and classes was assessed,
resorting to the Phi (φ) statistics [53]. The association between grade and the common
classes is reported in Table 7.9 (the total number of patients here is 324, as there were 3
missing information for Grade). This table proves once again what is know from litera-
ture. As a matter of fact, it can be seen that the majority of high grade patients, which are
known to have a poor prognosis [48], are grouped in classes 1, which, according to the
Kaplan-Meier curves reported in Figure 7.18 is the group with the worst overall survival.
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Figure 7.18: Kaplan - Meier curves for months of survival divided by class
Common classes
1 2 3 φ
Low Grade 33 31 11
Interm. Grade 35 42 30 0.292
High Grade 73 22 47
Table 7.9: Common classes distribution in relation to grading score
Comparing the results obtained not considering the SIRT1 biomarker with those ob-
tained at the beginning of this study, it can be seen that the three common classes identi-
fied by the consensus clustering on four markers dataset have a clearer definition. In fact
the three groups are somehow characterised by low / intermediate / high markers levels.
Moreover, the agreement between classifications (kappa and weighted kappa indexes) is
higher for the four markers data than for the one with five biomarkers. This in part justifies
the choice of removing SIRT1 from the analysis.
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7.4 Summary
In this chapter a proposed framework for emphasize core classes within a dataset was
presented. It follows a logical scheme in which at the beginning unsupervised clustering
techniques are used to group patients (or any kind of data) in clusters which share similar
characteristics. It is important to use more than a single clustering method, as it has been
proved in literature [5] that different algorithms return different groups and it is not possi-
ble to say which, if it really exists, is the best clustering technique. By a visual inspection
of the results and by using an index to assess the degree of agreement between different
classifications, an informal consensus clustering may be derived, considering those pa-
tients assigned to the same group by different algorithms as ‘in-class’ and labelling all the
others as ‘not classified’. The resulting classes may then be analysed in different ways,
either using again biplots and boxplots, or looking at their relations with other variables
(which, in this study, were several clinical information). In any of those cases, an auto-
mated supervised classification technique may be used to confirm and assess the identified
grouping.
In the second part of the chapter, the proposed approach was validated over a dataset
of histone biomarkers which was provided by the Division of Molecular and Cellular Sci-
ences in the School of Pharmacy of the University of Nottingham. It is important to note
that this work is still in progress and the results obtained so far still need an accurate
interpretation from clinicians and researchers at the Schools of Pharmacy and Molecu-
lar Medical Sciences. However, this study served to present and validate the proposed
procedure, which, so far, has given very promising and encouraging results.
Chapter 8
Conclusions
This thesis focused on the development of advanced computational techniques for
the classification of breast cancer into sub-types of the disease based on protein expres-
sion levels of selected markers. This multi-disciplinary research work aimed to identify
breast cancer profiles with novel clinical relevance and to propose a new computational
framework to elucidate core representative classes in a general dataset. To reach these
objectives, at the beginning of this study different clustering algorithms were applied over
a breast cancer case series to assess the stability of the resulting classification across dif-
ferent methods.
Clustering is the process of grouping a set of unlabelled multidimensional patterns
(objects or data points), such that patterns in the same cluster have the most similar char-
acteristics, and patterns within different clusters have the most dissimilar characteristics.
Cluster analysis is a powerful technique to explore complex diseases and improve prog-
nosis. The recent literature on ‘omic’ data is rich of new methods of cluster analysis able
to deal with huge datasets. Moreover techniques of visualisations are usually adopted to
suggest the number of clusters [47]. At the same time many papers warn against the pos-
sible misuse of clustering techniques [70]. One of the main problems is the subjectivity
of the analysis and the ability of clustering algorithms to create clusters even in absence
of real structure. However, in many studies, clustering techniques have been successfully
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used to emphasise several breast cancer profiles [1, 5, 137, 158, 159, 161, 170].
Using clustering algorithms and a consensus between the resulting classifications, six
diverse groups were identified and their characterisation appeared to be somehow novel.
Two of these classes, in fact, were not emphasised in literature yet. After considering
several supervised learning methods and developing a new algorithm to cope with non-
normality of the data in many real world problems, a framework to highlight and validate
representative core clusters within any kind of data was developed. This proposed guide-
line, together with its application over a novel case study, has been presented in this thesis.
In the next section, the main contributions of this work are reported, followed by
several directions for future research that may be followed to complement this thesis. The
chapter is concluded with the dissemination resulted from this research work.
8.1 Contributions
This work has resulted in the following contributions.
• Comparison of several clustering techniques for breast cancer data.
Hierarchical clustering, K-means, Partitioning Around Medoids, Fuzzy c-means
and Adaptive Resonance Theory were analysed and applied over a novel breast
cancer data set. It does not seem that a systematic comparison of these techniques
on breast cancer has been performed in literature yet. In many works [1, 47, 137,
158, 159, 161, 170], hierarchical algorithm has been used to detect and characterise
breast cancer phenotypes using both gene expression profiles and tissue microarray
approach. One limitation of this technique is its subjectivity in the clusters iden-
tification, since there is not a standard criterion or algorithm for choosing a cutoff
point for a dendrogram produced by the algorithm. Moreover the hierarchical ap-
proach can cause difficulties in assessing the validity of the grouping [70]. From an
opposite point of view, the use of different clustering techniques may lead to a va-
riety of different groupings which can then be either analysed separately or merged
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together in what is called ‘consensus clustering’.
In Chapter 4, experiments based on the techniques mentioned above were reported.
Several validity measures were examined as well, in an attempt to define the best
number of clusters to consider rather than choosing a priori the proper number
of groups. The results obtained were compared to previous work and discussed
resorting to manual and visual characterisations. Six groups were then identified
using a consensus clustering approach. These breast cancer classes appeared to
have significant clinical meaning in terms of response to treatments and difference
in survival rates. It has been observed that patients assigned to three of the six
classes had the best survival, with up to 90% of women surviving at least 10 years.
On the other side, the poorest survival was observed in women with HER2-positive
breast cancer, where 30% died within four years. These six classes also appeared
to be quite novel in literature, as two of them have not been emphasised yet.
This part of the project once again demonstrated the importance of using more
than just a single clustering algorithm in breast cancer studies, as diverse methods
usually produce different groupings. From a clinical perspective, it also served to
move the field of breast tumours analysis from a single-technique approach toward a
multi-technique one. However, the six identified groups could not be termed breast
cancer ‘phenotypes’, as a consistent number of patients presented mixed class char-
acteristics. It is a clear challenge for future work to investigate the proper charac-
teristics of this big group of patients and their proper treatment.
• A ‘non-parametric’ approach for supervised learning.
Supervised classification is a widely use approach in machine learning, and several
different methods have been developed in recent years. One of the main advantages
of supervised classification is that a set of rules is returned.
To validate the breast cancer classes described above and in order to define a model
for future patients classification, three different supervised classifiers were analysed
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and applied to the same data. Results showed a surprising good performance of the
naive Bayes classifier, even though one of its underlying assumptions (the norma-
lity distribution of variables) was strongly violated in the data. To overcome this
limitation, a ‘non-parametric’ approach, similar to the naive Bayes and applicable
independently from the covariates distribution was developed. This newly proposed
algorithm is based on the ratio between areas under histograms representing vari-
ables distributions in each class, and the main decision criterion is related to how
close to the median of a variable distribution in a specific class a particular data-
point is (the closer to the median, the higher the probability of being assigned to
that particular class is). The method was also validated over three different data
sets available from the Machine Learning Repository and results showed a better
accuracy of the novel approach compared to the ones obtained by traditional tech-
niques.
To complete the analysis, a comparison with Logistic Regression approach was
performed, distinguishing between situations where the response variable is bi-
nary/boolean from those where a Multinomial model is needed (response variable
may take more than two values). The technical details of the algorithms used have
been presented in Chapter 5, together with all the results obtained.
• CPU time for Affinity Propagation.
Several model-based algorithms have been proposed (see Section 2.5) in the last few
years, but the most interesting one was the technique developed by Frey and Dueck
called Affinity Propagation [60]. This method combines properties of both model-
based and heuristic approaches to determine the optimal grouping. According to
a more technical point of view, Affinity Propagation can be derived as the sum-
product algorithm in a graphical model describing the mixture model [59]. The
algorithm is claimed to be feasible with large data sets and faster than multiple runs
of K-means [60].
This algorithmwas applied to several different cancer data sets, in particular to cuta-
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neous melanoma and breast cancer case studies. Results confirmed what is already
published in literature, but also gave novel insights, especially for the number of
clusters to consider and for the clinical relevance of particular groups identified in
the breast cancer data provided by the Nottingham City Hospitals. However, when
considering the CPU time needed for the computation of affinity propagation, it was
found that the relationship between the problem size and the CPU time was almost
exponential, while a linear trend was observed for the same relationship for the
K-means method. Based on this results, it was decided to exclude the affinity prop-
agation from the clustering techniques considered in the proposed framework for
the elucidation of core classes. Full details of the results are reported in Chapter 6.
• Framework for classes identification.
One of the objectives of this thesis was to develop an algorithmic framework for the
identification and characterisation of core stable groups in a collection of data (in
order to determine their fundamental characteristics expressed by different groups).
Cluster analysis may be thought as the discovery of distinct and non-overlapping
sub-partitions within a larger population [130]. Using different algorithms and com-
bining the results by a form of consensus clustering, core classes may be defined
and characterised. Through clustering approaches, identifying labels may be as-
signed to objects and then used by supervised classification algorithms to learn
classification rules and label new cases in a test set.
This framework was presented in detail in Chapter 7, but the main structure is as
follows. After pre-processing the data, dealing with all the missing information and
computing the basic descriptive statistics, the application of several unsupervised
clustering techniques was suggested. If the number of clusters is not known prior
to commencing the analysis, many validation criteria are available to assess the
goodness of the partitions obtained and to indicate the best number of groups to
consider. Through biplots and boxplots clusters may be characterised and groups
labels aligned to facilitate the analysis. Indices for the degree of agreement between
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classification may be also computed to verify the results obtained so far and to
have an indication about how likely a consensus between grouping will be. In
the following step clusters are combined together and core classes are defined by
considering only those cases which were assigned to the same group by different
algorithms. Depending on the clustering results, this rule may be lighten by not
considering all the clustering methods. The core classes obtained by this informal
consensus may be again characterised by resorting to biplots and boxplots. To
validate them, supervised classification techniques may be applied. Three different
methods were suggested, which in general perform quite well with large data sets,
with one of those being replaced by another approach developed in this work if
particular hypotheses are not satisfied by the data under investigation.
This algorithmic framework was applied to a novel data set of histone markers pro-
vided by the Division of Molecular and Cellular Sciences in the School of Pharmacy
at the University of Nottingham. Even though it is still a work in progress, the re-
sults obtained so far are very encouraging. The different classifications obtained
by using different clustering methods have a high degree of agreement and the core
classes identified by the consensus properly reflect the main characteristics of the
data. They also appear to have distinct clinical qualities: they differ, indeed, in
terms of survival rates and association with grading scores.
8.2 Potential clinical implications
In addition to the contributions already reported, this thesis and in particular the pro-
posed framework may be also helpful for the development of a personalised breast cancer
care. Nowadays, more and more research is focused on reaching this aim, as it is everyday
more evident that each patient has his/her own requirements and needs specific treatment.
The discover of the six novel breast cancer classes (presented in Chapter 4) may be
helpful for the future when a new patient may present to the hospital with the disease.
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By analysing the results of the first biological tests and relate them with the principal
characteristics of the six groups, it might be possible to categorise this new patient in a
specific class. Then, the most powerful treatment could be directly given, thus reducing
the pain for the patient and the clinical costs.
Moreover, as the proposed framework is aimed to be applicable to any kind of prob-
lem, it might be useful to train a small number of clinicians so that they can directly use
the framework and find different possible categories of the disease they are investigating.
8.3 Future work
Several directions of research may be followed for further improvements of this thesis
work. Some of them are reported below, including those which are currently being carried
out.
Clustering algorithms
For cluster analysis, several unsupervised methods were used in this study to enhance
groups in breast cancer data. Different methods have their own advantages and disad-
vantages for specific clustering criteria. Therefore, it may be useful to investigate the
combination of other clustering algorithms, which may have different optimisation crite-
ria. Model-based or density-based clustering algorithms could be examined, instead of
hierarchical and partitional methods. As already highlighted in this thesis, different algo-
rithms produce different clusters and a ‘perfect’ technique suitable for any kind of data
has not been developed yet.
Clustering initialisation techniques
For those clustering techniques that do not use actual data points as cluster centres,
the initial set of centroids is of particular importance. Usually a random assignment is
performed at the beginning, thus resulting in minor differences in clustering groupings
in different runs of the same algorithm. In order to reproduce the results, the approach
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followed in this work was to set the initial cluster centres using the first run of a hierar-
chical algorithm. However, various techniques have been proposed for clustering initial-
isation [4] and could be used as a future research. In particular, there is still place for
the investigation of a method which can set ‘the appropriate’ initial cluster centres inde-
pendently from the type of data being studied. This could make the clustering algorithms
working more efficiently and perhaps leading to different and more convincing results for
the fuzzy c-means method applied to the same breast cancer data set.
Distances for clustering approaches
In all clustering techniques used throughout this work the Euclidean distance was used
to measure the separation of data in multi-dimensional space and to represent dissimila-
rities. However, if the shape of clusters is far from being spherical, it may result in an
inappropriate clustering. For this reason, other distance measures and other forms of dis-
similarities may be employed. One minus Pearson correlation, Canberra or Manhattan
distances may be used instead of the Euclidean one.
Validity indices
To assess clustering results and to define the best number of groups to consider in the
analysis, several validity indices were used. As reported in [126, 183] many different va-
lidity indices have been proposed in recent years. For the clustering analysis described in
this work, only six indices, that were already implemented in R, have been used. However,
one direction for future research could be the investigation of different indices or even the
use of clustering algorithms which have an internal criterion to verify the stability of the
returned clusters.
Investigation of ‘not-classified’ patients
By a form of consensus clustering six core breast cancer classes have been defined
in this work. However, as highlighted in Chapter 4, not all the available patients were
classified in one of these six groups. A very important future research will be to define a
proper classification for those patients in order to help doctors give them more accurate
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prognoses, as well as targeting patients with more specialised treatments. This represents
a big challenge for future work, as finding the proper cure for each patient will decrease
hospital costs as well as the patient pain.
Getting new patients
One of the strategies that may be followed to achieve the previous goal might be
to increase the number of available patients. This could be done by retrieving medical
records or by performing again the same biological analyses in order to recover some
missing data. It would be interesting to investigate if it could be feasible to combine
different sources of data by merging studies, from different research groups, in which
data have been collected using very similar protocols.
Different supervised learning
Different supervised classification techniques have been used to verify known group-
ings. Following valuable comments and suggestions raised during conferences presenta-
tions, a direction for future research could be the investigation of support vector machines
as supervised learning. Support vector machines (SVMs) are a set of related supervised
learning methods used for classification and regression. Viewing input data as two sets
of vectors in an n-dimensional space, an SVM will construct a separating hyperplane in
that space, one which maximises the margin between the two data sets. To calculate the
margin, two parallel hyperplanes are constructed, one on each side of the separating hy-
perplane, which are ‘pushed up against’ the two data sets. Intuitively, a good separation
is achieved by the hyperplane that has the largest distance to the neighboring datapoints
of both classes, since in general the larger the margin the lower the generalization error
of the classifier. SVMs were firstly developed by Cortes and Vapnik (1995) for binary
classification [32].
Characterisation of Affinity Propagation groups
As shown in Chapter 6, the Affinity Propagation (AP) algorithm combines properties
of both model-based and heuristic approaches. This method was successfully applied to
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several cancer studies and interesting results, compared with those of original works, were
obtained. As a further investigation, it would be interesting to characterise the AP groups
on the basis of gene expressions and to relate the clinical outcomes of these groups with
the ones obtained by standard techniques in the original papers.
R package for Affinity Propagation algorithm
The Affinity Propagation was recently developed by Frey and Dueck [60]. In the
Supplementary Material on Science website, authors provided the MatLab code (Version
7, Release 14) for the implementation of this deterministic algorithm. As members of
a School of Computer Science there is a particular interest in developing a free R pack-
age for the implementation of Affinity Propagation, as from many parts in the scientific
community this request was raised. At time of writing (November 2009), a first version
working only with small and trivial data sets was developed.
Complete the analysis on histone markers
In this thesis a guideline to detect core classes in a data set was proposed and validated
over a novel case study on histone markers for breast cancer. As already mentioned, this is
still an ongoing work, and the next steps will be concentrated on both technical and clini-
cal aspects. For the former, a tri-dimensional visualisation of classes distribution will be
provided using the first three principal components, in order to verify the compactness of
groups and their separation in 3D space. Concerning the clinical aspect, more information
will be provided by researcher in the School of Pharmacy and the association between the
identified core classes and these further clinical variables will be studied. As the cohort
of patients under investigation is the same for both studies, it would be very interesting
to investigate a possible relation between the six breast cancer classes emphasised by the
consensus methodology described in Chapter 4 and the ones identified in this part of the
work.
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8.4 Dissemination
The research work reported in this thesis has been used in various conference and
journal papers as well as several internal and international talks. What follows is a list
of publications and presentations derived from this work, together with a reference to the
chapter in which the topic is covered.
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